20.11.2012 Views

SILVER BULLETS - Espirito Santo Investment Bank incorporating ...

SILVER BULLETS - Espirito Santo Investment Bank incorporating ...

SILVER BULLETS - Espirito Santo Investment Bank incorporating ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>SILVER</strong> <strong>BULLETS</strong><br />

Q 3 2010


EUROPEAN EQUITY CONTACTS<br />

Aerospace & Defence<br />

Edward Stacey +44 20 7456 9135<br />

<strong>Bank</strong>s<br />

Fiona Swaffield +44 20 7456 1693<br />

Alan Broughton +44 20 3364 6761<br />

Anke Reingen +44 20 7456 1653<br />

Joseph Dickerson +44 20 7426 4228<br />

Robert Noble<br />

Capital Goods<br />

+44 20 3364 6752<br />

Nick Paton +44 20 7456 1190<br />

Rob Virdee<br />

Food & Beverages<br />

+44 20 7426 4222<br />

James Edwardes Jones +44 20 7456 1697<br />

Martin Dolan +44 20 7456 1674<br />

Ved Vyas<br />

Diversified Financials<br />

+44 20 7426 4262<br />

Nitin Arora<br />

General Insurance<br />

+44 20 3364 6786<br />

Joy Ferneyhough +44 20 7456 1670<br />

<strong>Santo</strong>sh Singh<br />

Healthcare<br />

+91 22 4211 0999<br />

Stefan Hamill +44 20 3364 6768<br />

Chirag Talati<br />

Leisure<br />

+44 20 3364 6769<br />

Alistair Macdonald +44 20 7456 9126<br />

Geetanjali Sharma<br />

Media<br />

+44 20 3364 6774<br />

Giasone Salati +44 20 7456 1163<br />

Mark Evans<br />

Real Estate<br />

+44 20 3364 6753<br />

Michael Burt +44 20 3364 6784<br />

Retail<br />

Caroline Gulliver +44 20 7456 9173<br />

Richard Cathcart +44 20 7456 9155<br />

Rob Evans +44 20 7426 4210<br />

Sanjay Vidyarthi<br />

Support Services<br />

+44 20 3364 6788<br />

David Brockton<br />

Technology<br />

+44 20 3364 6780<br />

Arun George +44 20 3364 6783<br />

Vijay Anand<br />

Telecommunications<br />

+44 20 3364 6775<br />

Will Draper +44 20 7456 1694<br />

Andrew Hogley +44 20 7456 1652<br />

Nick Brown<br />

Utilities<br />

+44 20 7456 1669<br />

Lawson Steele +44 20 3364 6771<br />

Andrew Fisher +44 20 3364 6773<br />

Lucas Ocelewicsz +44 20 3364 6772<br />

Sales<br />

Dipesh Patel +44 20 7456 1675<br />

Austin Quick +44 20 7456 1160<br />

Catherine Pitcher +44 20 7456 9134<br />

Chris Wilson +44 20 7456 1685<br />

Derek Buckley +44 20 7456 1149<br />

Duncan Haward +44 20 7456 1148<br />

Iain Whiteley +44 20 7456 1651<br />

James Goldstone +44 20 7456 1681<br />

Jeremy McKeown +44 20 3364 6732<br />

Mileen Rash +44 20 3364 6734<br />

Patrick Mayhew +44 20 7456 9156<br />

Patrick Mortensen +44 20 7456 1147<br />

Vicki Miller +44 20 3364 6737<br />

David Walker (US) +1 203 622 8713<br />

Amy Johnston (US) +1 203 983 3222<br />

Burr Clark (US) +1 617 531 7100<br />

Elena Newman (US) +1 212 843 8810<br />

Jan Halaska (US) +1 617 531 7101<br />

Kevin Steuerer (US) +1 203 983 3232<br />

Laura Burke (US)<br />

Sales Trading Europe<br />

+1 212 843 8811<br />

Garreth Hodgson +44 20 7456 1150<br />

John Moore +44 20 7456 1140<br />

Alistair Thomson +44 20 7456 1690<br />

Andy Leonard +44 20 3364 6731<br />

Chris Haase +44 20 7456 1159<br />

James Lawless +44 20 7456 1125<br />

Laura Mould +44 20 3364 6733<br />

Peter Homan +44 20 7456 1677<br />

Peter Ward +44 20 7456 1145<br />

Richard Archbold +44 20 7456 1666<br />

Russell Clifton +44 20 7456 1680<br />

Chris Davidson (US) +1 203 622 8733<br />

Mike Cahill (US)<br />

Corporate Access<br />

+1 203 983 3224<br />

Danielle Poulain +44 20 7456 1699<br />

Pippa Todd +44 20 7456 9170<br />

Suzanne King +44 20 7456 9175<br />

Marianne Headey +44 20 7426 4263<br />

Derivatives<br />

Nick Tranter +44 20 7426 4255<br />

David Gibbs +44 20 7456 4251<br />

Jim Hoogewerf +44 20 7456 1691<br />

Christophe de la Celle +44 20 3364 6738<br />

Andrew Miller +44 20 7426 4253<br />

Jiban Nath +44 20 7456 1657<br />

Simon Dooley +44 20 7426 4256<br />

Simon West<br />

Portfolio and Electronic Trading<br />

+44 20 7426 4254<br />

Tony Nash +44 20 7456 1156<br />

Ben Johnson +44 20 7456 1655<br />

Nishad Vallonthaiel +44 20 3364 6711


THIRD QUARTER 2010<br />

Q3 Silver Bullets<br />

Load Up with Silver Bullets<br />

For Q3 2010, Execution Noble Silver Bullet Buys are ABB, Aviva,<br />

Cable & Wireless Communications, Centrica, Credit Suisse,<br />

Finmeccanica, H&M, Lloyds <strong>Bank</strong>ing Group, Mitchells & Butlers,<br />

Prysmian, Reed Elsevier, Unilever & Vodafone<br />

Silver Bullet Sells are BBVA, Deutsche Telekom, Electrolux, Home<br />

Retail Group, Reckitt Benckiser, Rolls Royce, RWE and Wolters<br />

Kluwer.<br />

Do look back in anger<br />

Ouch, glad that quarter’s behind us. The second quarter of 2010 started with<br />

increasing acknowledgement of a Southern European sovereign debt crisis and<br />

ended with a shocking drop in US consumer confidence figures and had very few<br />

bright spots in between. Against that background, the 7.7% decline in the key Pan<br />

European benchmark index (SXXP) may not appear that bad but this hides<br />

extreme uncertainty in terms of future momentum and sentiment as evinced by the<br />

drying up of European equity volumes.<br />

Bullets or duds<br />

Nor did we cover ourselves in glory either. Our Silver Bullets portfolio declined by<br />

5%. Sure this was better than the market but given that the portfolio was only 22%<br />

net long, we would have hoped for better. In the second quarter we produced a<br />

negative alpha of 3.5% which is the second poorest excess return since we<br />

instigated Silver Bullets in Q3 2007 – albeit only the fourth time in twelve quarters<br />

we have produced a negative alpha. Our Q2 picks certainly suffered from Greecian<br />

contagion most directly in the case of Hellenic Telecom but also for Axa and BNP.<br />

In hindsight Hellenic Telecom was not our most inspired pick ever and certainly<br />

one which suffered from the choose and hold for the quarter discipline. However to<br />

a certain extent this was counterbalanced by the increased weighting of UK<br />

domiciled stocks where we received a significant performance boost (+1.8% in<br />

total) from the 8% move in the £/€ rate in our € based portfolio.<br />

Q3 2010 – Onwards and upwards<br />

Enough reflection – let’s look forward. This quarter’s picks as ever contain a fair<br />

mix of brand new, retained and re-invigorated calls. Aviva, Lloyds, Cable & Wireless<br />

Communications and Prysmian are retained as Buys. Deutsche Telekom, Home and<br />

Wolters Kluwer are rolled over from last quarter as high conviction Sells. Centrica,<br />

Electrolux, H&M, Finmeccanica, Mitchells & Butlers, RWE and Rolls Royce are all<br />

brand new ideas to Silver Bullets and Reckitt Benckiser makes its first appearance<br />

on the Sell side of the list (good luck James). Overall the portfolio is 24% net long<br />

which is roughly the average position of the portfolio since inception and for the<br />

first time UK calls outweigh those domiciled in continental Europe.<br />

http://www.execution-noble.com<br />

Q3 Silver Bullet Buys<br />

ABB 3<br />

Aviva 5<br />

Cable&Wireless Comms 7<br />

Centrica 9<br />

Credit Suisse 11<br />

Finmeccanica 13<br />

H&M 15<br />

Lloyds <strong>Bank</strong>ing Group 17<br />

Mitchells & Butlers 19<br />

Prysmian 21<br />

Reed Elsevier 23<br />

Unilever 25<br />

Vodafone 27<br />

Q3 Silver Bullet Sells<br />

BBVA 29<br />

Deutsche Telekom 31<br />

Electrolux 33<br />

Home Retail Group 35<br />

Reckitt Benckiser 37<br />

Rolls Royce 39<br />

RWE 41<br />

Wolters Kluwer 43<br />

Page 1 of 44


THIRD QUARTER 2010<br />

Figure 1: Looking back at Q2 performance<br />

(1) Silver Bullet sector relative performance measures stock performance relative to a corresponding net (long or short) investment in the relevant sector index<br />

(2) Silver Bullet market relative performance measures stock and sector performance relative to the move in the market (not adjusted for direction of call)<br />

(3) Silver Bullet portfolio alpha is an amalgamation of individual stock calls relative to a corrresponding position (long or short) in the market<br />

Performance based in € Quarterly Share Price Silver Bullet € Rebased Silver Bullet Sector Silver Bullet Market Silver Bullet Portfolio<br />

Move (local currency) Performance Relative Performance Relative Performance Market Alpha<br />

WPP Buy -7.0% 1.1% 6.5% 8.8% 9.5%<br />

Wolters Kluw er Sell -1.7% 1.7% -3.7% 9.4% -5.6%<br />

Silver Bullets Media 1.4% 6.8% 9.1% 1.4%<br />

Media Sector (SXMP) -5.4% -5.4%<br />

Cable & Wireless Coms Buy 4.3% 13.4% 19.6% 21.1% 22.8%<br />

Hellenic Telecom Buy -32.5% -32.5% -26.4% -24.8% -26.9%<br />

Deutsche Telecom Sell -3.3% 3.3% -2.8% 11.0% -4.0%<br />

Silver Bullets Telecom -5.3% 0.9% 2.4% -2.8%<br />

Telecom Sector (SXKP) -6.2% -6.2%<br />

Aviva Buy -18.6% -11.5% 0.6% -3.8% -4.1%<br />

AXA Buy -23.4% -23.4% -11.3% -15.7% -17.0%<br />

RSA Sell -6.2% -1.9% -14.1% 5.7% -8.9%<br />

Silver Bullets Insurance -12.3% -0.2% -4.6% -10.0%<br />

Insurance Sector (SXIP) -12.1% -12.1%<br />

Enterprise Inns Buy -29.1% -23.0% -19.6% -15.3% -16.5%<br />

DSGI Buy -29.0% -22.9% -19.5% -15.2% -16.5%<br />

Home Retail Sell -20.8% 14.0% 10.6% 21.7% 5.8%<br />

Silver Bullets Retail -10.6% -7.2% -2.9% -8.3%<br />

Retail Sector (SXRP) -3.4% -3.4%<br />

Lloyds <strong>Bank</strong>ing Group Buy -14.4% -7.0% 5.9% 0.7% 0.7%<br />

BNP Paribas Buy -21.2% -21.2% -8.3% -13.5% -14.6%<br />

Santander Sell -11.2% 11.2% -1.7% 18.9% 3.2%<br />

Nordea Sell -8.9% 6.8% -6.1% 14.5% -0.8%<br />

Silver Bullets <strong>Bank</strong>s -2.6% 10.4% 5.1% -2.6%<br />

<strong>Bank</strong>s Sector (SX7P) -12.9% -12.9%<br />

Pernod Ricard Buy 1.8% 1.8% -0.4% 9.5% 10.2%<br />

ABI Buy 6.7% 6.7% 4.5% 14.4% 15.6%<br />

L'Oreal Sell 4.0% -4.0% -1.8% 3.7% -10.9%<br />

Silver Bullets Consumer 1.5% -0.7% 9.2% 4.2%<br />

Consumer Sector (SX3P) 2.2% 2.2%<br />

Prysmian Buy -18.6% -18.6% 8.9% -10.9% -11.8%<br />

Qinetiq Buy -12.6% -5.0% 22.5% 2.7% 2.9%<br />

BAE Systems Sell -16.1% 8.9% -18.7% 16.5% 1.1%<br />

Silver Bullets Industrials -4.9% 22.6% 2.8% -2.4%<br />

Industrials Sector (SXNP) -27.5% -27.5%<br />

Suez Environment Buy -20.2% -20.2% -6.7% -12.5% -13.5%<br />

Silver Bullets Utilities -20.2% -6.7% -12.5% -13.5%<br />

Utilities Sector (SX6P) -13.5% -13.5%<br />

Silver Bullets Portfolio -6.8% -5.0% 2.7% -3.5%<br />

Market (SXXP) -7.7%<br />

Source: ExecutionNoble<br />

Figure 2: Indexed Performance and Benchmarks<br />

120<br />

110<br />

7 100<br />

0<br />

2<br />

e 90<br />

n<br />

u<br />

J<br />

to 80<br />

d<br />

e<br />

x<br />

e<br />

d 70<br />

In<br />

s<br />

rn<br />

60<br />

tu<br />

e<br />

R<br />

50<br />

40<br />

30<br />

Q2<br />

2007<br />

Source: ExecutionNoble<br />

Silver Bullets Absolute Performance<br />

Credit Suisse/Tremont Equity long/short (€)<br />

SXXP Index<br />

Q3<br />

2007<br />

Q4<br />

2007<br />

Q1<br />

2008<br />

Q2<br />

2008<br />

Q3<br />

2008<br />

Q4<br />

2008<br />

Q1<br />

2009<br />

Q2<br />

2009<br />

Q3<br />

2009<br />

Q4<br />

2009<br />

Q1<br />

2010<br />

Q2<br />

2010<br />

http://www.execution-noble.com<br />

Page 2 of 44


THIRD QUARTER 2010<br />

ABB<br />

Right end markets, wrong valuation<br />

We do not believe ABB’s valuation reflects the recovery that its core<br />

Power market is currently experiencing. It is one of the highest<br />

quality franchises in the European Capital Goods sector having<br />

leading positions in both Transmission and Distribution (T&D) and<br />

Industrial Automation. Fears over Chinese competition for its<br />

products are subsiding now, which coupled with the potential for a<br />

beat on restructuring savings could be a catalyst for the stock over<br />

the 2Q results. We reiterate our Buy rating and CHF24 price target.<br />

Transmission and distribution is recovering strongly<br />

In 2010 we estimate ABB’s Power division will generate 53% of group revenues and<br />

61% of group EBIT. Anecdotal evidence that orders have recovered for both<br />

Transmission and Distribution has increased steadily through the quarter and<br />

ABB’s exposure to this business is the highest in the European Capital Goods<br />

sector. We believe ABB is likely to show an orderbook which has recovered<br />

materially in this business and thus 2011 revenues and EBIT will be substantially<br />

improved over 2010 which is suffering from the trough in orders in 2009.<br />

$5bn still to spend on the acquisition programme<br />

We view CEO Hogan’s restraint in not chasing Emerson’s bid for Chloride as<br />

positive news – it was neither a game-changing or must-do acquisition in our view<br />

and will not impact ABB’s ability to compete in its core end markets. Ventyx,<br />

however, has the potential to be a transformational deal and despite the high price<br />

at 3.3x 2011E EV/Sales and around 30x 2011E EV/EBITA, we see it as positive. The<br />

potential for this business to generate revenues within the structure of ABB and<br />

the potential of the smartgrid industry warrants the high price. The acquisition of<br />

ABB’s Indian minorities was strategically and economically smart in our view. At<br />

0.6x 2011E EV/Sales and 7.5x 2011E EV/EBITA it was a relatively inexpensive way<br />

to get greater exposure to a high-growth market and with low risk. Investors are<br />

cautious on ABB’s execution of its acquisition programme but we believe this is<br />

somewhat unfair (particularly in light of the Chloride withdrawal) and that any<br />

future acquisitions may be taken more positively.<br />

Restructuring programme could positively surprise<br />

ABB has a target to generate $1.5bn incremental cost savings to achieve the total<br />

savings for the whole programme of $3.0bn. This would imply a run-rate of<br />

$375mn per quarter that ABB missed 1Q10, generating only $325mn. We believe<br />

the company will catch up in the 2Q and that this will be taken positively by the<br />

market. Savings for such programmes are inherently lumpy due to the timing of<br />

reductions in the workforce. While the short-cycle companies see the benefit of<br />

the restructuring taken during 2009 in their valuations, the same cannot be said of<br />

the long-cycle companies. The dramatic order falls late 2008 and 2009, translate<br />

into revenue contraction and falling margins due to the operational gearing, which<br />

has masked the impact from restructuring at the long-cycle companies we believe.<br />

Valuation: At an all-time low sector-relative<br />

ABB has historically enjoyed a 10-15% premium to the European Capital Goods<br />

sector on 12-month forward EV/EBITA but is now trading on a >15% discount to<br />

the sector. Its FCF yield at 8.1% is above the sector average 7.0x and the likelihood<br />

of earnings upgrades from this point is high. We ascribe a 10.0x 2011E EV/EBITA<br />

multiple to ABB on which we find CHF24 fair value, which is our target price. ABB<br />

has not rested at such a large discount to the European Capital Goods sector since<br />

the (long since resolved) asbestos issues of 2000-2002. We reiterate our Buy<br />

rating.<br />

http://www.execution-noble.com<br />

BUY<br />

23% upside<br />

Fair Value CHF 24<br />

RIC, Bloomberg Code ABB.VX, ABBN VX<br />

Share Price CHF 19<br />

Market Capitalisation $40,795m<br />

Free Float 100%<br />

$m 2009 2010E 2011E 2012E<br />

Sales 31,795 32,280 34,707 35,839<br />

Adjusted EBITA 4,157 3,425 4,509 4,642<br />

Adjusted EPS 1.35 1.03 1.38 1.44<br />

Dividend 0.51 0.39 0.52 0.55<br />

FCF* 3,549 1,540 3,237 3,263<br />

EV Adjustments** 4,528 3,740 4,849 5,021<br />

Net Debt / (Cash) -7,219 -7,684 -10,086 -12,239<br />

* FCF = EBITDA - capex - NWC - int ex. - tax<br />

** Pension, Tax, Equity and non-consolidated assets<br />

X (unless stated) 2009 2010E 2011E 2012E<br />

EV/Sales 1.1 1.1 1.0 0.9<br />

EV/EBITA Adjusted 8.3 10.8 7.9 7.2<br />

P/E Adjusted 12.8 18.1 13.5 13.0<br />

Dividend Yield (%) 2.7% 2.0% 2.7% 2.9%<br />

FCF Yield (%) 9.5% 3.8% 7.9% 8.0%<br />

Net Debt/EBITDA -1.5 -1.8 -1.9 -2.2<br />

Analysts<br />

Nick Paton, CFA<br />

+44 20 7456 1190<br />

nick.paton@execution-noble.com<br />

Rob Virdee<br />

+44 20 7456 9222<br />

rob.virdee@execution-noble.com<br />

Page 3 of 44


THIRD QUARTER 2010<br />

ABB<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: BUY Execution P/E 16.3 13.1 18.4 13.7 13.2<br />

Fair Value: 24 Reported P/E 16.3 13.1 18.4 13.7 13.2<br />

EV / Sales 1.4 1.1 1.1 1.0 0.9<br />

Share Price: CHF 24 EV / Ex. EBITDA 9.3 7.2 8.5 6.6 6.1<br />

Upside / Downside -1.8% EV / Ex. EBITA 10.6 8.3 10.7 7.8 7.2<br />

FCF Yield 6.8% 9.5% 3.8% 8.0% 8.1%<br />

Previous Fair Value CHF 24 Dividend yield 2.0% 2.1% 1.6% 2.2% 2.3%<br />

% change to fair value -1.8%<br />

Bloomberg: ABBN VX Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: ABB.VX<br />

Model Published On: 02 July 2010 Ex. EBITDA margin 15.0% 15.1% 13.4% 15.3% 15.3%<br />

Ex. EBITA margin 13.1% 13.1% 10.6% 13.0% 13.0%<br />

Capex / Revenue 3.4% 2.4% 2.7% 2.7% 2.7%<br />

Shares In Issue, mn 2,289.4 Capex / Depreciation -1.77 -1.15 -0.97 -1.16 -1.16<br />

Market Cap 54,946 Net Debt / Ex. EBITDA -1.0 -1.5 -1.8 -1.9 -2.2<br />

Net Debt -10,086 Ex. EBITDA / Net Interest 153.7 -41.8 -363.0 -85.0 -43.5<br />

Adjustment for Minorities 4,661 ROE 28% 21% 15% 17% 16%<br />

Nuclear provisions 155<br />

Unrecognised tax losses/deferred tax assets -867<br />

Power Transformer EU fine 300 P&L Summary 2008 2009 2010E 2011E 2012E<br />

SEC/DoJ Suspect payments fine 300<br />

HV DC Cable fine 300 Revenue 34,912 31,795 32,280 34,707 35,839<br />

Enterprise Value (2011E) 48,810 % change 19.3% -8.9% 1.5% 7.5% 3.3%<br />

Execution EBITDA 5,227 4,812 4,321 5,318 5,477<br />

% change 14.6% -7.9% -10.2% 23.1% 3.0%<br />

Forthcoming Catalysts % margin 15.0% 15.1% 13.4% 15.3% 15.3%<br />

AGM 26 April 2010 Depreciation 661 655 896 810 835<br />

2Q10 results 27 April 2010 Execution EBITA 4,566 4,157 3,425 4,509 4,642<br />

Execution Investor Trip 25 May 2010 % change 15.3% -9.0% -17.6% 31.6% 3.0%<br />

3Q10 results 28 October 2010 % margin 13.1% 13.1% 10.6% 13.0% 13.0%<br />

Execution EBIT 4,566 4,157 3,425 4,509 4,642<br />

Net Financials -34 115 12 63 126<br />

Execution Analyst Other Pre-tax Income 0 0 0 0 0<br />

Nick Paton, CFA Pre Tax Profit 4,518 4,120 3,406 4,540 4,736<br />

(44) 20 7456 1190 Income Tax Expense -1,119 -1,001 -962 -1,282 -1,337<br />

nick.paton@executionlimited.com Minority Interests -260 -235 -194 -259 -270<br />

Net Income 3,139 2,884 2,250 2,999 3,129<br />

Execution Net Income 3,155 2,884 2,250 2,999 3,129<br />

Revenue Breakdown<br />

Reported EPS 1.47 1.38 1.06 1.41 1.47<br />

Execution EPS 1.46 1.35 1.03 1.38 1.44<br />

DPS 0.48 0.51 0.39 0.52 0.55<br />

Payout Ratio 32.6% 37.0% 36.8% 36.8% 37.3%<br />

Shares In Issue (mn) 2,287 2,289 2,289 2,289 2,289<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

Net Income 3,139 2,884 2,250 2,999 3,129<br />

Discontinued operations -21 17 18 18 19<br />

Depreciation & Amortisation 661 655 896 810 835<br />

Change in Working Capital -94 339 -629 -370 -22<br />

EBIT Breakdown Increase in Provisons 720 78 -317 458 0<br />

Other Operating Cash Flow 230 332 194 259 270<br />

Operating cash flow 4,635 4,305 2,412 4,174 4,231<br />

Capital Expenditure -1,171 -756 -872 -937 -968<br />

Free Cash Flow 3,464 3,549 1,540 3,237 3,263<br />

Acquisitions & Disposals -513 -157 0 0 0<br />

Dividends Paid To Shareholders -1,060 -1,027 -1,075 -835 -1,110<br />

Equity Raised / Bought Back -621 0 0 0 0<br />

Other Financing Cash Flow -1,263 -589 0 0 0<br />

Net Cash Flow 7 1,776 465 2,401 2,153<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Margin Trends Cash & Equivalents 7,806 9,552 9,251 10,890 12,239<br />

Margin<br />

18%<br />

16%<br />

14%<br />

12%<br />

10%<br />

8%<br />

6%<br />

4%<br />

2%<br />

0%<br />

Automation<br />

Technology<br />

49%<br />

Automation<br />

Technology<br />

42%<br />

Power Technology<br />

51%<br />

Power Technology<br />

58%<br />

2007 2008 2009 2010E 2011E 2012E<br />

Ex. EBITDA margin Ex. EBIT margin<br />

Tangible Fixed Assets 3,562 4,072 4,048 4,175 4,308<br />

Goodwill & Intangibles 3,228 3,469 3,469 3,469 3,469<br />

Associates & Financial <strong>Investment</strong>s 3,797 3,398 3,398 3,398 3,398<br />

Other Assets 14,788 14,237 15,088 16,570 17,110<br />

Total Assets 33,181 34,728 35,254 38,502 40,524<br />

Interest Bearing Debt 2,363 2,333 1,567 804 0<br />

Other Liabilities 19,048 17,922 17,827 19,397 19,915<br />

Total Liabilities 21,411 20,255 19,394 20,201 19,915<br />

Shareholders' Equity 11,158 13,790 14,983 17,165 19,202<br />

Minority Interests 612 683 877 1,136 1,406<br />

Total Equity 11,770 14,473 15,860 18,301 20,609<br />

Net Debt / (Cash) -5,443 -7,219 -7,684 -10,086 -12,239<br />

http://www.execution-noble.com<br />

Page 4 of 44


THIRD QUARTER 2010<br />

Aviva<br />

Turning the Corner<br />

Technical headwinds from the proposed Prudential rights issue, plus<br />

the macroeconomic uncertainty for the entire sector meant Aviva<br />

underperformed in Q2 as a Silver Bullet. However, we have stuck<br />

with it for Q3 2010 as we believe Q1 results proved our fundamental<br />

thesis on cost savings, sales recovery and margin expansion is on<br />

track and expect full H1 figures on Aug. 5 th to reinforce this.<br />

Furthermore we expect fresh disclosure and increased investor<br />

marketing by new CFO Pat Regan in the coming quarter will provide<br />

further impetus to the buy case.<br />

Prudential Deal Failure Relives Selling Pressure<br />

The collapse of Prudential’s bid for AIA has relieved some of the technical pressure<br />

on Aviva’s share price seen in Q2 as UK investors looked to free up cash to invest<br />

in the proposed $20bn rights issue of the Pru. Furthermore with the uncertainty<br />

this now throws up over the Pru’s management and strategy we would expect<br />

Aviva’s constant strategic message of organic growth focus in the UK and Europe<br />

and delivery of cost savings /restructuring to attract new and old investors back to<br />

the underlying story.<br />

Q1 Sales Figures Ahead of Consensus Bodes well for H1<br />

Despite the difficult share price trading in Q2, the Aviva Q1 trading statement and<br />

conference call was more upbeat on top line experience and outlook than at Q4<br />

and vs Q1 consensus. With two consecutive quarters of double digit sales growth<br />

(+14% Q4, 16% Q1) under their belt, management admitted that the trends “bode<br />

well” for FY10. With new product launches in France, Italy and Ireland, we believe<br />

there is evidence of Aviva looking to target specific market segments rather than<br />

the historic “all things to all people” approach. As such we believe Q2 sales figures<br />

( Aug 5 th ) should show further improvement and given positive comments on costs<br />

at Q1 we expect further progress on restructuring to drive better margins.<br />

Greater Transparency and new CFO to Provide Catalyst<br />

New CFO Pat Regan will meet analysts for the first time on July 2 nd followed by<br />

meetings with key investors. Regan has already stated that one of his key targets is<br />

to improve disclosure at Aviva in order for the market to more easily track cash<br />

flows and life insurance profit drivers and to able to more readily compare these<br />

like for like with European peers. We expect this new transparency will form part of<br />

the H1 results disclosure. The recently announced cash flow target for 2010 of<br />

£1.3bn (a 30% yoy increase) also highlights how internal strategy is increasing its<br />

focus on improving capital efficiency and growing the cash generation within the<br />

firm.<br />

Valuation Attractive; Earnings Momentum Ahead of Peers<br />

Aviva is now trading at 0.9x 2010e TBV despite an operating ROE of 15% and a<br />

dividend yield of 6.5% which is >2x covered. Whilst we expect macro concerns<br />

over the global recovery and the potential for a double dip recession will cause<br />

short term volatility we expect that H1 10 results should underpin Aviva’s positive<br />

fundamental restructuring story. Relative to peers we expect Aviva to show better<br />

earnings momentum with operating earnings growth of +7% for FY10, ahead of<br />

European peers Allianz and RSA and in line only with AXA . This is driven by the<br />

weighting to life and asset management which we believe will continue to recover<br />

in 2010 and 2011. Finally we still believe Aviva could easily achieve a further £200m<br />

of cost saves in 2010e as the European operation consolidates to one holding<br />

company in Dublin. If delivered these £200m cost savings imply a 10% upgrade to<br />

IFRS earnings in 2010e vs. current consensus.<br />

http://www.execution-noble.com<br />

BUY<br />

80% upside<br />

Fair Value 550p<br />

RIC, Bloomberg Code AV.L, AV/ LN<br />

Share Price 306<br />

Market Capitalisation £8,470m<br />

Free Float 95%<br />

£m (unless stated) 2008 2009 x 2010e x 2011e x<br />

Gross Written Premium 36,206 36,594 36,123 36,200<br />

Net Income -885 1,492 1,847 2,227<br />

EPS -36.78 37.86 57.13 68.31<br />

TBV per share 281 268 336 429<br />

Combined ratio 98.4% 98.6% 98.1% 98.2%<br />

<strong>Investment</strong> Yield 4.9% 4.8% 4.6% 4.6%<br />

DPS 33.0p 24.0p 25.0p 27.5p<br />

X (unless stated) 2008 2009 x 2010e x 2011e x<br />

P/E -8.3 8.1 5.4 4.5<br />

P/TBV 1.1 1.1 0.9 0.7<br />

ROE 17.6% 16.4% 16.5% 14.8%<br />

Yield incl. buybacks 10.8% 7.8% 8.2% 9.0%<br />

Premium growth 16.8% 1.1% -1.3% 0.2%<br />

Book Value growth -14.6% -6.3% 18.2% 21.2%<br />

Analysts<br />

Joy Ferneyhough<br />

+44 20 7456 1670<br />

joy.ferneyhough@execution-noble.com<br />

<strong>Santo</strong>sh Singh<br />

+91 22 2570 1152<br />

santosh.singh@execution-noble.com<br />

Page 5 of 44


THIRD QUARTER 2010<br />

Aviva<br />

Valuation Metrics 2008 2009 2010E 2011E<br />

Recommendation: BUY Reported P/E -8.3 8.1 5.3 4.5<br />

Fair Value: GBp 525 Operating P/E 5.3 6.8 6.1 5.4<br />

P/NTA 1.1 1.1 0.9 0.7<br />

Share Price: GBp 305 RONTA -13.1% 14.2% 17.0% 15.9%<br />

Upside / Downside 72.1% Op. RONTA 17.6% 16.4% 16.6% 14.8%<br />

Dividend yield 10.8% 7.9% 8.2% 9.0%<br />

Bloomberg: AV/ LN Buy back yield<br />

Model Published On: 1st April 2010<br />

Key ratios 2008 2009 2010E 2011E<br />

Shares In Issue 2,767 Loss ratio 62.6% 66.7% 66.2% 66.8%<br />

Market Cap 8,439 Expense ratio 35.4% 32.3% 31.8% 31.0%<br />

Free Float 100% Combined ratio 98.2% 99.1% 98.0% 97.8%<br />

Accident year combined ratio 105.7% 102.2% 101.4% 100.5%<br />

Net Tangible Assets 7,399 Running yield on investments 4.9% 4.8% 4.6% 4.6%<br />

NTA per share GBp 267 Reported ROI 1.0% 4.0% 4.5% 4.6%<br />

Investable asset base/NTA 14.2 14.2 11.6 9.5<br />

Dividend payout ratio -90% 63% 44% 40%<br />

Forthcoming Catalysts Ceded Reinsurance ratio 5.1% 5.2% 5.2% 5.2%<br />

Tax rate 21.2% 27.1% 22.0% 22.0%<br />

AGM April 28th 2010 Minority -2.3% 12.7% 15.0% 18.0%<br />

1Q 2010 New Business May 11th 2010<br />

Q2 2010 Results August 5th 2010<br />

Q3 new business 4th November 2010 P&L Summary (GBP m) 2008 2009 2010E 2011E<br />

Gross Written Premium 36,206 36,594 36,123 36,200<br />

Net Written Premium 34,365 34,685 34,241 34,309<br />

Execution Noble Analysts Net Earned Premium 34,642 34,755 34,261 34,319<br />

Joy Ferneyhough Net claims incurred -29,353 -27,890 -28,516 -29,111<br />

(44) 20 7456 1670 Underwriting expenses -8,095 -6,942 -7,073 -7,355<br />

joy.ferneyhough@execution-noble.com Underwriting Result<br />

<strong>Investment</strong> income<br />

Rakshit Ranjan Realised and Unrealised gains<br />

(44) 20 3364 6787 Other income<br />

rakshit.ranjan@execution-noble.com Other expenses<br />

Finance charges -436 -697 -691 -692<br />

Revenue Breakdown Pre Tax Profit -1,300 1,805 2,296 2,734<br />

Income Tax Expense 415 -490 -506 -606<br />

Net Income -885 1,315 1,790 2,128<br />

Diluted EPS -37 38 57 68<br />

Operating EPS 58 45 50 57<br />

DPS 33.0 24.0 25.0 27.5<br />

Growth rates 2008 2009 2010E 2011E<br />

Gross Written Premium 1% -1% 0%<br />

Net Written Premium 1% -1% 0%<br />

Net Earned Premium 0% -1% 0%<br />

<strong>Investment</strong>s Breakdown Net Tangible Assets -1% 25% 28%<br />

Cost of capital, Combined ratio, RONTA trend<br />

Margin<br />

Life<br />

51%<br />

ST<br />

investments<br />

3%<br />

20%<br />

18%<br />

16%<br />

14%<br />

12%<br />

10%<br />

8%<br />

6%<br />

4%<br />

2%<br />

0%<br />

Cash<br />

6%<br />

Loans<br />

19%<br />

Asset<br />

managament<br />

4%<br />

ABS/MBS<br />

7%<br />

Other<br />

8%<br />

P&C<br />

45%<br />

Governments<br />

28%<br />

Corporates<br />

29%<br />

2007 2008 2009 2010E 2011E<br />

Underwriting margin Cost of capital RONTA<br />

EPS -203% 51% 20%<br />

DPS -27% 4% 10%<br />

Balance Sheet Summary (GBPm) 2008 2009 2010E 2011E<br />

Investable asset base 106,035 105,069 107,452 112,905<br />

Goodwill & Intangibles -3,578 -3,381 -3,381 -3,381<br />

Shareholders' Equity 11,052 10,356 12,242 14,837<br />

Net Tangible Assets 7,474 7,399 9,285 11,880<br />

NTA per share 281 267 336 429<br />

Interest Bearing Debt 6,715 6,782 6,782 6,782<br />

Preference shares 200 200 200 200<br />

http://www.execution-noble.com<br />

Page 6 of 44


THIRD QUARTER 2010<br />

Cable&Wireless Communications<br />

Cyclical upside and strong cashflow<br />

CWC Group’s results for the full year 2009/10 were robust, with<br />

many encouraging signs for the year ahead. Foremost amongst these<br />

is the prospect of a cyclical recovery, which appears to be well<br />

established in three of four CWC regions. Our analysis of leading<br />

indicators in these regions suggests that the recovery in tourism,<br />

hotel occupancy, gambling and GDP is continuing, with<br />

improvements in the Caribbean too, and we believe it will act as a<br />

driver of CWC’s FY10/11 results starting with Q1 on 21 st July.<br />

Growing evidence of cyclical upside<br />

A cyclical recovery appears to be well established in Macau, Panama and Monaco &<br />

Islands. Macau has been particularly strong with gaming revenue more than<br />

doubling in the first quarter of 2010 and real GDP growth of 30% y-o-y. CWC’s<br />

other region, the Caribbean, seems to have stabilized and we continue to see<br />

improvements in both GDP growth and the growth of tourist arrivals (see chart<br />

below). We believe this recovery will translate into a better performance for CWC<br />

in the coming months. Even the biggest problem area – Jamaica – has seen<br />

improving GDP growth and tourist arrival trends (the latter up 9% in 1Q 2010).<br />

Figure 1: Growth of tourist arrivals in the Caribbean<br />

Tourist Arrivals (y-o-y growth, %)<br />

40%<br />

30%<br />

20%<br />

10%<br />

0%<br />

-10%<br />

-20%<br />

-30%<br />

-40%<br />

Jan-04<br />

May-04<br />

Sep-04<br />

Jan-05<br />

May-05<br />

Sep-05<br />

Jan-06<br />

May-06<br />

Sep-06<br />

Jan-07<br />

Jamaica Barbados East Caribbean North Caribbean Average<br />

Source: ExecutionNoble, Caribbean Tourism Organisation. Note: East Caribbean excludes St. Kitts & Nevis and North Caribbean<br />

excludes Turks & Caicos compared to CWC's definitions of the regions.<br />

We have not made many allowances for a recovery in our forecasts (1% revenue<br />

growth for FY10/11), recognizing the potential fragility. It could be much better<br />

than this especially if Caribbean swings into recovery. If there was 3% growth in all<br />

the regions for the next couple of years, EPS and FCFE would rise by 10-20%.<br />

Strong cashflow generation supports dividend<br />

Management is making a clear commitment to the dividend, which although being<br />

a “full payout” is covered by strong cashflow generation which will no longer have<br />

to support Cable&Wireless Worldwide. Moreover, the dividend policy has been set<br />

at the “low point” of the company’s cycle. On our forecasts the company will<br />

continue to deliver sufficient cashflow to pay a progressive dividend even without<br />

allowing for any potential cyclical upside.<br />

May-07<br />

Sep-07<br />

Jan-08<br />

May-08<br />

Sep-08<br />

Jan-09<br />

May-09<br />

Sep-09<br />

Jan-10<br />

http://www.execution-noble.com<br />

BUY<br />

29.9% upside<br />

Fair Value £0.75<br />

RIC, Bloomberg Code CWC.L, CWC LN<br />

Share Price £0.58<br />

Market Capitalisation £1.5bn<br />

Free Float 100.0%<br />

GBP m (unless stated) Mar-09 Mar-10 Mar-11 Mar-12<br />

Net revenue 2,447 2,346 2,379 2,380<br />

EBITDA 871 866 881 877<br />

Capex 337 310 350 325<br />

FCF 301 218 368 378<br />

Net Debt 571 664 733 758<br />

EPS (GBP) 0.10 0.12 0.07 0.08<br />

DPS (GBP) 0.15 0.05 0.08 0.08<br />

All financial estimates are "as reported"<br />

DPS includes special dividends<br />

Mar-09 Mar-10 Mar-11 Mar-12<br />

EV / Sales 1.6 1.7 1.7 1.6<br />

EV / EBITDA 4.7 4.8 4.6 4.6<br />

P/E 9.0 6.5 11.1 9.7<br />

FCF Yield (%) 10.7% 7.8% 13.1% 13.5%<br />

FCFE Yield (%) 6.6% 6.3% 12.7% 13.5%<br />

Dividend Yield (%) 17.8% 6.2% 9.5% 9.7%<br />

Net Debt / EBITDA 0.7 0.8 0.8 0.9<br />

All multiples based on underlying financials<br />

Proportionate adjustments made where appropriate<br />

Analysts<br />

Will Draper<br />

+44 20 7456 1694<br />

will.draper@execution-noble.com<br />

Andrew Hogley<br />

+44 20 7456 1652<br />

andrew.hogley@execution-noble.com<br />

Nick Brown<br />

+44 20 7456 1669<br />

nick.brown@execution-noble.com<br />

Page 7 of 44


THIRD QUARTER 2010<br />

CWC Group<br />

Valuation Metrics Mar 08 Mar 09 Mar 10 Mar 11 Mar 12<br />

Recommendation: BUY<br />

Fair Value: GBP 0.75 Execution P/E 13.5 9.0 6.5 11.1 9.7<br />

Reported P/E 9.9 8.5 7.0 11.8 9.9<br />

Share Price: GBP 0.58 EV / Sales 1.1 1.1 1.2 1.2 1.2<br />

Upside / Downside 29.9% EV / EBITDA 5.4 4.7 4.8 4.6 4.6<br />

EV / EBIT 6.2 5.2 6.0 5.7 5.3<br />

Previous Fair Value GBP 0.75 FCF Yield 10.1% 10.7% 7.8% 13.1% 13.5%<br />

% change to fair value 0.0% Dividend yield 17.9% 17.8% 6.2% 9.5% 9.7%<br />

Bloomberg: CWC LN<br />

T-One: CWC-LN Key ratios Mar 08 Mar 09 Mar 10 Mar 11 Mar 12<br />

Model Published On: 01 July 2010<br />

EBITDA margin 31.4% 35.6% 36.9% 37.0% 36.8%<br />

EBIT margin 18.5% 21.8% 19.9% 20.5% 22.2%<br />

Shares In Issue (Less Treasury) 2,544 Capex / Revenue 14.9% 14.7% 12.3% 14.7% 13.7%<br />

Market Cap 2,139 Capex / Depreciation 1.29 1.23 0.84 0.89 0.87<br />

Net Debt 664 Net Debt / EBITDA -0.6 0.7 0.8 0.8 0.9<br />

Adjustments For Associates & Minorities 0 EBITDA / Net Interest 14.9 5.5 10.3 9.1 9.8<br />

Enterprise Value 2,803 ROE 12% 9% 73% 47% 54%<br />

Net Pension Deficit 165<br />

P&L Summary Mar 08 Mar 09 Mar 10 Mar 11 Mar 12<br />

Forthcoming Catalysts<br />

Revenue 2,462 2,447 2,346 2,379 2,380<br />

1Q IMS 21 July 2010 % change 6.6% -0.6% -4.1% 1.4% 0.0%<br />

AGM 21 July 2010 EBITDA 774 871 866 881 877<br />

% change 0.9% 12.5% -0.6% 1.7% -0.5%<br />

% margin 31.4% 35.6% 36.9% 37.0% 36.8%<br />

Depreciation & Amortisation -284 -291 -344 -392 -372<br />

Associates 77 60 30 31 30<br />

EBIT 455 534 468 488 529<br />

% change -2.4% 17.4% -12.4% 4.3% 8.5%<br />

Execution Analyst % margin 18.5% 21.8% 19.9% 20.5% 22.2%<br />

Will Draper Net Financials -52 -159 -84 -97 -89<br />

(44) 20 7456 1694 Other Pre-tax Income 31 19 -1 0 0<br />

will.draper@executionlimited.com Pre Tax Profit 434 394 383 391 440<br />

Income Tax Expense -106 -88 -120 -109 -123<br />

Disconitinued Operations 0 91 180 0 0<br />

Revenue Breakdown Minority Interests -112 -146 -139 -100 -101<br />

Net Income 216 251 304 182 216<br />

Macau<br />

23%<br />

Execution Net Income 158 237 327 193 222<br />

Reported EPS 0.09 0.10 0.12 0.07 0.08<br />

Execution EPS 0.06 0.09 0.13 0.07 0.09<br />

DPS 0.15 0.15 0.05 0.08 0.08<br />

Payout Ratio 171.6% 149.3% 44.4% 113.8% 98.1%<br />

Shares In Issue (Less Treasury) 2,424 2,486 2,544 2,544 2,544<br />

Cash Flow Summary Mar 08 Mar 09 Mar 10 Mar 11 Mar 12<br />

Panama<br />

26%<br />

EBITDA 774 871 866 881 877<br />

Taxes Paid -92 -115 -110 -99 -117<br />

EBITDA Breakdown Interest Paid / Received -52 -159 -105 -97 -89<br />

Change in Working Capital -631 496 -3 -3 2<br />

Margin Trends<br />

Margin<br />

40%<br />

35%<br />

30%<br />

25%<br />

20%<br />

15%<br />

10%<br />

5%<br />

0%<br />

Monaco &<br />

Islands<br />

13%<br />

Monaco &<br />

Islands<br />

16%<br />

Macau<br />

20%<br />

Panama<br />

33%<br />

Caribbean<br />

38%<br />

Caribbean<br />

31%<br />

2008 2009 2010 2011 2012<br />

EBITDA margin EBIT margin<br />

Associate & Minority Dividends 8 -77 -106 -140 -141<br />

Other Operating Cash Flow 708 -380 24 218 225<br />

Operating cash flow 715 636 566 761 755<br />

Capital Expenditure -367 -359 -288 -350 -325<br />

Free Cash Flow 284 301 239 368 378<br />

Acquisitions & Disposals -44 -24 24 0 0<br />

Dividends Paid To Shareholders -277 -258 -268 -207 -205<br />

Equity Raised / Bought Back 24 5 23 0 0<br />

Other Financing Cash Flow -689 259 -107 -230 -199<br />

Net Cash Flow -702 283 -89 -69 -26<br />

Balance Sheet Summary Mar 08 Mar 09 Mar 10 Mar 11 Mar 12<br />

Cash & Equivalents 1,360 790 573 504 479<br />

Tangible Fixed Assets 1,660 2,976 1,725 1,743 1,752<br />

Goodwill & Intangibles 453 1,727 414 1,614 1,558<br />

Associates & Financial <strong>Investment</strong>s 299 327 231 250 275<br />

Other Assets 806 1,707 733 725 717<br />

Total Assets 4,578 7,527 3,676 4,836 4,780<br />

Interest Bearing Debt 873 1,336 1,237 1,140 1,051<br />

Other Liabilities 1,584 3,226 1,578 1,578 1,578<br />

Total Liabilities 2,457 4,562 2,815 2,718 2,629<br />

Shareholders' Equity 1,738 2,650 414 389 399<br />

Minority Interests 383 315 447 270 230<br />

Total Equity 2,121 2,965 861 659 629<br />

Net Debt -487 571 664 733 758<br />

http://www.execution-noble.com<br />

Page 8 of 44


THIRD QUARTER 2010<br />

Centrica<br />

Oasis in the UK<br />

Massive turmoil in Continental European utilities sets the UK<br />

surprisingly apart. Prime within this group is Centrica. We have long<br />

argued that earnings, dividend and cash flow sustainability is key in<br />

these turbulent times. Not only does Centrica offer this, but it also<br />

has sustainable growth - a precious commodity. With multiples in line<br />

with the sector, it is a steal, tripling sector EPS CAGR of 4% 2009-<br />

2013. We think that avoidance of the stock, simply because it is a<br />

consensus long, is misplaced.<br />

Utility sector in turmoil<br />

Many Continental European utility stocks are reeling from political backlash.<br />

Germany shocked the sector with a proposed windfall tax (even the companies did<br />

not see that one coming). Belgium has decided that might also be a good idea.<br />

Finland may follow suit with a tax discussed in 2009. Spain undid a decade of<br />

liberalization by freezing tariffs. French Finance Minister likes the idea of freezing<br />

gas tariffs, another step backward.<br />

Oasis in the UK<br />

Conversely, there has been no such talk in the UK. Nor do we think there will be.<br />

The over-riding rationale is that the UK is running out of power (see pg 14 of our<br />

Centrica Upgrade, 14 th June 2010). And this new government is more pragmatic,<br />

understanding these issues. Any sniff of a windfall tax would scare away muchneeded<br />

investment.<br />

Wrong to avoid a consensus long<br />

This is one of the more often-used excuses for not investing in Centrica. If nothing<br />

else, share price performance attests to the fact that this is a weak argument. Sure,<br />

we, like many investors, generally start from the principle that performance is likely<br />

to lie elsewhere than consensus views. However, in some cases, such as Centrica,<br />

the fundamentals and valuation stack up.<br />

Forecasts recently upgraded; consensus has to catch up<br />

On June 14 th , we raised our forecasts; we are now 1% to 8% ahead of consensus<br />

EPS in 2010-2012 and 9% to 21% for DPS. We believe consensus forecasts will rise<br />

as Centrica’s strategy delivers. Our changes reflect a mark to market in<br />

commodities and our expectations of a tighter generation market evolving in the<br />

UK, which favours cleaner generation and gas over coal. We continue to believe<br />

that Centrica’s growth strategy is largely deliverable. Growth comes from<br />

• British Gas Residential (electricity and gas supply): more stable margins<br />

with lower margin volatility and lower customer churn.<br />

• Services growth. We assume a doubling in EBIT by 2013.<br />

• Upstream gas: increased production from Venture and new fields.<br />

• Power generation: combination of higher CCGT output (as gas continues<br />

to displace coal in the merit order) and new offshore wind capacity.<br />

On sector multiples yet triple the growth<br />

On 14 th June, we raised our fair value by 9% to 375p per share, implying 26%<br />

upside. This reflects the improved cash flows we are now forecasting on the back<br />

of our earnings upgrades. Centrica looks attractive on multiples, trading at a 2010<br />

PE of 11.9x, in line with the sector average, yet offering far superior EPS growth<br />

(13% vs. 4% CAGR 2009-2013). Dividend yield of 5% is also tempting, with DPS<br />

growth matching EPS growth. A healthy balance sheet makes this even more<br />

compelling.<br />

http://www.execution-noble.com<br />

BUY<br />

26.4% upside<br />

Fair Value £3.75<br />

RIC, Bloomberg Code CNA.L, CNA LN<br />

Share Price £2.97<br />

Market Capitalisation £15,194<br />

Free Float 100.0%<br />

EUR 2009A 2010E 2011E 2012E<br />

Revenues m 21,963 22,716 24,169 25,586<br />

EBITDA m 2,538 3,062 3,325 3,884<br />

EPS 0.22 0.25 0.27 0.32<br />

DPS 0.13 0.15 0.16 0.19<br />

FCF ps 0.32 0.20 0.17 0.26<br />

EV 20,233 20,233 20,233 20,233<br />

Net Debt 3,386 3,609 4,411 4,813<br />

Net Debt/Ebitda 1.3 1.2 1.3 1.2<br />

At Current Price: 2009A 2010E 2011E 2012E<br />

PE 13.7 12.0 11.1 9.3<br />

EV/Ebitda 8.0 6.6 6.1 5.2<br />

Dividend Yield (%) 4.3% 5.0% 5.4% 6.4%<br />

FCF Yield (%) 10.9% 6.9% 5.7% 8.8%<br />

At Target Price: 2009A 2010E 2011E 2012E<br />

PE 17.3 15.1 14.0 11.8<br />

EV/Ebitda 10.6 8.8 8.1 6.9<br />

Dividend Yield (%) 3.4% 4.0% 4.3% 5.1%<br />

Analysts<br />

Lawson Steele<br />

+44 20 3364 6771<br />

lawson.steele@execution-noble.com<br />

Andrew Fisher<br />

+44 20 3364 6773<br />

andrew.fisher@execution-noble.com<br />

Page 9 of 44


THIRD QUARTER 2010<br />

Centrica<br />

25.0%<br />

20.0%<br />

15.0%<br />

10.0%<br />

£ per Share<br />

5.0%<br />

0.0%<br />

0.40<br />

0.35<br />

0.30<br />

0.25<br />

0.20<br />

0.15<br />

0.10<br />

0.05<br />

0.00<br />

Centrica Storage<br />

7%<br />

Centrica Energy<br />

41%<br />

Direct Energy<br />

11%<br />

British Gas<br />

41%<br />

ROIC Group WACC<br />

2005A 2006A 2007A 2008A 2009A 2010E 2011E 2012E 2013E<br />

2007A 2008A 2009A 2010E 2011E 2012E 2013E<br />

Actual Consensus EPS<br />

Key Metrics (Year to Dec) 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

Recommendation Buy Execution adj P/E 13.7 12.0 11.1 9.3 8.5 7.7 7.5<br />

Fair Value 3.75 EPS growth 0% 14% 8% 19% 10% 10% 3%<br />

EV / EBITDA 8.0 6.6 6.1 5.2 4.8 4.5 4.4<br />

Share Price 2.97 FCF Yield 10.9% 6.9% 5.7% 8.8% 11.3% 14.6% 13.6%<br />

Upside / Downside 26.4% Dividend yield 4.3% 5.0% 5.4% 6.4% 7.1% 7.8% 8.0%<br />

DPS growth 5% 16% 8% 19% 10% 10% 3%<br />

Previous Fair Value 3.45 Net Debt / EBITDA 1.6 1.4 1.5 1.4 1.2 1.0 0.9<br />

% change to previous Fair Value 8.7% ROIC 22.9% 18.5% 18.2% 18.6% 18.1% 18.6% 18.4%<br />

SOP DCF/EVA 3.73<br />

Bloomberg CNA LN Equity Key Drivers (Year to Dec) 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

T-One CNA-LN<br />

Model Published On 14 Jun 2010 Achieved Power Price (core GBP/MWh) 57.52 48.69 45.60 50.54 53.76 56.34 57.91<br />

Output sold forward (core market) 100.0% 50.0% 0.0% 0.0% 0.0% 0.0% 0.0%<br />

Market Coal Price (core GBP/MWh) 114.95 96.56 96.23 101.79 106.87 111.45 114.20<br />

Market Cap 15,194 Achieved Gas Price (core GBP/MWh) 20.25 14.04 13.87 14.86 16.76 17.67 17.67<br />

Economic Net Debt (ie inc nuclear provisions) 4,976 Achieved CO2 Price (GBP/t) 13.42 12.34 13.25 13.85 14.74 14.78 14.78<br />

Adjustments For Associates & Minorities 63<br />

Enterprise Value 20,233<br />

o/w nuclear provisions 0 P&L Summary (Year to Dec, £m) 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

Revenue 21,963 22,716 24,169 25,586 27,789 29,389 30,666<br />

Forthcoming Catalysts EBITDA by division<br />

1H 2010 Results 28 Jul 2010 British Gas 1,061 1,231 1,273 1,407 1,426 1,499 1,535<br />

3Q 2010 Results 17 Nov 2010 Centrica Energy 1,077 1,260 1,493 1,786 1,998 2,228 2,244<br />

Centrica Storage 191 199 191 245 293 286 290<br />

Direct Energy 242 345 342 418 461 506 552<br />

European Energy 0 0 0 0 0 0 0<br />

Other 0 0 0 0 0 0 0<br />

Execution Analysts EBITDA 2,538 3,062 3,325 3,884 4,205 4,546 4,647<br />

Lawson Steele / Andrew Fisher % change -3.2% 20.6% 8.6% 16.8% 8.3% 8.1% 2.2%<br />

(44) 20 3364 6771 / 6773 % margin 11.6% 13.5% 13.8% 15.2% 15.1% 15.5% 15.2%<br />

lawson.steele@execution-noble.com / andrew.fisher@execution-noble.com o/w associates 1 74 77 64 85 109 123<br />

Depreciation & Amortisation (724) (851) (861) (888) (915) (930) (935)<br />

EBIT 1,814 2,211 2,464 2,996 3,290 3,616 3,712<br />

EBITDA Breakdown (2010) % change -8.9% 21.9% 11.5% 21.6% 9.8% 9.9% 2.7%<br />

% margin 8.3% 9.7% 10.2% 11.7% 11.8% 12.3% 12.1%<br />

Net Financials (179) (221) (239) (280) (300) (297) (289)<br />

Exceptional items (454) (50) 0 0 0 0 0<br />

Pre Tax Profit 996 1,940 2,225 2,716 2,990 3,318 3,423<br />

Income Tax Expense (346) (709) (838) (1,074) (1,191) (1,332) (1,386)<br />

Disconitinued Operations 206 0 0 0 0 0 0<br />

Minority Interests 12 12 12 12 12 12 12<br />

Net Income 856 1,231 1,387 1,642 1,799 1,986 2,037<br />

Execution Net Income 1,104 1,281 1,387 1,642 1,799 1,986 2,037<br />

Reported EPS 0.17 0.24 0.27 0.32 0.35 0.39 0.40<br />

Execution EPS 0.22 0.25 0.27 0.32 0.35 0.39 0.40<br />

DPS 0.13 0.15 0.16 0.19 0.21 0.23 0.24<br />

Group ROIC vs WACC Payout Ratio 59.0% 60.0% 60.0% 60.0% 60.0% 60.0% 60.0%<br />

30.0%<br />

Weighted average shares in issue (m) 5,145 5,145 5,145 5,145 5,145 5,145 5,145<br />

EPS Forecasts vs Consensus (GBP ps)<br />

Cash Flow (Year to Dec, £m) 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

Operating cash flow 2,386 2,061 2,208 2,491 2,653 2,872 2,937<br />

Maintenance CAPEX (724) (1,014) (1,341) (1,161) (934) (647) (864)<br />

Free Cash Flow 1,662 1,046 866 1,330 1,719 2,225 2,072<br />

Growth CAPEX (474) (607) (907) (907) (600) (600) (600)<br />

Acquisitions & Disposals + Other (3,010) 2 0 0 0 0 0<br />

Cash used for investing (4,208) (1,619) (2,248) (2,068) (1,534) (1,247) (1,464)<br />

Cash used for financing 143 (227) 40 (423) (978) (1,072) (1,185)<br />

o/w Dividends Paid To Shareholders (635) (655) (761) (825) (978) (1,072) (1,185)<br />

Net Cash Flow (1,619) 215 0 0 141 553 288<br />

Balance Sheet (Year to Dec, £m) 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

Cash & Equivalents 1,294 1,500 1,500 1,500 1,641 2,194 2,482<br />

Tangible Fixed Assets 9,650 10,546 11,934 13,113 13,732 14,049 14,579<br />

Intangible Non-Current Assets 2,822 2,822 2,822 2,822 2,822 2,822 2,822<br />

Other Assets 5,676 5,354 5,656 5,951 6,408 6,741 7,006<br />

Total Assets 19,442 20,223 21,912 23,386 24,604 25,806 26,889<br />

Interest Bearing Debt 4,680 5,109 5,911 6,313 6,313 6,313 6,313<br />

Other Liabilities 10,507 10,293 10,554 10,809 11,206 11,494 11,724<br />

Total Liabilities (exc equity) 15,187 15,401 16,465 17,122 17,519 17,807 18,037<br />

Shareholders' Equity 4,192 4,758 5,384 6,201 7,022 7,936 8,789<br />

Minority Interests 63 63 63 63 63 63 63<br />

Total Equity 4,255 4,821 5,447 6,264 7,085 7,999 8,852<br />

Net Debt 3,386 3,609 4,411 4,813 4,671 4,119 3,831<br />

Economic Net Debt (ie inc nuclear provns) 3,951 4,174 4,976 5,378 5,236 4,684 4,396<br />

http://www.execution-noble.com<br />

Page 10 of 44


THIRD QUARTER 2010<br />

Credit Suisse<br />

Passes all the tests<br />

CS screens well on our sector criteria and is one of the banks in our<br />

universe that shows upside after taking account of regulatory hits to<br />

earnings and a delay in the macro recovery. Our fair value of CHF60<br />

(down from CHF70) would be closer to CHF50 taking into account<br />

potential regulatory hits showing upside of over 20% at these levels.<br />

CS is far less impacted by concerns on funding, the speed of a macro<br />

recovery and capital than peers and its key challenge has been<br />

earnings downgrades due to lower equity markets, which is more<br />

than discounted at current levels. The current share price is factoring<br />

in 1x TBV for the investment bank and 10x the non investment bank<br />

on 2010 assumptions.<br />

Earnings downgrades discounted<br />

CS is one of the banks in the sector that has been most correlated to consensus<br />

earnings changes year to date with the stock down 20% vs cumulative<br />

downgrades of some 14% (including Q2 revisions) for 2012. In advance of the Q2<br />

results we are downgrading our forecasts by 7% for 2012 and 9% for 2010/11 largely<br />

on account of weaker equity markets. These downgrades have been driven by a<br />

combination of a higher tax rate and weaker equity markets, which have affected<br />

our AUM growth forecast, equity revenues in the investment bank and held back<br />

the expected improvement in private banking gross margins. At this stage this is<br />

more than in the price and the market is pricing in a continued subdued outturn in<br />

markets. Importantly even after bringing down our investment banking forecasts<br />

the Q2 assumed ROE in the IB is some 19% annualized post tax, albeit down from<br />

31% in Q1 but still a respectable level. The pre-tax margin assumed in the private<br />

bank is low for 2010 at 28% vs the 40% goal and we now only expect 32% by 2012.<br />

CS screens well on regulatory changes<br />

Regulation and the impact on both the p&l and the capital base remain a key<br />

consideration for any bank. On our regulatory screen a combination of new<br />

liquidity rules, OTC derivative changes and likely taxes take some 15% off net profit.<br />

CS is one of the few banks in Europe that screens well to the upside post taking<br />

into account regulatory earnings. In addition there remains uncertainty over the<br />

new capital rules under B3 and CS screens well relative to peers due to a starting<br />

core T1 of 10% and strong capital generation from the private bank as well as a<br />

relatively limited impact from the proposals other than on DTAs, which should be<br />

largely used by the time of implementation. On a stress test CS screens well.<br />

Private bank remains a differentiator<br />

The private bank remains a source of significant capital generation. In spite of the<br />

issues with the European offshore business the net inflows have remained<br />

relatively robust and net new money growth of over 5% remains achievable. The<br />

Asian business is growing flows at over 20% and growth in Europe remains<br />

positive in spite of the impact of German funds flowing offshore. The gross margin<br />

has been an issue with clients being far slower to re risk than initially expected but<br />

consensus has now come down and assumptions are that gross margins will be<br />

towards 120bp below the bank’s range of 125-135bp. We still expect the business to<br />

show decent operating leverage in an event of an equity market upturn.<br />

Valuation attractive<br />

A price to book model on current forecasts CS looks significantly undervalued.<br />

Adding in regulatory impacts at 15% hit to earnings brings our FV down to CHF50.<br />

We also look at CS on a SOP and the current price is valuing the IB at 1x TBV (GS<br />

trades on 1.2x) and the non investment bank on 10x 2010 earnings, which is a low<br />

level (Julius Baer trades on 12x 2010).<br />

http://www.execution-noble.com<br />

BUY<br />

47% upside<br />

Fair Value CHF 60.0<br />

RIC, Bloomberg Code CSGN.VX, CSGN VX<br />

Share Price CHF 41<br />

Market Capitalisation CHF 47,235m<br />

Free Float 87%<br />

CHFm (unless stated) 2009 2010E 2011E 2012E<br />

Pre-provision profit 10,125 9,672 10,695 12,146<br />

Pre-tax profit 8,269 8,558 9,505 10,927<br />

Adjusted net profit 6,593 5,974 6,684 7,648<br />

EPS adj (CHF) 5.67 5.02 5.65 6.46<br />

BVps (CHF) 30.1 33.2 36.9 41.5<br />

BVps adj (CHF) 21.9 24.8 28.4 33.0<br />

LLP as % Loans -0.21 -0.07 -0.10 -0.11<br />

Cost income ratio (%) 67.8 68.5 67.1 66.0<br />

X (unless stated) 2009E 2010E 2011E 2012E<br />

Adjusted P/E 7.2 8.1 7.2 6.3<br />

Pre-provision multiple 4.7 4.9 4.4 3.9<br />

Price / book 1.36 1.23 1.11 0.98<br />

Price / book adj 1.87 1.65 1.44 1.24<br />

Yield (%) 4.9 4.9 4.9 4.9<br />

ROE (%) 19.6 16.2 16.5 16.9<br />

ROE (adj) (%) 28.6 22.2 21.9 21.7<br />

Tier 1 ratio (%) 10.0 9.8 10.9 12.0<br />

Analysts<br />

Fiona Swaffield<br />

+44 20 7456 1693<br />

fiona.swaffield@execution-noble.com<br />

Page 11 of 44


THIRD QUARTER 2010<br />

Credit Suisse<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: BUY PER (adjusted) (x) -5.7 7.2 8.1 7.2 6.3<br />

Fair Value: CHF 60.00 Price/Pre Provis Profit per share (x) -4.7 4.7 4.9 4.4 3.9<br />

P/NAV (adjusted) (x) 2.12 1.87 1.65 1.44 1.24<br />

Share Price: CHF 40.90 RoE (%) (adjusted) -29.2 28.6 22.2 21.9 21.7<br />

Upside / Downside RoRWA (%) -2.85 2.75 2.48 2.49 2.67<br />

Implied cost of equity (curve) (%) 17.0 14.5 14.9 14.8<br />

Bloomberg: CSGN Yield (net) (%) 0.2 4.9 4.9 4.9 4.9<br />

Key ratios 2008 2009 2010E 2011E 2012E<br />

Core tier 1 ratio 7.9 10.0 9.8 10.9 12.0<br />

Shares In Issue 1,155 Leverage ratio 52.2 40.3 38.2 34.6 31.5<br />

Market Cap 47,235 Cost income ratio 205.9 67.8 68.5 67.1 66.0<br />

Free Float 90% Loan loss charges / loans -0.34 -0.21 -0.07 -0.10 -0.11<br />

RoE (%) (adjusted) -29.2 28.6 22.2 21.9 21.7<br />

NAV 2010E 28,598 RoA (stated) -0.65 0.60 0.56 0.60 0.65<br />

NAV per share 2010 24.8 RoRWA -2.85 2.75 2.48 2.49 2.67<br />

Forthcoming Catalysts<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Q2 results 22 July 2010 Net interest income 8,349 6,760 6,860 7,360 7,361<br />

Total non interest income 1,241 24,649 23,865 25,165 28,375<br />

Total gross operating income 9,590 31,409 30,725 32,525 35,736<br />

Costs -19,744 -21,284 -21,053 -21,830 -23,590<br />

Pre Provision Net Operating Income -10,154 10,125 9,672 10,695 12,146<br />

Execution Noble Analysts Loan loss charges -813 -506 -164 -240 -270<br />

Post provision profit -10,967 9,619 9,508 10,455 11,877<br />

Fiona Swaffield Pre Tax Profit -12,223 8,269 8,558 9,505 10,927<br />

(44) 20 7456 1693 Net profit -8,278 6,593 5,974 6,684 7,648<br />

fiona.swaffield@execution-noble.com<br />

EPS adj. -7.14 5.67 5.02 5.65 6.46<br />

Growth rates % 2008 2009 2010E 2011E 2012E<br />

Operating income -70 228 -2 6 10<br />

Pre provision profit -201 -200 -4 11 14<br />

EPS adj. -202 -179 -11 12 14<br />

NAV (adjusted)/share -33 14 13 15 16<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Total adj assets 1,170,350 1,031,427 1,091,427 1,135,084 1,203,189<br />

Goodwill & Intangibles 9,753 9,595 9,797 9,797 9,797<br />

Shareholders' Equity (adjusted) 22,433 25,584 28,598 32,832 38,168<br />

NAV (adjusted)/share 19.3 21.9 24.8 28.4 33.0<br />

NAV per share 27.7 30.1 33.2 36.9 41.5<br />

RWA 257,467 221,609 261,041 276,704 296,073<br />

Tier 1 equity 34,208 36,207 39,624 43,998 49,334<br />

Core tier 1 equity 20,367 22,267 25,684 30,058 35,394<br />

http://www.execution-noble.com<br />

Page 12 of 44


THIRD QUARTER 2010<br />

Finmeccanica<br />

Ready to rebound<br />

Finmeccanica has market leading positions, under-recognised<br />

cyclical recovery upside, and potential asset disposal upside. The<br />

stock is trading at 10 year lows on EV/Sales or on P/E relative, which<br />

we attribute to market fears of further earnings downgrades. We<br />

argue that the EPS downgrade cycle has in fact played out, and we<br />

would buy ahead of Farnborough airshow and H1 results in July.<br />

Earnings bottom<br />

The share price underpeformance in Finmeccanica in the past 2 years has been<br />

driven by falling earnings expectations. Consensus 2010e EPS stood at €1.48 a year<br />

ago (Bloomberg June 30 th 2009) compared with €1.15 now. The stock has derated<br />

in P/E terms due to market loss of confidence in the EPS outlook, and<br />

Finmeccanica now trades on a 2010e PE of 7.7x, at the bottom of its historic range<br />

and the bottom of our A&D coverage universe.<br />

We believe that the company’s high visibility for the remainder of 2010 means it is<br />

unlikely that earnings will fall below our €1.12 forecast. We believe the downgrade<br />

cycle is over, and the stock will rerate significantly when the market recognises<br />

this.<br />

Recovery<br />

In 2011 we believe that earnings will recover materially, based on groupwide cost<br />

savings, the ramp-up of the Boeing 787 programme benefitting Aeronautics,<br />

ongoing growth in the US part of Defence Electronics, and a recovery in some of<br />

the cyclical businesses. In particular, we believe that demand is now bottoming in<br />

the 30% civil portion of Helicopters.<br />

Portfolio change<br />

We believe Finmeccanica may be close to announcing a partner for Ansaldo<br />

Energia (AE), probably a developing world player, as a preliminary step to a 2011<br />

IPO. A recent report in Milano Finanza suggested that the Russian group OAO<br />

Power Machines will take a 20% stake in AE as a first step. We believe that AE<br />

could be worth over €1bn, and any step towards crystalising this value would be<br />

positive for the share price.<br />

Catalysts<br />

The Farnborough airshow, July 19-23 rd , is the main industry event of the year, and<br />

often serves as a catalyst for share price moves in the sector.<br />

The following week Finmeccanica will report H1 results, July 28 th . We believe that if<br />

the company is able to confidently reaffirm 2010 guidance then this could begin to<br />

convince the market that the downgrades are over.<br />

Finally, at any time during the coming months the company could reveal a partner<br />

for the Ansaldo Energia exit strategy, which we believe would be positive for the<br />

shares.<br />

Valuation<br />

In addition to P/E near its 10 year low on an absolute or relative basis, the stock is<br />

also trading at a 10 year low on EV/Sales. Although the defence sector generally is<br />

trading at a discount to historic levels, we believe that in the case of Finmeccanica<br />

the extent of the discount implies further declines in earnings, which we do not<br />

believe will happen.<br />

Our fair value of €11.50 would apply a 2011e P/E of 9x, which is the midpoint of the<br />

valuations of BAE Systems and Thales, which are Finmeccanica’s closest peers.<br />

http://www.execution-noble.com<br />

BUY<br />

34.1% upside<br />

Fair Value € 11.50<br />

RIC, Bloomberg Code SIFI.MI, FNC IM<br />

Share Price € 8.57<br />

Market Capitalisation € 4,954m<br />

Free Float 70%<br />

Eur m (unless stated) 2009 2010E 2011E 2012E<br />

Sales 18176 18119 18740 19185<br />

Ebitda 2146 2214 2305 2352<br />

Adj. EPS (Eur) 1.31 1.12 1.29 1.39<br />

Dividend (Eur p/s) 0.41 0.45 0.45 0.45<br />

FCF 489 231 733 893<br />

EV adjustments 0.0 0.0 0.0 0.0<br />

Net Debt 5014 5020 4547 3914<br />

X (unless stated) 2009 2010E 2011E 2012E<br />

EV/Sales 0.55 0.55 0.53 0.52<br />

EV/Ebitda 4.65 4.50 4.33 4.24<br />

PE 6.53 7.68 6.65 6.16<br />

Dividend Yield (%) 4.78 4.78 5.25 5.25<br />

FCF Yield (%) 4.90 2.32 7.35 8.95<br />

Net Debt/Ebitda 2.34 2.27 1.97 1.66<br />

Analysts<br />

Edward Stacey<br />

+44 20 7456 9135<br />

edward.stacey@execution-noble.com<br />

Rob Virdee<br />

+44 20 7456 9222<br />

rob.virdee@execution-noble.com<br />

Page 13 of 44


THIRD QUARTER 2010<br />

Finmeccanica<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: Buy Execution P/E 6.4 6.5 7.7 6.6 6.2<br />

Fair Value: € 11.5 Reported P/E 7.3 7.3 7.9 7.0 6.5<br />

EV / Sales 0.7 0.5 0.6 0.5 0.5<br />

Share Price: € 8.6 EV / EBITDA 5.4 4.6 4.5 4.3 4.2<br />

Upside / Downside 34.1% EV / EBIT 8.2 7.16 7.05 6.63 6.43<br />

FCF Yield 2.6% 4.9% 2.3% 7.3% 9.0%<br />

Previous Fair Value € 11.5 Dividend yield 4.8% 4.8% 5.2% 5.2% 5.2%<br />

% change to fair value 0.0%<br />

Bloomberg: FNC IM Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: FNC-MI<br />

Model Published On: 01 July 2010 EBITDA margin 12.2% 11.8% 12.2% 12.3% 12.3%<br />

Adj. EBITA margin 8.0% 7.7% 7.8% 8.0% 8.1%<br />

Capex / Revenue 4.8% 2.6% 3.4% 3.7% 3.6%<br />

Shares In Issue (Less Treasury) 578 Capex / Depreciation 1.17 0.63 0.76 0.88 0.88<br />

Market Cap (mn) 4,954 Net Debt / EBITDA 2.8 2.3 2.3 2.0 1.7<br />

Net Debt (incl Pension liability) 5,020 EBITDA / Net Interest 6.2 7.3 5.6 7.2 8.7<br />

ROE 9% 11% 9% 10% 10%<br />

Enterprise Value 9,974<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Forthcoming Catalysts<br />

Revenue 15,037 18,176 18,119 18,740 19,185<br />

1H 2010 Interim results 29 July 2010 % change 12.0% 20.9% -0.3% 3.4% 2.4%<br />

3Q 2010 results 04 November 2010 EBITDA 1,832 2,146 2,214 2,305 2,352<br />

% change 2.2% 17.1% 3.2% 4.1% 2.0%<br />

% margin 12.2% 11.8% 12.2% 12.3% 12.3%<br />

Depreciation & Amortisation -622 -754 -799 -800 -800<br />

EBIT 1,210 1,392 1,415 1,505 1,552<br />

% change 11.6% 15.0% 1.7% 6.4% 3.1%<br />

Execution Analyst % margin 8.0% 7.7% 7.8% 8.0% 8.1%<br />

Edward Stacey Associates 16 17 16 16 16<br />

(44) 20 7456 9135 Operating Profit 1,226 1,409 1,431 1,521 1,568<br />

edward.stacey@executionlimited.com Net Financials -294 -293 -395 -320 -270<br />

Minority Interests -50 -64 -64 -64 -64<br />

Pre Tax Profit 882 1,052 972 1,137 1,234<br />

Revenue Breakdown Income Tax Expense -367 -377 -348 -432 -469<br />

Net Income 515 675 624 705 765<br />

Transportation<br />

12%<br />

Energy<br />

Helicopters<br />

20%<br />

Execution Net Income<br />

Reported EPS<br />

609<br />

1.17<br />

755<br />

1.17<br />

709<br />

1.08<br />

790<br />

1.22<br />

850<br />

1.32<br />

9%<br />

Execution EPS 1.33 1.31 1.12 1.29 1.39<br />

DPS 0.41 0.41 0.45 0.45 0.45<br />

Payout Ratio 35.1% 35.1% 41.7% 36.9% 34.0%<br />

Shares In Issue (Weighted, Less Treasury) 441 578 578 578 578<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

Pre Tax Profit 882 1,052 972 1,137 1,234<br />

EBITA Breakdown Depreciation & Amortisation 622 754 799 800 800<br />

Margin Trends<br />

Margin<br />

14%<br />

12%<br />

10%<br />

8%<br />

6%<br />

4%<br />

2%<br />

0%<br />

Defence System<br />

7%<br />

Space<br />

7%<br />

Defence System<br />

9%<br />

Space<br />

4%<br />

Aeronautics<br />

17%<br />

Energy<br />

8%<br />

Aeronautics<br />

17%<br />

Transportation<br />

8%<br />

Defence<br />

Electronics<br />

28%<br />

Helicopters<br />

24%<br />

Defence Electronics<br />

30%<br />

2008 2009 2010E 2011E 2012E<br />

Adj. EBITDA margin Adj. EBIT EBIT margin margin<br />

Taxes Paid -200 -377 -348 -432 -469<br />

Change in Working Capital -518 -488 -630 -120 -20<br />

Other Operating Cash Flow 203 26 48 48 48<br />

Operating cash flow 989 967 841 1,433 1,593<br />

Capital Expenditure -725 -478 -610 -700 -700<br />

Free Cash Flow 264 489 231 733 893<br />

Dividends Paid To Shareholders -187 -237 -237 -260 -260<br />

Equity Raised / Bought Back 1,206 0 0 0 0<br />

Other Financing Cash Flow 0 0 0 0 0<br />

Net Cash Flow 1,283 252 -6 473 633<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Cash & Equivalents 2,297 2,630 2,624 3,097 3,730<br />

Tangible Fixed Assets 4,529 4,245 4,141 4,126 4,111<br />

Goodwill & Intangibles 8,237 8,367 8,282 8,197 8,112<br />

Associates & Financial <strong>Investment</strong>s 347 351 367 383 399<br />

Other Assets 14,512 14,892 16,398 16,960 17,363<br />

Total Assets 29,922 30,485 31,812 32,763 33,714<br />

Interest Bearing Debt 7,387 7,644 7,644 7,644 7,644<br />

Other Liabilities 16,405 16,292 17,168 17,610 17,993<br />

Total Liabilities 23,792 23,936 24,812 25,254 25,637<br />

Shareholders' Equity 5,974 6,351 6,738 7,183 7,688<br />

Minority Interests 156 198 262 326 390<br />

Total Equity 6,130 6,549 7,000 7,509 8,078<br />

Net Debt (including pension liability) 5,090 5,014 5,020 4,547 3,914<br />

http://www.execution-noble.com<br />

Page 14 of 44


THIRD QUARTER 2010<br />

Hennes & Mauritz<br />

Maur of the Same<br />

H&M has sold off 14% since its April highs and has underperformed<br />

the SXRP by 6% following its second quarter earnings release. With<br />

easier comps in the second half, H&M’s likely ability to pass on price<br />

inflation and an almost unparalleled predictability of strong<br />

cashflows, we see this underperformance and the absolute and<br />

relative valuation as providing an attractive entry point for the<br />

longer-term growth story. .<br />

Trading conditions improve post 2Q10<br />

At first glance, H&M’s second quarter results last week were a mixed bag with the<br />

disappointment of May’s +6% constant currency sales growth offset by an<br />

impressive 480bps improvement in gross margin (80bps ahead of consensus).<br />

Importantly however, current trading through June was reported as up 22% in<br />

constant currency, significantly ahead of our 13% FY10 and our 17% 3Q10 estimates.<br />

Whilst this performance reflects an improvement for just a short period, it<br />

highlights two important issues; firstly that trade rebounded strongly when the<br />

weather improved across Europe and second, the comps become significantly<br />

easier across much of Western Europe in the coming quarter (-6% versus -2%).<br />

H&M will report June sales on 15 July and 9m results on 29 September which could<br />

prove to be a catalyst for the shares.<br />

Concerns over gross margin seemingly misplaced<br />

Much of the share price deterioration and investor comment seems to concern the<br />

impact to gross margins from adverse currency moves and higher input costs. We<br />

are more sanguine on the impact of such pressures because we consider H&M best<br />

placed amongst its peers to cope, for two reasons. First, H&M’s higher income<br />

customer has shown themselves to be relatively price inelastic in the past so we<br />

believe H&M will be able to pass on price inflation as it sees fit in each of its<br />

markets (H&M has said it will follow the market on pricing while – of course – still<br />

investing in a competitive, fashionable offer). Second, and fairly obviously, H&M’s<br />

market leading high operating margin (of 21.3% in 2009) means H&M is less<br />

sensitive than its competition to a deterioration in either LfL sales growth or gross<br />

margins. We estimate each 1% change in LfL impacts EBIT by 3% and each 100bps<br />

of gross margin impacts EBIT by only 4%. We would also note that H&M has<br />

already warned the market that markdowns may be higher in this year’s June sale<br />

so we see the risk to the upside.<br />

Longer-term growth story in tact, under-represented brand<br />

From our demographic analysis first published in February, where we evaluated<br />

the potential store footprint relative to the urban population under 49 years of age,<br />

we deduced that the growth profile of H&M will only be arrested by the availability<br />

of property. Excluding the Nordics, we concluded that with less than 5 stores per<br />

1m population within this catchment, H&M has significant scope to grow space by<br />

10-15% per annum driving a return to 14% EPS growth in FY2011e.<br />

Multiple, stability of cashflow and dividend yield supportive<br />

With high operating margins and stable enough cash flows to warrant a DCFbased<br />

valuation, H&M is a rare example in the general retailer space and our DCF<br />

valuation of SEK250 suggests 19% upside. We appreciate the ‘de-risking’ mentality<br />

affecting the sector but with only 7% PIGS revenue exposure, we feel H&M’s<br />

underperformance has been overdone. H&M’s premium to the European market<br />

has contracted to 60% versus the 70% 6 year average and, although still expensive<br />

in absolute terms, H&M now trades on 17.5x cons 12m fwd EPS, versus the 6-year<br />

average of 20x. Add to this a growing net cash position and a 4.3% dividend yield<br />

and we feel SEK 211 is a good entry point for the longer term growth story and<br />

cyclical recovery (when it comes).<br />

http://www.execution-noble.com<br />

BUY<br />

18% upside<br />

Fair Value SEK250<br />

RIC, Bloomberg Code HMb.ST, HMB SS<br />

Share Price SEK212.50<br />

Market Capitalisation SEK351,703m<br />

Free Float 58%<br />

Y/e 30 Nov, SEKm 2009 2010E 2011E 2012E<br />

Sales 101,393 108,228 121,920 136,836<br />

PBT 22,103 24,854 28,285 32,043<br />

EPS (SEK) 9.90 11.11 12.65 14.33<br />

Dividend (SEK) 16.00 9.20 10.58 12.17<br />

FCF*1 12,219 15,315 16,856 19,044<br />

Invested Capital 21,248 24,308 28,349 32,979<br />

Net Debt<br />

1. Post CAPEX<br />

22,025 22,113 21,458 20,365<br />

Y/e 30 Nov, X 2009 2010E 2011E 2011E<br />

EV / Sales 3.7 3.5 3.1 2.7<br />

EV / Ebitda 15.3 13.6 12.0 10.6<br />

PE 21.5 19.1 16.8 14.8<br />

Dividend Yield (%) 7.5 4.3 5.0 5.7<br />

FCF Yield (%) 3.5 4.4 4.8 5.4<br />

ROIC (%) 84.7 79.3 77.9 75.8<br />

Net Debt / Ebitda 0.9 0.8 0.7 0.6<br />

Analysts<br />

Caroline Gulliver<br />

+44 20 7456 9173<br />

caroline.gulliver@execution-noble.com<br />

Robert Evans<br />

+44 20 7426 4210<br />

robert.evans@execution-noble.com<br />

Richard Cathcart<br />

+44 20 7456 9155<br />

richard.cathcart@execution-noble.com<br />

Page 15 of 44


THIRD QUARTER 2010<br />

H&M<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: BUY Execution P/E 11.6 10.8 19.2 16.9 14.9<br />

Fair Value: SEK 250 Reported P/E 11.6 10.8 19.2 16.9 14.9<br />

EV / Sales 3.7 3.3 3.1 2.7 2.4<br />

Share Price: SEK 213.7 EV / EBITDA 14.8 13.5 12.1 10.7 9.4<br />

Upside / Downside 17.0% EV / EBIT 16.5 15.3 13.6 12.0 10.6<br />

FCF Yield 3.7% 3.6% 4.5% 4.9% 5.5%<br />

Previous Fair Value N/A Dividend yield 7.3% 7.5% 4.3% 5.0% 5.7%<br />

% change to fair value N/A<br />

Bloomberg: HMB SS Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: HM'B.SK<br />

EBITDA margin 25.2% 24.1% 25.3% 25.5% 25.7%<br />

EBIT margin 22.7% 21.3% 22.5% 22.7% 22.9%<br />

Capex / Revenue 5.3% 5.4% 5.3% 5.4% 5.5%<br />

Shares In Issue (Less Treasury) 1,655 Capex / Depreciation 2.1 1.9 1.9 1.9 2.0<br />

Market Cap 353,689 Net Debt / EBITDA (1.0) (0.8) (0.8) (0.7) (0.6)<br />

Net (debt) / cash (22,113) EBITDA / Net Interest (21.2) (53.3) (60.7) (56.3) (54.7)<br />

Adjustments For Associates & Minorities 0 ROE 41% 40% 42% 44% 47%<br />

Enterprise Value 331,576<br />

Net Pension Deficit<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Forthcoming Catalysts Revenue 88,532 101,393 108,228 121,920 136,836<br />

% change 14.5% 14.5% 6.7% 12.7% 12.2%<br />

Monthly sales figures 15th of each month EBITDA 22,340 24,474 27,424 31,125 35,198<br />

9M results 29 September 2010 % change 19.3% 9.6% 12.1% 13.5% 13.1%<br />

% margin 25.2% 24.1% 25.3% 25.5% 25.7%<br />

Depreciation & Amortisation (2,202) (2,830) (3,022) (3,393) (3,799)<br />

EBIT 20,138 21,644 24,402 27,733 31,399<br />

% change 20.0% 7.5% 12.7% 13.6% 13.2%<br />

% margin 22.7% 21.3% 22.5% 22.7% 22.9%<br />

Associates 0 0 0 0 0<br />

Execution Analysts Operating Profit 20,138 21,644 24,402 27,733 31,399<br />

Caroline Gulliver +44 207 456 9173 Net Financials 1,052 459 452 553 644<br />

Robert Evans +44 207 426 9210 Other Pre-tax Income 0 0 0 0 0<br />

Richard Cathcart +44 207 456 9155 Pre Tax Profit 21,190 22,103 24,854 28,285 32,043<br />

Income Tax Expense (5,896) (5,719) (6,462) (7,354) (8,331)<br />

Minority Interests 0 0 0 0 0<br />

Revenue Breakdown (2009) Net Income 15,294 16,384 18,392 20,931 23,712<br />

Execution Net Income 15,294 16,384 18,392 20,931 23,712<br />

Reported EPS 18.5 19.8 11.1 12.6 14.3<br />

Execution EPS 18.5 19.8 11.1 12.6 14.3<br />

DPS 15.50 16.00 9.20 10.58 12.17<br />

Payout Ratio 83.9% 80.8% 82.8% 83.7% 84.9%<br />

Shares In Issue (Less Treasury) 828 828 1,655 1,655 1,655<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

EBITDA 22,340 24,474 27,424 31,125 35,198<br />

Taxes Paid (5,940) (6,468) (6,462) (7,354) (8,331)<br />

Sales growth trends Interest Paid / Received 1,052 459 452 553 644<br />

Sales growth<br />

Profit margin trends<br />

Gross profit margin<br />

14%<br />

12%<br />

10%<br />

8%<br />

6%<br />

4%<br />

2%<br />

0%<br />

-2%<br />

-4%<br />

-6%<br />

62.2%<br />

62.0%<br />

61.7%<br />

61.5%<br />

61.3%<br />

61.1%<br />

Rest of World<br />

27%<br />

12% 12%<br />

5%<br />

-1%<br />

Nordic<br />

16%<br />

Euro ex-<br />

Finland<br />

57%<br />

9%<br />

-5%<br />

10%<br />

3%<br />

9%<br />

3%<br />

2008 2009 2010E 2011E 2012E<br />

New space sales growth LFL sales growth<br />

2008 2009 2010E 2011E 2012E<br />

Gross profit margin EBIT margin<br />

24%<br />

23%<br />

22%<br />

21%<br />

20%<br />

Operating profit margin<br />

Change in Working Capital 442 (518) (370) (878) (957)<br />

Associate & Minority Dividends 0 0 0 0 0<br />

Other Operating Cash Flow 72 26 (17) (34) (37)<br />

Operating cash flow 17,966 17,973 21,027 23,411 26,517<br />

Capital Expenditure (4,724) (5,481) (5,712) (6,556) (7,472)<br />

Free Cash Flow 13,242 12,492 15,315 16,856 19,044<br />

Acquisitions & Disposals (820) (93) 0 0 0<br />

Dividends Paid To Shareholders (11,584) (12,825) (15,227) (17,511) (20,137)<br />

Equity Raised / Bought Back 0 0 0 0 0<br />

Other Financing Cash Flow (446) (180) 0 0 0<br />

Net Cash Flow 392 (606) 88 (655) (1,093)<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Cash & Equivalents 22,726 19,024 22,113 21,458 20,365<br />

Tangible Fixed Assets 12,441 14,811 17,501 20,664 24,337<br />

Goodwill & Intangibles 1,656 1,674 1,674 1,674 1,674<br />

Associates & Financial <strong>Investment</strong>s 1,775 1,797 1,797 1,797 1,797<br />

Other Assets 12,645 17,057 14,632 16,001 17,492<br />

Total Assets 51,243 54,363 57,717 61,594 65,665<br />

Interest Bearing Debt 0 0 0 0 0<br />

Other Liabilities (14,293) (13,750) (13,974) (14,498) (15,069)<br />

Total Liabilities (14,293) (13,750) (13,974) (14,498) (15,069)<br />

Shareholders' Equity 36,950 40,613 43,744 47,096 50,596<br />

Minority Interests 0 0 0 0 0<br />

Total Equity 36,950 40,613 43,744 47,096 50,596<br />

Net debt / (cash) (22,726) (19,024) (22,113) (21,458) (20,365)<br />

http://www.execution-noble.com<br />

Page 16 of 44


THIRD QUARTER 2010<br />

Lloyds <strong>Bank</strong>ing Group<br />

Reaping the rewards of deleveraging<br />

This is the fourth consecutive quarter we recommend LLOY as a<br />

Silver Bullet BUY. This quarter, we are pairing the LLOY long with a<br />

SELL call on BBVA. We continue to like LLOY for three key reasons:<br />

1) the rigorous stress testing carried out by the UK's FSA in 2009,<br />

which substantially improved the leverage profile of the bank (and<br />

which should continue to improve as the group runs off assets and<br />

retains earnings); 2) improving fundamental backdrop against which<br />

LLOY should see materially lower levels of loan impairments<br />

(£10.7bn for 2010E, v £24bn in 2009; 3) compelling risk/reward - we<br />

estimate a tangible book value of 79p in 2012 and a 14pct ROTE. Our<br />

fair value is based on 1.4x 2012 tbv/share and generates 112% upside,<br />

which we view as extremely compelling.<br />

Dividend paying capacity in 2012?<br />

There is substantial optionality for shareholders of LLOY given a return to more<br />

‘normal’ profitability levels by 2012. Further, as the EC mandated prohibition on<br />

dividend payments to shareholders will be lifted at end 2011 (meaning that the<br />

company can pay a full year dividend in early 2012 out of 2011 earnings), we<br />

believe that LLOY will be in a strong position to pay a dividend in early 2012.<br />

Assuming a 35% payout ratio (or £2.2bn), in-line with the current European<br />

average, LLOY would yield 5.6% on its current market cap.<br />

Rewards of de-leveraging<br />

LLOY is set to reduce its balance sheet by c£40bn per annum through 2013.<br />

Consequences are that the group will become fundamentally less capital intensive<br />

(run-off businesses have a 3x RWA/loan load factor to the core business), and also<br />

less reliant on wholesale funding (run-off businesses rely more on wholesale<br />

funding than do core businesses).<br />

Furthermore, while an improving leverage profile means cross-cycle returns in the<br />

‘new world’ of 10-20%, though given an 81% correlation of price/tbv and leverage,<br />

we surmise that investors will be prepared to pay a higher multiple for reduced<br />

leverage and better quality equity base.<br />

Figure 1: Leverage and price/book multiple progression: 1999 to Date<br />

40.0<br />

35.0<br />

30.0<br />

25.0<br />

20.0<br />

15.0<br />

Source: ExecutionNoble<br />

31/12/1999<br />

30/09/2000<br />

30/06/2001<br />

31/03/2002<br />

31/12/2002<br />

30/09/2003<br />

30/06/2004<br />

31/03/2005<br />

31/12/2005<br />

30/09/2006<br />

30/06/2007<br />

31/03/2008<br />

31/12/2008<br />

30/09/2009<br />

Leverage multiple (LHS) Price/book multiple (RHS)<br />

5.0<br />

4.5<br />

4.0<br />

3.5<br />

3.0<br />

2.5<br />

2.0<br />

1.5<br />

1.0<br />

0.5<br />

0.0<br />

http://www.execution-noble.com<br />

BUY<br />

112% upside<br />

Fair Value 114p<br />

RIC, Bloomberg Code LLOY.L, LLOY LN<br />

Share Price 53.7p<br />

Market Capitalisation £35,975m<br />

Free Float 57%<br />

£m (unless stated) 2009 2010E 2011E 2012E<br />

Pre-provision profit 12,355 12,634 13,096 12,860<br />

Pre-tax profit -6,815 4,416 8,249 8,991<br />

Adjusted net profit 2,827 3,774 6,399 6,989<br />

EPS adj (p) 4.1 5.6 9.6 10.4<br />

DPS(p) 0.0 0.0 0.0 3.3<br />

BVps(p) 63 68 78 88<br />

BVps (adj) (p) 54 59 69 79<br />

LLP as % loans -3.5% -1.7% -0.8% -0.7%<br />

Cost income ratio (%)<br />

Pre-APS<br />

48.4% 45.5% 44.4% 44.2%<br />

Figures are pro forma HBOS<br />

X (unless stated) 2009 2010E 2011E 2012E<br />

Adjusted P/E 13.0 9.5 5.6 5.1<br />

Pre-provision multiple 1.9 2.8 2.7 2.8<br />

Price / book 0.9 0.8 0.7 0.6<br />

Price / adj book 1.0 0.9 0.8 0.7<br />

Yield (%) 0.0% 0.0% 0.0% 6.2%<br />

ROE (%) 7.4% 8.6% 13.1% 12.5%<br />

ROE (adj) (%) 5.8% 9.9% 14.9% 14.1%<br />

Core Tier 1 ratio (%)<br />

Pre-APS<br />

Figures are pro forma HBOS<br />

8.0% 9.1% 11.3% 13.2%<br />

Analysts<br />

Joseph Dickerson<br />

+44 20 7426 4228<br />

joseph.dickerson@execution-noble.com<br />

Page 17 of 44


THIRD QUARTER 2010<br />

Lloyds <strong>Bank</strong>ing Group<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: BUY PER (adjusted) (x) -1.2 13.1 9.6 5.7 5.2<br />

Fair Value: 114p Price/Pre Provis Profit per share (x) 4.0 2.9 2.9 2.8 2.8<br />

P/NAV (adjusted) (x) 0.43 1.00 0.91 0.79 0.68<br />

Share Price: 54p RoE (%) (adjusted) -33.9 -18.9 9.9 14.9 14.1<br />

Upside / Downside 111% RoRWA (%) -1.88 0.57 0.78 1.41 1.62<br />

Implied cost of equity (curve) (%) -17.0 10.0 15.6 14.5<br />

Bloomberg: LLOY Yield (net) (%) 0.0 0.0 0.0 0.0 5.8<br />

Key ratios 2008 2009 2010E 2011E 2012E<br />

Core tier 1 ratio 6.2 8.0 9.1 11.3 13.2<br />

Shares In Issue 66,993 Leverage ratio 40.1 26.7 23.1 18.8 15.7<br />

Market Cap 36,176 Cost income ratio 57.3 48.4 45.5 44.4 44.2<br />

Free Float 81% Loan loss charges / loans -2.20 -3.52 -1.67 -0.85 -0.71<br />

RoE (%) (adjusted) -33.9 -18.9 9.9 14.9 14.1<br />

NAV 2010E 39,649 RoA (stated) -0.86 0.26 0.38 0.68 0.77<br />

NAV per share 2010 0.6 RoRWA -1.88 0.57 0.78 1.41 1.62<br />

Forthcoming Catalysts<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

H1 results 4 August 2010 Net interest income 14,903 12,726 13,582 13,836 13,333<br />

Total non interest income 6,452 11,238 9,588 9,718 9,718<br />

Total gross operating income 21,355 23,964 23,170 23,554 23,051<br />

Costs -12,236 -11,609 -10,536 -10,458 -10,190<br />

Pre Provision Net Operating Income 9,119 12,355 12,634 13,096 12,860<br />

Execution Noble Analysts Loan loss charges -14,880 -23,988 -10,673 -5,153 -4,164<br />

Post provision profit -5,761 -5,533 4,461 8,244 8,998<br />

Joseph Dickerson Pre Tax Profit -9,230 -6,815 4,416 8,249 8,991<br />

(44) 20 7456 4228 Net profit -9,218 2,827 3,774 6,399 6,989<br />

joseph.dickerson@execution-noble.com<br />

EPS adj. -0.43 0.04 0.06 0.10 0.10<br />

Growth rates % 2008 2009 2010E 2011E 2012E<br />

Operating income -2 12 -3 2 -2<br />

Pre provision profit -22 35 2 4 -2<br />

EPS adj. -260 -110 36 70 9<br />

NAV (adjusted)/share -4 -57 9 16 15<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Total adj assets 1,098,841 969,213 916,610 867,348 832,285<br />

Goodwill & Intangibles 6,731 5,779 6,183 6,183 6,183<br />

Shareholders' Equity (adjusted) 27,386 36,279 39,649 46,048 53,051<br />

NAV (adjusted)/share 1.3 0.5 0.6 0.7 0.8<br />

NAV per share 1.6 0.6 0.7 0.8 0.9<br />

RWA 498,500 493,300 468,877 436,226 426,190<br />

Tier 1 equity 47,368 51,056 49,655 56,054 63,057<br />

Core tier 1 equity 30,680 39,325 42,752 49,151 56,154<br />

http://www.execution-noble.com<br />

Page 18 of 44


THIRD QUARTER 2010<br />

Mitchells and Butlers<br />

Margin expansion on track<br />

Operating margin expansion is key to upgrades at MAB and the early<br />

signs from 1H suggest it is on track to hit its three year target. The<br />

market remains skeptical, but two strong IMS statements this quarter<br />

should help build confidence in the story. Whilst, consumer concerns<br />

remain, MAB is stretching average spend northwards replacing price<br />

sensitive consumers with more affluent ones. This will help it pass<br />

through price increases in advance of the VAT hike and offer<br />

protection should spending further deteriorate. Buy, Fair Value 360p.<br />

Target of 200-300bps is ambitious, but not unrealistic<br />

MAB’s operating margin seems to lag the food led competition, on a lease adjusted<br />

basis, despite operating from a larger estate. Management is targeting a c.200-<br />

300bps increase from the FY2009 operating margin (15.3%) over the next three<br />

years. Achieving this would imply a margin more in kilter with the competition.<br />

Big divide between consensus and the company<br />

MAB told us that there is a ‘big divide between consensus and what we think we<br />

can do’ as the market, including us, has not fully factored in the targeted margin<br />

expansion into estimates. Already, MAB surprised the market with an impressive 1H<br />

margin performance (albeit partly due to one-offs). A flat 2H margin will still imply<br />

a c.70bps improvement this year, positioning it on track to hit its year three target.<br />

MAB recognises the food opportunity<br />

In our Nov 2009 Pub survey we highlighted that consumers were willing to spend<br />

more per meal than what most pubcos charge. MAB appear to be have recognized<br />

this and started to push up average spend per head in 1H. MAB believes this<br />

strategy has seen it replace some of its more price sensitive consumers with more<br />

affluent ones. This is clearly an opportunity to drive LFL sales and margins for the<br />

business and reduces exposure from the more price sensitive demographics.<br />

MAB best positioned to pass through inflation<br />

VAT is going up, and we may yet see a hike in duty announced in the autumn, but<br />

MAB dealt with these issues relatively easily last year. Consumer weakness remains<br />

a concern so pushing through inflation is going to be tough, but we believe MAB is<br />

the best equipped pubco to do this successfully due to its multi brand strategy. At<br />

the same time, its food led offer protects it against increases in alcohol duty while<br />

VAT increases should aid its strategy of gaining more affluent consumers who are<br />

trading down from more expensive alternatives.<br />

World Cup washout a good thing…sunshine remains key<br />

The World Cup is a net negative for MAB due to its food led estate, but a poor<br />

show by England ended any trading fears. Additionally, Whitbread said the impact<br />

from the first two England games was less than expected on its pub restaurants. Of<br />

more importance to MAB is the weather, and although a barbeque is a growing<br />

temptation, as long as the sun is shining the pub trade will benefit.<br />

IMS statements to give market confidence over margins<br />

Confidence over the margin performance will lead to upgrades and with two IMS<br />

statements this quarter (22 July and late September) the opportunity exists to give<br />

the market plenty of assurance. LFL comps get tougher in 2H, but there has been<br />

nothing from the competition to suggest trade has collapsed. Nonetheless, MAB’s<br />

share price has slipped 13% relative to the FTSE All Share since its positive 1H. On<br />

an EV/EBITDA basis, MAB trades on 8.1x our calendar 2010 estimates (sector<br />

average of 8.5x). Additionally, applying a 15% discount to its EPRA adjusted NAV<br />

(to account for its non REIT status) implies a value of 345p per share. Buy.<br />

http://www.execution-noble.com<br />

BUY<br />

31.4% upside<br />

Fair Value 360p<br />

RIC, Bloomberg Code MAB.L, MAB LN<br />

Share Price 274p<br />

Market Capitalisation £1,118m<br />

Free Float 52%<br />

£m (unless stated) 2008 2009 2010E 2011E<br />

Sales 1,908 1,958 1,979 2,013<br />

Ebitda 477 428 435 458<br />

EPS (p) 30.6 23.5 25.7 30.4<br />

Dividend (p) 5 0 0 10<br />

FCF post asset churn 190 234 156 177<br />

Net Debt (2,735) (2,600) (2,444) (2,444)<br />

X (unless stated) 2008 2009 2010E 2011E<br />

EV/Sales 2.0 1.9 1.8 1.8<br />

EV/Ebitda 8.1 8.7 8.2 7.8<br />

PE 8.9 11.6 10.7 9.0<br />

Dividend Yield (%) 1.7% 0.0% 0.0% 3.6%<br />

FCF Yield (%) 17.0% 20.9% 14.0% 15.8%<br />

Net Debt/Ebitda 5.7 6.1 5.6 5.3<br />

Analysts<br />

Alistair Macdonald<br />

+44 20 7456 9126<br />

alistair.macdonald@execution-noble.com<br />

Geetanjali Sharma<br />

+44 20 3364 6774<br />

geetanjali.sharma@execution-noble.com<br />

Caroline Gulliver<br />

+44 20 7456 9173<br />

caroline.gulliver@execution-noble.com<br />

Page 19 of 44


THIRD QUARTER 2010<br />

Mitchells & Butlers<br />

Valuation Metrics Sept 2009 Sept 2010E Sept 2011E Sept 2012E Sept 2013E<br />

Recommendation: BUY Execution P/E 11.6 10.7 9.0 7.9 7.3<br />

Fair Value: 360.0p Reported P/E 279.5 10.7 9.0 7.9 7.3<br />

EV / Sales 1.8 1.8 1.8 1.7 1.7<br />

Share Price: 274p EV / EBITDA 8.3 8.2 7.8 7.5 7.3<br />

Upside / Downside 31.4% EV / EBIT 11.9 11.7 10.9 10.4 10.1<br />

FCF Yield 9.3% 7.6% 6.5% 6.2% 6.3%<br />

Previous Fair Value 300p Dividend yield 0.0% 0.0% 3.6% 4.4% 4.7%<br />

% change to fair value 20.0% REP Ratio 0.99 1.01 1.08 1.11 1.13<br />

NAV 244 274 302 320 339<br />

Bloomberg: BBG Code LFL sales % 2% 1% 3% 3% 2%<br />

T-One: MAB NAV goodwill adjusted 244 274 302 320 339<br />

Model Published On: 01 July 2010 EPRA+ 377 406 433 453 472<br />

Key ratios Sept 2009 Sept 2010E Sept 2011E Sept 2012E Sept 2013E<br />

Shares In Issue (Less Treasury) 408<br />

Market Cap 1,118 EBITDA margin 21.9% 22.0% 22.8% 23.3% 23.4%<br />

Net Debt 2,444 EBIT margin 15.3% 15.4% 16.2% 16.7% 16.8%<br />

Adjustments For Associates & Minorities 0 Capex / Revenue 6.2% 7.1% 8.9% 8.6% 8.5%<br />

Enterprise Value 3,562 Capex / Depreciation 0.95 1.08 1.36 1.31 1.30<br />

Net Pension Deficit -130 Net Debt / EBITDA 6.1 5.6 5.0 4.6 4.3<br />

EBITDA / Net Interest 2.0 2.7 3.0 3.3 3.5<br />

ROE 0.4% 9.4% 10.1% 10.9% 11.0%<br />

Forthcoming Catalysts<br />

Adj ROCE 7.0% 7.6% 8.2% 8.7% 9.0%<br />

Third quarter results 22 July 2010<br />

Fourth quarter results September 2010<br />

Full year results November 2010 P&L Summary Sept 2009 Sept 2010E Sept 2011E Sept 2012E Sept 2013E<br />

First quarter results January 2011<br />

Second quarter results April 2011 Revenue 1,958 1,979 2,013 2,052 2,094<br />

Interims results May 2011 % change 1.1% 1.7% 1.9% 2.0%<br />

EBITDA 428 435 458 478 489<br />

% change 1.5% 5.4% 4.2% 2.5%<br />

Execution Analyst % margin 21.9% 22.0% 22.8% 23.3% 23.4%<br />

Alistair Macdonald Depreciation & Amortisation -128 -129 -132 -134 -137<br />

(44) 20 7456 9126 EBIT 300 305 326 343 352<br />

alistair.macdonald@executionlimited.com % change 1.7% 7.0% 5.2% 2.7%<br />

% margin 15.3% 15.4% 16.2% 16.7% 16.8%<br />

Operating Profit 300 305 326 343 352<br />

Revenue Breakdown Net Financials -217 -158 -152 -144 -138<br />

Pre Tax Profit 83 147 175 200 214<br />

Income Tax Expense 14 -42 -51 -58 -62<br />

Net Income 4 105 124 142 152<br />

Execution Net Income 96 105 124 142 152<br />

Operating Profit Breakdown<br />

Reported EPS 1.0 25.7 30.4 34.8 37.3<br />

Execution EPS 23.5 25.7 30.4 34.8 37.3<br />

DPS (p) 0.0 0.0 10.0 12.0 13.0<br />

Payout Ratio 0.0% 0.0% 32.9% 34.5% 34.8%<br />

Shares In Issue (Less Treasury) 408 408 408 408 408<br />

Cash Flow Summary Sept 2009 Sept 2010E Sept 2011E Sept 2012E Sept 2013E<br />

EBITDA 428 435 458 478 489<br />

Taxes Paid 25 -2 -25 -58 -62<br />

Interest Paid / Received -160 -158 -152 -144 -138<br />

Change in Working Capital 0 -22 -23 -23 -23<br />

Operating cash flow 293 252 258 253 266<br />

Capital Expenditure -122 -140 -180 -176 -178<br />

Free Cash Flow 171 112 78 76 88<br />

Acquisitions & Disposals 65 44 99 53 48<br />

Dividends Paid To Shareholders 0 0 -12 -43 -50<br />

Equity Raised / Bought Back 4 0 0 0 0<br />

Other Financing Cash Flow -97 0 0 0 0<br />

Net Cash Flow 143 156 165 87 86<br />

Margin Trends Balance Sheet Summary Sept 2009 Sept 2010E Sept 2011E Sept 2012E Sept 2013E<br />

Margin<br />

25%<br />

20%<br />

15%<br />

10%<br />

5%<br />

0%<br />

Restaurants<br />

51%<br />

Restaurants<br />

47%<br />

Pubs & Bars<br />

49%<br />

Pubs & Bars<br />

53%<br />

2009 20010E 2011E 2012E 2013E<br />

EBITDA margin EBIT margin<br />

Cash & Equivalents 107 97 97 97 97<br />

Tangible Fixed Assets 4,461 4,428 4,377 4,365 4,359<br />

Goodwill & Intangibles 0 0 0 0 0<br />

Associates & Financial <strong>Investment</strong>s 25 25 25 25 25<br />

Other Assets 176 177 178 179 180<br />

Total Assets 4,769 4,727 4,677 4,667 4,661<br />

Interest Bearing Debt 2,707 2,541 2,376 2,289 2,203<br />

Other Liabilities 1,065 1,068 1,070 1,071 1,073<br />

Total Liabilities 3,772 3,609 3,445 3,360 3,276<br />

Shareholders' Equity 997 1,118 1,232 1,306 1,385<br />

Total Equity 997 1,118 1,232 1,306 1,385<br />

Net Debt 2,600 2,444 2,279 2,192 2,106<br />

http://www.execution-noble.com<br />

Page 20 of 44


THIRD QUARTER 2010<br />

Prysmian<br />

Order book recovering, profits will follow<br />

Prysmian’s orderbook for higher margin products has recovered<br />

during the 2Q which gives us increased confidence on 2010 earnings.<br />

2011 should see strong earnings growth due to more profitable<br />

Transmission, Submarine and OGP projects flowing through<br />

Prysmian’s P&L. We continue to believe the stock is inexpensive,<br />

trading on 6.9x 2011E EV/EBITA versus the sector on 9.2x. Our target<br />

multiple of 9.0x 2011E EV/EBITA implies a fair value of €17.5 per<br />

share. We reiterate our Buy rating.<br />

T&D newsflow and orderbook are recovering<br />

Prysmian’s order book fell from 5.4 months to 4.7 months during 1Q2010, due to<br />

unfavorable weather conditions for the T&D businesses and continued investment<br />

uncertainty. Over the 2Q, newsflow and orders have improved markedly, with<br />

Siemens now publicly stating power orders have troughed, some high profile T&D<br />

orders and most other power players reporting more supportive conditions. This<br />

has bolstered Prysmian’s order book materially and the company now has 5.9<br />

months of orders for the group. High Voltage has increased from 6.0 to 9.0<br />

months during the 2Q, Power Distribution from 3.0 to 4.5 and Industrial from 4.0<br />

to 5.3. This should give investors improved confidence both on 2010 guidance and<br />

the potential for growth in 2011.<br />

2011 earnings growth driven by Utilities and OGP<br />

Our 2011 adj EBITDA growth is primarily driven the Utilities business (which<br />

comprises the High Voltage, Distribution and Submarine businesses) and Industrial<br />

(which includes Oil, Gas and Petrochemicals (OGP) and Nuclear). Both of these<br />

businesses are long-cycle and order-driven and the recovery in orderbook gives<br />

considerable visibility on 2011 earnings. In the case of the OGP business, Prysmian<br />

has a firm order from Petrobras for flexible flowlines worth $600mn in revenues<br />

with a 30% EBITDA margin. In the Utilities business the recent Borwind2 order<br />

carries a value of €200mn and will impact revenues over the next three years. We<br />

have not assumed a dramatic improvement in the more cyclical short-cycle<br />

businesses such as Trade and Installer (T&I) and the remainder of Industrial: we<br />

assume T&I generates only €9mn additional EBITDA in 2011 and that Industrial<br />

(excluding Nuclear and OGP) is flat. We believe our estimates are achievable even<br />

without incremental economic recovery.<br />

Optical fibre a big potential positive for Telecom<br />

We continue to believe that it is a matter of when, rather than if, European<br />

Telecom operators implement a large expansion of European fibre networks.<br />

Smaller cable companies are able to offer higher performance and a more<br />

competitive price than incumbent operators which is allowing the cable players to<br />

take significant market share. TEF and DT recently raised capex guidance for 2010<br />

to reflect the requirement for increased fibre rollout but this is yet to be confirmed<br />

as orders. We estimate the European market could see between €1bn and €2bn<br />

incremental revenues during the rollout phase, which given Prysmian’s 15% market<br />

share and 15% EBITDA margin in the business could generate between €23 and<br />

€45 additional EBITDA, or 6% to 11% upside to FY2009 reported adj EBITDA. .<br />

Valuation: €17.5 price target on xxx 2011E EV/EBITA<br />

With the sector now trading on 9.2x 2011E EV/EBITA and Prysmian’s outlook<br />

relative to the remainder of the sector looking highly attractive, we feel<br />

comfortable at a target multiple of 9.0x 2011EV/EBITA giving a price target of<br />

€17.5. On DCF we find fair value of €18.0 for Prysmian and we note that Prysmian<br />

offers very good value on 15% 2011E FCF yield at the current price. The dividend<br />

yield of 3.7% for 2011E is very well supported in our view.<br />

http://www.execution-noble.com<br />

BUY<br />

41% upside<br />

Fair Value € 17.5<br />

RIC, Bloomberg Code PRY.MI, PRY IM<br />

Share Price € 12.4<br />

Market Capitalisation $3,654m<br />

Free Float 83%<br />

€m (unless stated) 2009 2010E 2011E 2012E<br />

Sales 3,731 3,881 4,254 4,530<br />

Adjusted EBITA 315 307 394 451<br />

Adjusted EPS 1.1 1.0 1.4 1.7<br />

Dividend 0.4 0.3 0.4 0.5<br />

FCF* 252 214 324 301<br />

EV Adjustments** 23 174 235 297<br />

Net Debt 544 410 145 -71<br />

* FCF = EBITDA - capex - NWC - int ex. - tax<br />

** Pension, Tax, Equity and non-consolidated assets<br />

X (unless stated) 2009 2010E 2011E 2012E<br />

EV/Sales 0.7 0.7 0.6 0.5<br />

EV/EBITA Adjusted 8.1 9.2 6.7 5.5<br />

P/E Adjusted 10.0 12.5 8.6 7.1<br />

Dividend Yield (%) 3.4% 2.4% 3.5% 4.3%<br />

FCF Yield (%) 12.7% 9.5% 14.4% 13.3%<br />

Net Debt/EBITDA 1.4 1.1 0.3 -0.1<br />

Analysts<br />

Nick Paton, CFA<br />

+44 20 7456 1190<br />

nick.paton@execution-noble.com<br />

Rob Virdee<br />

+44 20 7456 9222<br />

rob.virdee@execution-noble.com<br />

Page 21 of 44


THIRD QUARTER 2010<br />

Prysmian<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: BUY Execution P/E 11.5 10.0 12.0 8.2 6.8<br />

Fair Value: 17.5 Reported P/E 10.5 8.0 12.1 8.2 6.8<br />

EV / Sales 0.6 0.7 0.7 0.6 0.5<br />

Share Price: EUR 11.8 EV / EBITDA 5.8 6.6 7.2 5.4 4.5<br />

Upside / Downside 47.6% EV / EBITA 6.7 8.1 8.9 6.4 5.3<br />

FCF Yield 15.6% 12.7% 9.9% 15.0% 14.0%<br />

Previous Fair Value EUR 18.5 Dividend yield 3.5% 3.5% 2.5% 3.7% 4.5%<br />

% change to fair value -5.5%<br />

Bloomberg: PRY IM Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: I:PRY<br />

Model Published On: 03 July 2010 EBITDA margin 10.5% 10.8% 10.2% 11.1% 11.7%<br />

Adj. EBITA margin 9.2% 9.0% 8.3% 9.4% 10.1%<br />

Capex / Revenue 2.3% 2.9% 1.8% 1.8% 1.8%<br />

Shares In Issue 182m Capex / Depreciation 1.66 1.55 0.95 1.04 1.10<br />

Market Cap 2,155 Net Debt / EBITDA 1.2 1.3 1.0 0.3 -0.1<br />

Net Debt 410 EBITDA / Net Interest 3.3 7.8 6.8 16.9 66.1<br />

Adjustments For Associates & Minorities 23 ROE 53% 37% 23% 27% 26%<br />

Net Pension Deficit 148<br />

Tax Loss carry forward -97<br />

Umbilicals fine 100 P&L Summary 2008 2009 2010E 2011E 2012E<br />

Enterprise Value (Dec 2010E) 2,738<br />

Revenue 5,144 3,731 3,881 4,254 4,530<br />

% change 0.5% -27.5% 4.0% 9.6% 6.5%<br />

Forthcoming Catalysts Adj. EBITDA 542 403 394 473 531<br />

% change 2.4% -25.6% -2.2% 20.1% 12.3%<br />

Q2 2009 Results 03 August 2010 % margin 10.5% 10.8% 10.2% 11.1% 11.7%<br />

Q3 2009 Results 10 November 2010 Depreciation & Amortisation -70 -69 -74 -73 -74<br />

Adj. EBIT 472 334 320 400 457<br />

% change 3.0% -29.2% -4.1% 24.7% 14.4%<br />

% margin 9.2% 9.0% 8.3% 9.4% 10.1%<br />

Operating Profit 448 386 307 394 451<br />

Execution Analyst Associates 3 3 2 2 2<br />

Nick Paton, CFA Net Financials -165 -52 -58 -28 -8<br />

(44) 20 7456 1190 Pre Tax Profit 286 337 251 368 445<br />

nick.paton@executionlimited.com Income Tax Expense -51 -85 -72 -105 -127<br />

Minority Interests 2 -4 -2 -1 -1<br />

Net Income 237 248 177 262 317<br />

Revenue Breakdown Execution Net Income 218 198 180 262 317<br />

Reported EPS 1.30 1.36 0.97 1.44 1.74<br />

Execution EPS 1.20 1.09 0.99 1.44 1.74<br />

DPS 0.42 0.42 0.30 0.44 0.53<br />

Payout Ratio 32.0% 30.6% 30.6% 30.6% 30.6%<br />

Shares in Issue 182m 182m 182m 182m 182m<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

Pre Tax Profit 286 337 251 368 445<br />

Depreciation & Amortisation 66 71 74 73 74<br />

Taxes Paid -83 -62 -72 -105 -127<br />

EBIT Breakdown Net Financials 165 52 58 28 8<br />

Change in Working Capital 66 36 25 50 -20<br />

Other Operating Cash Flow 5 -75 -52 -14 2<br />

Operating cash flow 505 359 284 400 382<br />

Capital Expenditure -116 -107 -70 -77 -82<br />

Free Cash Flow 389 252 214 324 300<br />

Acquisitions & Disposals -12 11 -4 -4 -5<br />

Dividends Paid To Shareholders -76 -75 -76 -54 -80<br />

Equity Raised / Bought Back 0 0 0 0 0<br />

Other Financing Cash Flow -167 -61 0 0 0<br />

Net Cash Flow 134 127 134 265 216<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Margin Trends Cash & Equivalents 492 492 626 891 1,107<br />

Tangible Fixed Assets 806 872 874 882 895<br />

14%<br />

Goodwill & Intangibles 31 43 41 40 40<br />

12%<br />

Associates & Financial <strong>Investment</strong>s 76 62 64 68 72<br />

10%<br />

Other Assets<br />

Total Assets<br />

1,693<br />

3,098<br />

1,575<br />

3,044<br />

1,588<br />

3,193<br />

1,633<br />

3,516<br />

1,724<br />

3,838<br />

8%<br />

Interest Bearing Debt 1,158 1,036 1,036 1,036 1,036<br />

6%<br />

Other Liabilities 1,477 1,310 1,356 1,470 1,554<br />

4%<br />

Total Liabilities 2,635 2,346 2,392 2,506 2,590<br />

2%<br />

Shareholders' Equity<br />

Minority Interests<br />

447<br />

16<br />

677<br />

21<br />

779<br />

23<br />

986<br />

24<br />

1,223<br />

25<br />

0%<br />

2008 2009 2010E 2011E 2012E<br />

Total Equity 463 698 802 1,010 1,248<br />

Adj. EBITDA margin Adj. EBITA margin<br />

Net Debt 666 544 410 145 -71<br />

Margin<br />

Industrial<br />

17%<br />

Trade and<br />

Installer<br />

27%<br />

Telecom<br />

6%<br />

Industrial<br />

11%<br />

Telecom<br />

11%<br />

Other<br />

24%<br />

Trade and<br />

Installer<br />

4%<br />

Other<br />

2%<br />

Utilities<br />

43%<br />

Utilities<br />

55%<br />

http://www.execution-noble.com<br />

Page 22 of 44


THIRD QUARTER 2010<br />

Reed Elsevier<br />

Trading buy ahead of numbers<br />

We believe that Reed Elsevier will give a positive message at interim<br />

results on 29th July: an improvement in the group’s organic revenue<br />

growth could be accompanied by an encouraging outlook for H2<br />

margins, in our view. We remain concerned long term, but we see a<br />

short term buying opportunity.<br />

Improving results<br />

At the last trading statement in April, Reed Elsevier reiterated its previous trading<br />

outlook: i) slower growth for the STM division; ii) weak revenue for the legal<br />

division; iii) lower revenues for B2B, after adjusting for positive effect of biennial<br />

shows; iv) modest reduction in 2010 group operating margin due to investments in<br />

legal. But such conservative guidance hides a significant improvement from the 7%<br />

organic revenue decline recorded in 2009, in our view. We forecast -1% revenue<br />

growth in H1, though partly due to mechanical factors such as 1- the consolidation<br />

of Choicepoint (~100bps contribution to group organic growth), 2- the change in<br />

accounting standards of the directory segment (50bps positive contribution) and<br />

3- the partial disposal of the business information plus cyclical recovery of the<br />

exhibition units (400bps positive contribution).<br />

Legal restructuring uncertain<br />

Many more quarters will be necessary before the market will be able to judge on<br />

the complete restructuring of the legal segments, but Reed Elsevier is moving in<br />

the right direction, in our view. Increased focus on new products’ development<br />

may succeed in filling the gap opened versus Thomson Reuters’ Westlaw during<br />

the years of under-investment. However, our law librarian survey still shows no<br />

significant improvement in preferences for Reed Elsevier. US legal headcount trend<br />

has improved from 3.4% decline in 2009 to only 1.9% decline in May, but budget<br />

expectations for 2010 are still conservative (please see Figure 1 below). Longer<br />

term, we believe that increased competition from Thomson Reuters and continued<br />

weakness in the reference market will put further pressure on margins.<br />

Figure 1: Legal survey shows budgets under pressure<br />

10.0%<br />

5.0%<br />

0.0%<br />

-5.0%<br />

-10.0%<br />

-15.0%<br />

-2.2%<br />

Source: ExecutionNoble<br />

Valuation<br />

-3.8%<br />

summer 2009 "panic"<br />

-11.7%<br />

-0.8%<br />

-2.0%<br />

-3.2%<br />

Q109 Q209 Q309 Q409 Q1 10 Q2 10<br />

Headcount Price Budget<br />

Expectations<br />

w orsening in 2010<br />

On our estimates (broadly in line with consensus for EPS 10, but ~15% below<br />

consensus on EPS 2011-12), Reed Elsevier trades in line with industry peers on PE<br />

‘10E. The stock has underperformed the media sector by 10% since we upgraded to<br />

hold in April and consensus EPS 2010 remained stable. We reaffirm our hold rating<br />

and target price of 480p / eu8.4.<br />

http://www.execution-noble.com<br />

HOLD<br />

4% downside<br />

Fair Value 480p<br />

RIC, Bloomberg Code REL.L, REL LN<br />

Share Price 499.0p<br />

Market Capitalisation £5,696m<br />

Free Float 100%<br />

(GBPm) 2008A 2009A 2010E 2011E<br />

Revenues 5,334 6,071 5,939 6,075<br />

Adj. EBITDA 1,340 1,540 1,699 1,704<br />

Adj. EBITA 1,379 1,570 1,527 1,488<br />

Adj. EPS (GBp)* 44.2 45.5 42.4 39.8<br />

Dividend (GBp) 20.3 20.4 20.4 20.0<br />

FCF** 889 780 954 986<br />

Net Debt 5,767 3,972 3,673 3,184<br />

* fully diluted, ex. GW amortisation<br />

** FCF = EBITDA - capex - NWC - int ex. - tax<br />

2008A 2009A 2010E 2011E<br />

EV/Sales*** 3.2x 2.6x 2.7x 2.6x<br />

EV/Ebitda*** 12.6x 10.1x 9.3x 9.3x<br />

EV/EBITA*** 12.2x 9.9x 10.4x 10.7x<br />

P/E*** 12.2x 11.8x 12.6x 13.4x<br />

Dividend Yield*** 3.8% 3.8% 3.8% 3.8%<br />

FCF Yield*** 8.0% 6.8% 7.9% 7.7%<br />

Net Debt/Ebitda 4.3x 2.6x 2.2x 1.9x<br />

*** adjusted for Pension, tax and other assets/liabilities<br />

Analysts<br />

Giasone Salati<br />

+44 20 7456 1163<br />

giasone.salati@execution-noble.com<br />

Mark Evans<br />

+44 20 3364 6753<br />

mark.evans@execution-noble.com<br />

Page 23 of 44


THIRD QUARTER 2010<br />

Reed Elsevier (PLC)<br />

Valuation Metrics 2008A 2009A 2010E 2011E 2012E<br />

Recommendation: HOLD Execution P/E 12.2 11.8 12.6 13.4 13.3<br />

Fair Value: GBp 480 Reported P/E 22.8 29.2 19.0 19.8 18.5<br />

EV / Sales 3.2 2.6 2.7 2.6 2.5<br />

Share Price: GBp 499 EV / EBITDA 12.6 10.1 9.3 9.3 8.8<br />

Upside / Downside -3.8% EV / EBITA 12.2 9.9 10.4 10.7 10.4<br />

FCF Yield 8.0% 6.8% 7.9% 7.7% 8.5%<br />

Previous Fair Value GBp 350 Dividend yield 3.8% 3.8% 3.8% 3.8% 3.8%<br />

% change to fair value 37.1%<br />

Bloomberg: REL LN Key ratios 2008A 2009A 2010E 2011E 2012E<br />

T-One: REL-LN<br />

Model Published On: 05 July 2010 EBITDA margin 19.7% 16.4% 22.2% 21.8% 21.9%<br />

EBIT margin 16.6% 12.7% 17.9% 17.3% 17.3%<br />

Capex / Revenue 3.2% 4.0% 5.0% 5.0% 5.0%<br />

Shares In Issue (Less Treasury) 1,141 Capex / Depreciation 1.03 1.09 1.16 1.11 1.08<br />

Market Cap 5,696 Net Debt / Adj. EBITDA 4.3 2.6 2.2 1.9 1.5<br />

Net Debt 3,673 EBITDA / Net Interest 3.7 2.8 4.9 5.4 6.7<br />

Adjustments 816 ROE 25% 11% 17% 16% 16%<br />

Enterprise Value 10,185<br />

Net Pension Deficit -380<br />

P&L Summary 2008A 2009A 2010E 2011E 2012E<br />

Forthcoming Catalysts Revenue 5,334 6,071 5,939 6,075 6,360<br />

% change 16.4% 13.8% -2.2% 2.3% 4.7%<br />

Interim management statement 20 April 2010 EBITDA 1,050 995 1,319 1,324 1,394<br />

AGM 21 April 2010 % change 2.9% -5.2% 32.5% 0.4% 5.3%<br />

Half year results 29 July 2010 % margin 19.7% 16.4% 22.2% 21.8% 21.9%<br />

Interim management statement 18 November 2010 Depreciation & Amortisation -167 -223 -255 -273 -295<br />

Full year results expected 18 February 2011 EBIT 883 772 1,063 1,050 1,099<br />

% change 1.3% -12.6% 37.7% -1.2% 4.7%<br />

% margin 16.6% 12.7% 17.9% 17.3% 17.3%<br />

Associates 18 15 15 16 16<br />

Execution Analyst Operating Profit 901 787 1,078 1,066 1,116<br />

Giasone Salati Net Financials -284 -352 -268 -247 -207<br />

+44 20 7456 1163 Other Pre-tax Income 0 0 0 0 0<br />

giasone.salati@execution-noble.com Pre Tax Profit 617 435 811 819 908<br />

Income Tax Expense -155 -40 -186 -188 -219<br />

Minority Interests -4 -4 -4 -4 -4<br />

Revenue Breakdown Net Income (PLC) 241 195 316 319 349<br />

International<br />

Legal<br />

Execution Net Income (PLC) 486 519 511 503 518<br />

Reported EPS 21.90 17.07 26.22 25.19 26.95<br />

Execution EPS 44.22 45.51 42.40 39.78 39.97<br />

DPS 20.30 20.40 20.44 20.05 20.14<br />

Payout Ratio 45.5% 44.4% 47.8% 50.0% 50.0%<br />

Shares In Issue (Less Treasury) 1,100 1,141 1,204 1,265 1,296<br />

Cash Flow Summary 2008A 2009A 2010E 2011E 2012E<br />

EBITDA 1,340 1,540 1,699 1,704 1,774<br />

Taxes Paid -215 -120 -124 -128 -141<br />

Operating Profit Breakdown Interest Paid / Received -179 -293 -268 -247 -207<br />

Margin Trends<br />

Margin<br />

Exhibitions<br />

11%<br />

Business<br />

information<br />

12%<br />

Exhibitions<br />

10%<br />

International<br />

Legal<br />

7%<br />

25%<br />

20%<br />

15%<br />

10%<br />

5%<br />

0%<br />

North<br />

American<br />

Legal<br />

32%<br />

9%<br />

Scientific<br />

34%<br />

Business<br />

information<br />

5%<br />

North<br />

American<br />

Legal<br />

34%<br />

Scientific<br />

46%<br />

2008A 2009A 2010E 2011E 2012E<br />

EBITDA margin EBIT margin<br />

Change in Working Capital 69 59 7 -7 -14<br />

Associate & Minority Dividends 23 23 15 16 16<br />

Other Operating Cash Flow -2 -164 -63 -32 18<br />

Operating cash flow 1,036 1,045 1,266 1,305 1,446<br />

Capital Expenditure -172 -242 -297 -304 -318<br />

Free Cash Flow 864 803 969 1,001 1,128<br />

Acquisitions & Disposals -2,152 -95 50 0 0<br />

Dividends Paid To Shareholders -418 -457 -486 -512 -517<br />

Equity Raised / Bought Back -40 834 0 0 0<br />

Other Financing Cash Flow -343 -895 -235 0 0<br />

Net Cash Flow -2,089 190 299 489 612<br />

Balance Sheet Summary 2008A 2009A 2010E 2011E 2012E<br />

Cash & Equivalents 375 734 734 734 734<br />

Tangible Fixed Assets 329 292 334 364 387<br />

Goodwill & Intangibles 9,305 7,971 7,591 7,211 6,831<br />

Associates & Financial <strong>Investment</strong>s 194 176 176 176 176<br />

Other Assets 2,663 2,161 2,363 2,346 2,310<br />

Total Assets 12,866 11,334 11,197 10,830 10,438<br />

Interest Bearing Debt 6,142 4,706 4,407 3,918 3,307<br />

Other Liabilities 5,743 4,869 4,892 4,896 4,943<br />

Total Liabilities 11,885 9,575 9,300 8,815 8,250<br />

Shareholders' Equity 953 1,732 1,866 1,980 2,148<br />

Minority Interests 28 27 31 36 40<br />

Total Equity 981 1,759 1,898 2,016 2,188<br />

Net Debt 5,767 3,972 3,673 3,184 2,573<br />

http://www.execution-noble.com<br />

Page 24 of 44


THIRD QUARTER 2010<br />

Unilever<br />

King of cash<br />

Unilever is well down the line of delivering a sustainable operating<br />

performance driven primarily by top line volume growth. More<br />

importantly management is now incentivised to focus on this. We<br />

believe. Unilever’s strong cash conversion will now take greater<br />

precedence in the investment case. We recently upgraded our fair<br />

value by 10% (“Through to the next round” 24 June 2010) and<br />

Unilever is now our favourite stock in the Food sector.<br />

Our favourite food stock<br />

It took the recent investor trip to Anheuser-Busch InBev to remind us of one of<br />

Unilever’s undoubted qualities: it’s a strong cash generator. In fact, according to ABI,<br />

it is the best cash convertor of an exalted peer group. It’s always been a good cash<br />

generator, but in the past, owing to well founded concerns about its operating<br />

performance, this has missed the point from an investment perspective. In our view<br />

the operating performance looks increasingly sustainable for a number of reasons.<br />

• Emerging markets. It’s hardly breaking new ground to point out that with<br />

50% of its sales in emerging markets Unilever is more exposed to the<br />

growthier bits of the world than many others.<br />

• Europe. Unilever’s European business is predominantly a food business with<br />

lacklustre market dynamics. Europe is a good test of the extent to which the<br />

company is genuinely improving rather than being helped out by market<br />

growth. It seems to be responding to the Polman treatment.<br />

• Remuneration. The structure of directors’ compensation, particularly the<br />

focus on ‘underlying’ EPS, has been a big bugbear of ours. This has changed.<br />

Management’s interests are well aligned with those of shareholders now.<br />

Some quarterly volatility expected<br />

That said, the second half of 2010 is not going to be straightforward. As the<br />

commodity price ‘dividend’ rolls over, further increases in both A&P and margins<br />

are going to be more modest. Unilever’s primary focus is on re-invigorating top line<br />

volume growth with a key test case in Western Europe. As we move in to H2 this<br />

might not be compatible with quarterly margin expansion. The new business model<br />

calls for progressive incremental volume and revenue growth and annual<br />

improvement in operating margins. Looking at Unilever’s progress in the context of<br />

the last two years – so not just mirroring comps from 12 months ago – we believe it<br />

has scope to do both, even at the expense of potentially volatile quarterly<br />

performance.<br />

Stepping up to the plate<br />

We have been tepid buyers of Unilever so far this year. We believe that the market<br />

understands the risk of some quarterly volatility now, and that a properly<br />

sustainable operating model is emerging, facilitating a focus on Unilever’s strong<br />

cash conversion. We recently increased our fair value by 10% to reflect a closer<br />

alignment between capex and depreciation moving forward. Unilever already sits<br />

at the top of the table when it comes to cash conversion but it still has more to do<br />

– particularly in regard to creditor days. Contrary to popular opinion, the Unilever<br />

recuperation has not been reflected in superior share price performance and the<br />

shares have actually only performed in line with the consumer index (+2% vs SX3P)<br />

since Paul Polman was announced as incoming CEO – and have actually<br />

underperformed Nestle in a similar time frame (-8% currency adjusted). We are<br />

happy to re-iterate our Buy and install Unilever as a consumer Silver Bullet for the<br />

third quarter of 2010.<br />

http://www.execution-noble.com<br />

Unilever NV<br />

BUY<br />

19% upside<br />

Fair Value €26.9<br />

RIC, Bloomberg Code UNc.AS, UNA NA<br />

Share Price €22.54<br />

Market Capitalisation €65,141m<br />

Free Float 95%<br />

€m (unless stated) 2009 2010E 2011E 2012E<br />

Sales 39,823 43,663 46,159 48,546<br />

Ebitda 6,920 7,536 7,999 8,405<br />

EPS (€) 1 1.37 1.44 1.57 1.68<br />

Dividend (€) 0.76 0.83 0.91 0.97<br />

FCF 4,072 3,477 3,928 4,366<br />

Invested Capital 36,206 36,556 36,675 36,810<br />

Net Debt 6,357 5,187 3,784 2,171<br />

1. pre restructuring charges<br />

Unilever plc<br />

BUY<br />

23% upside<br />

Fair Value 2,209p<br />

RIC, Bloomberg Code ULVR.L, ULVR LN<br />

Share Price 1,801p<br />

Market Capitalisation £52,049m<br />

Free Float 100%<br />

£m (unless stated) 2009 2010E 2011E 2012E<br />

Sales 32,695 35,847 37,896 39,856<br />

Ebitda 5,681 6,187 6,567 6,901<br />

EPS (p) 1 95.7 118.0 128.5 137.9<br />

Dividend (p) 62.4 68.3 74.4 79.8<br />

FCF (£) 3,343 2,854 3,225 3,584<br />

Invested capital (£) 29,725 30,012 30,110 30,221<br />

Net Debt 5,219 4,258 3,107 1,782<br />

1. pre restructuring charges<br />

Page 25 of 44


THIRD QUARTER 2010<br />

Unilever<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: BUY Execution P/E 16.2 16.4 15.7 14.4 13.4<br />

Fair Value: EUR 26.9 Reported P/E 13.0 19.3 17.5 16.0 14.9<br />

EV / Sales 1.7 1.8 1.6 1.5 1.4<br />

Share Price: EUR 22.54 EV / EBITDA 10.2 10.2 9.6 9.1 8.6<br />

Upside / Downside 19.3% EV / EBIT 11.9 11.9 10.8 10.1 9.5<br />

FCF Yield 3.7% 6.3% 5.3% 6.0% 6.7%<br />

Previous Fair Value EUR 24.5 Dividend yield 3.4% 3.4% 3.7% 4.0% 4.3%<br />

% change to fair value 9.8%<br />

Bloomberg: UNA NA Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: UNA-AE<br />

Model Published On: 01 July 2010 EBITDA margin 17.0% 17.4% 17.3% 17.3% 17.3%<br />

EBIT margin 14.6% 14.8% 14.9% 15.1% 15.2%<br />

Capex / Revenue 2.7% 3.2% 3.5% 3.5% 3.5%<br />

Shares In Issue (Less Treasury) 2,890 Capex / Depreciation 1.12 1.22 1.48 1.57 1.65<br />

Market Cap 65,141 Net Debt / EBITDA 1.2 0.9 0.7 0.5 0.3<br />

Net Debt 6,357 EBITDA / Net Interest 17.2 16.1 21.0 27.7 38.4<br />

Adjustments For Associates & Minorities 0 ROE 41% 33% 31% 30% 29%<br />

Enterprise Value 71,498<br />

Net Pension Deficit 0<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Forthcoming Catalysts Revenue 40,523 39,823 43,663 46,159 48,546<br />

% change 0.8% -1.7% 9.6% 5.7% 5.2%<br />

Half Year 2010 results 05 August 2010 EBITDA 6,881 6,920 7,536 7,999 8,405<br />

Q3 2010 results 04 November 2010 % change 1.2% 0.6% 8.9% 6.1% 5.1%<br />

% margin 17.0% 17.4% 17.3% 17.3% 17.3%<br />

Depreciation & Amortisation -982 -1,032 -1,032 -1,032 -1,032<br />

EBIT 5,899 5,888 6,504 6,967 7,373<br />

% change 1.4% -0.2% 10.5% 7.1% 5.8%<br />

% margin 14.6% 14.8% 14.9% 15.1% 15.2%<br />

Execution Analyst<br />

James Edwardes Jones Net Financials -400 -429 -359 -289 -219<br />

(44) 20 7456 1697 Associates 131 115 3 3 3<br />

james.edwardesjones@executionlimited.com Other Pre-tax Income 231 210 -119 -119 -119<br />

Pre Tax Profit (underlying) 5,861 5,784 6,029 6,562 7,038<br />

Income Tax Expense -1,559 -1,527 -1,568 -1,706 -1,830<br />

Minority Interests -258 -289 -309 -331 -354<br />

Nor recurring items 983 -598 -437 -462 -485<br />

Revenue Breakdown Execution Net Income 4,044 3,968 4,153 4,525 4,854<br />

Reported Net Income 5,027 3,370 3,716 4,063 4,369<br />

Execution EPS 1.39 1.37 1.44 1.57 1.68<br />

Reported EPS 1.73 1.17 1.29 1.41 1.51<br />

DPS 0.77 0.76 0.83 0.91 0.97<br />

Payout Ratio 55.3% 55.3% 57.9% 57.9% 57.9%<br />

Shares In Issue (Less Treasury) 2,906 2,890 2,890 2,890 2,890<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

Americas<br />

Operating profit 7,167 5,020 6,068 6,505 6,888<br />

32%<br />

Depreciation 1,003 1,032 1,176 1,341 1,529<br />

Operating Profit Breakdown Taxes Paid -1,455 -959 -1,568 -1,706 -1,830<br />

Interest Paid / Received -382 -444 -359 -289 -219<br />

Margin Trends<br />

Margin<br />

20%<br />

18%<br />

16%<br />

14%<br />

12%<br />

Europe<br />

29%<br />

Europe<br />

28%<br />

Americas<br />

34%<br />

Asia/Africa<br />

39%<br />

Asia/Africa<br />

38%<br />

2008 2009 2010E 2011E 2012E<br />

EBITDA margin EBIT margin<br />

Change in Working Capital -161 1,701 50 50 -100<br />

Other Operating Cash Flow -2,683 -1,020 -363 -358 -203<br />

Operating cash flow 3,489 5,330 5,005 5,543 6,065<br />

Capital Expenditure -1,099 -1,258 -1,528 -1,616 -1,699<br />

Free Cash Flow 2,390 4,072 3,477 3,928 4,366<br />

Acquisitions & Disposals 2,265 -139 0 0 0<br />

Dividends Paid To Shareholders -2,086 -2,106 -2,306 -2,526 -2,752<br />

Equity Raised / Bought Back -1,400 103 0 0 0<br />

Other Financing Cash Flow -846 -275 0 0 0<br />

Net Cash Flow 323 1,655 1,170 1,402 1,614<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Cash & Equivalents 2,561 2,642 2,642 2,642 2,642<br />

Tangible Fixed Assets 5,957 6,644 6,996 7,270 7,440<br />

Goodwill & Intangibles 16,091 17,047 17,047 17,047 17,047<br />

Associates & Financial <strong>Investment</strong>s 2,919 2,514 2,514 2,514 2,514<br />

Other Assets 8,578 8,152 8,828 9,267 9,687<br />

Total Assets 36,106 36,999 38,026 38,740 39,330<br />

Interest Bearing Debt 11,205 9,971 9,133 7,716 6,124<br />

Other Liabilities 14,565 14,509 14,947 15,541 16,106<br />

Total Liabilities 25,770 24,480 24,081 23,257 22,230<br />

Shareholders' Equity 9,948 12,065 13,475 15,012 16,629<br />

Minority Interests 424 471 471 471 471<br />

Total Equity 10,372 12,536 13,946 15,483 17,100<br />

Net Debt 8,012 6,357 5,187 3,784 2,171<br />

http://www.execution-noble.com<br />

Page 26 of 44


THIRD QUARTER 2010<br />

Vodafone<br />

VZW continues to act as a driver<br />

Vodafone is our favourite large cap telco; we like its leading<br />

positioning in mobile data, exposure to cyclical recovery, the<br />

lessening regulatory drag, and potential for portfolio rationalisation.<br />

In the coming quarter we expect improving revenue trends in<br />

Europe, and increasing discussion around the timing and potential<br />

scale of a dividend from VZW. We reiterate our BUY rating and<br />

recently raised fair value of £1.75.<br />

Operational and dividend upside from Verizon Wireless<br />

Our survey of 3000 US wireless consumers builds upon the similar survey we did<br />

last year. It confirms Verizon Wireless as the dominant US wireless operator, with<br />

the best reputation for network, lowest churn, highest mobile data growth, and<br />

leading overall customer perception scores. This has all been achieved even<br />

without the iPhone, which it will probably get in January 2011. If anything VZW has<br />

increased its dominance over the last 12 months, and this is set to continue as<br />

customer perception of AT&T weakens under pressure from the network problems.<br />

VZW’s operational performance is translating directly into its financials: we believe<br />

it has now fully repaid the intercompany loan to its parent, and it will turn net cash<br />

positive in 12-14 months’ time. Its enormously strong cashflow generation of<br />

$1.5bn/month will eventually turn into dividends for Vodafone, with a good chance<br />

this happens earlier than consensus in 2011 or 2012 at the latest – a view that is<br />

supported by recent comments from the VZ CFO. There is also the possibility of a<br />

large one-off distribution from VZW, instead of a drip feed of annual dividends.<br />

Europe is improving, despite drag from regs and austerity<br />

We expect Vodafone’s Q1 results on 23 rd July to show another improvement in<br />

European revenue trends of around 0.4%, with decent growth in Northern Europe<br />

compensating for weakness in the South. Italy and Greece are likely to be<br />

particularly weak, as price cuts and austerity measures start to bite. The iPhone in<br />

Germany and Spain will help in 2H.<br />

MTR cuts are still creating a c.2% revenue drag, although we see this lessening as<br />

we move down to the €1-2c/minute floor over the next 2-3 years. The aggregate<br />

revenue base subject to regulation is falling, with roaming now just 5% of sales and<br />

no new areas of control on the horizon as the EU turns its attention to Fixed<br />

instead of Mobile.<br />

Best positioned for mobile data<br />

We believe Vodafone has the best or joint-best network in every country in which<br />

it operates, with very few exceptions and in these cases the country managers<br />

have a mandate to invest (e.g. Turkey). Its utilisation rates are lower than its peers,<br />

and this is increasingly acting as a differentiating factor for consumers.<br />

Vodafone’s moves towards variable pricing for mobile data will enable data<br />

revenues to capture at least some of the enormous expected future growth in<br />

volumes.<br />

Rationalising the portfolio<br />

Vodafone appears to have re-focussed its strategy down to just three regions:<br />

Europe, India and sub-Saharan Africa. In our view there are some notable<br />

exclusions from this footprint including the holdings in USA (£68.4bn in our SOTP),<br />

China (£4.3bn), Egypt (£2.2bn), Australia & New Zealand (£3.1bn). Within Europe<br />

we believe France (£9.2bn) may also be deemed non-core.<br />

Disposals may not come this quarter, but it would be reasonable to expect<br />

significant proceeds from asset sales in the medium term.<br />

http://www.execution-noble.com<br />

BUY<br />

25.8% upside<br />

Fair Value £1.75<br />

RIC, Bloomberg Code VOD.L, VOD LN<br />

Share Price £1.39<br />

Market Capitalisation £73.3bn<br />

Free Float 100.0%<br />

GBP bn Mar-10 Mar-11E Mar-12E Mar-13E<br />

Net revenue 44.47 44.07 43.00 42.74<br />

EBITDA 14.74 13.97 13.71 13.73<br />

Capex 6.19 6.13 5.52 5.11<br />

FCFE 6.25 3.56 6.04 7.99<br />

Net Debt 33.32 34.32 33.20 30.67<br />

EPS (p) 16.36 15.12 14.90 15.14<br />

DPS (p) 8.31 9.00 10.00 11.00<br />

All financial estimates are "as reported"<br />

DPS includes special dividends<br />

Mar-10 Mar-11E Mar-12E Mar-13E<br />

EV / Sales 1.7 1.7 1.7 1.7<br />

EV / EBITDA 4.9 4.9 4.9 4.9<br />

P/E 6.9 9.2 9.3 9.2<br />

FCF Yield (%) 7.1% 4.7% 7.0% 8.7%<br />

FCFE Yield (%) 8.5% 4.9% 8.2% 10.9%<br />

Dividend Yield (%) 6.0% 6.5% 7.2% 7.9%<br />

Net Debt / EBITDA 2.4 2.6 2.6 2.4<br />

All multiples based on underlying financials<br />

Proportionate adjustments made where appropriate<br />

Analysts<br />

Will Draper<br />

+44 20 7456 1694<br />

will.draper@execution-noble.com<br />

Andrew Hogley<br />

+44 20 7456 1652<br />

andrew.hogley@execution-noble.com<br />

Nick Brown<br />

+44 20 7456 1669<br />

nick.brown@execution-noble.com<br />

Page 27 of 44


THIRD QUARTER 2010<br />

Vodafone<br />

Valuation Metrics Mar 09 Mar-10 Mar-11E Mar-12E Mar-13E<br />

Recommendation: BUY Execution P/E 8.1 6.9 9.2 9.3 9.2<br />

Fair Value: GBP 1.75 Reported P/E 23.8 8.5 9.2 9.3 9.2<br />

EV / Sales 1.9 1.8 1.7 1.8 1.7<br />

Share Price: GBP 1.39 EV / EBITDA 5.4 5.1 5.1 5.1 5.1<br />

Upside / Downside 25.8% EV / EBIT 9.0 9.2 9.2 9.2 8.9<br />

FCF Yield 5.3% 6.8% 4.5% 6.7% 8.4%<br />

Previous Fair Value GBP 1.70 Dividend yield 5.6% 6.0% 6.5% 7.2% 7.9%<br />

% change to fair value 2.9%<br />

Bloomberg: VOD LN Key ratios Mar 09 Mar-10 Mar-11E Mar-12E Mar-13E<br />

T-One: VOD-LN<br />

Model Published On: 40361 EBITDA margin 35.3% 33.1% 31.7% 31.9% 32.1%<br />

EBIT margin 18.7% 15.1% 13.6% 13.5% 14.2%<br />

Capex / Revenue 12.7% 10.9% 13.9% 12.8% 11.9%<br />

Shares In Issue (Less Treasury) 52,595 Capex / Depreciation 0.76 0.60 0.77 0.70 0.67<br />

Market Cap 73,186 Net Debt / EBITDA 2.5 2.4 2.6 2.6 2.4<br />

Net Debt 33,316 EBITDA / Net Interest 6.0 9.7 6.8 6.7 6.8<br />

Adjustments For Associates & Minorities 7,000 ROE 4% 10% 8% 8% 8%<br />

Enterprise Value 113,502<br />

Net Pension Deficit 0<br />

P&L Summary (GBP m) Mar 09 Mar-10 Mar-11E Mar-12E Mar-13E<br />

Forthcoming Catalysts Revenue 41,017 44,471 44,071 42,999 42,743<br />

% change 15.6% 8.4% -0.9% -2.4% -0.6%<br />

Ex-Dividend Date 02 Jun 2010 EBITDA 14,490 14,735 13,968 13,711 13,731<br />

1Q 2010/11 IMS 23 Jul 2010 % change 10.0% 1.7% -5.2% -1.8% 0.1%<br />

1H 2010/11 Results 09 Nov 2010 % margin 35.3% 33.1% 31.7% 31.9% 32.1%<br />

Depreciation & Amortisation -6,824 -8,011 -7,984 -7,911 -7,660<br />

EBIT 7,666 6,724 5,984 5,800 6,071<br />

% change 6.4% -12.3% -11.0% -3.1% 4.7%<br />

% margin 18.7% 15.1% 13.6% 13.5% 14.2%<br />

Associates 4,091 4,742 5,294 5,574 5,631<br />

Execution Analyst Operating Profit 11,757 11,466 11,278 11,374 11,702<br />

Will Draper Net Financials -2,419 -1,512 -2,057 -2,051 -2,008<br />

(44) 20 7456 1694 Other Pre-tax Income -5,149 -1,280 850 867 884<br />

will.draper@executionlimited.com Pre Tax Profit 4,189 8,674 10,071 10,190 10,578<br />

Income Tax Expense -1,109 -56 -2,011 -2,132 -2,372<br />

Disconitinued Operations 0 0 0 0 0<br />

Revenue Breakdown (Mar11E) Minority Interests -2 27 -100 -200 -204<br />

Net Income 3,078 8,645 7,960 7,859 8,002<br />

Execution Net Income 9,022 10,641 7,960 7,859 8,002<br />

Reported EPS 5.81 16.36 15.12 14.90 15.14<br />

Execution EPS 16.95 20.33 15.12 14.90 15.14<br />

DPS 7.77 8.31 9.00 10.00 11.00<br />

Payout Ratio 133.7% 50.8% 59.5% 67.1% 72.6%<br />

Shares In Issue (Less Treasury) 52,737 52,595 52,695 52,795 52,895<br />

Cash Flow Summary (GBP m) Mar 09 Mar-10 Mar-11E Mar-12E Mar-13E<br />

EBITDA 14,490 14,735 13,968 13,711 13,731<br />

Taxes Paid -2,421 -2,273 -2,361 -2,482 -2,455<br />

Operating Profit Breakdown (Mar-11E) Interest Paid / Received 302 195 0 0 0<br />

Change in Working Capital 274 -980 900 675 450<br />

Margin Trends<br />

Margin<br />

40%<br />

35%<br />

30%<br />

25%<br />

20%<br />

15%<br />

10%<br />

5%<br />

0%<br />

Europe<br />

63%<br />

Europe<br />

48%<br />

Verizon<br />

Wireless<br />

43%<br />

Africa and<br />

Central<br />

Europe<br />

20%<br />

Asia, Pacific<br />

and Middle<br />

East<br />

16%<br />

Common<br />

Functions<br />

1%<br />

Africa and<br />

Central<br />

Europe<br />

6%<br />

Asia, Pacific<br />

and Middle<br />

East<br />

3%<br />

Mar-08 Mar-09 Mar-10 Mar-11E Mar-12E Mar-13E<br />

EBITDA margin EBIT margin<br />

Associate & Minority Dividends 755 1,577 1,194 2,651 3,717<br />

Other Operating Cash Flow -130 1,582 340 137 138<br />

Operating cash flow 13,270 14,836 14,042 14,693 15,581<br />

Capital Expenditure -5,204 -4,841 -6,131 -5,520 -5,107<br />

Free Cash Flow 6,000 7,666 5,095 7,573 9,473<br />

Acquisitions & Disposals -1,043 -1,729 0 0 0<br />

Dividends Paid To Shareholders -4,175 -4,195 -4,633 -5,004 -5,544<br />

Equity Raised / Bought Back -941 70 0 0 0<br />

Other Financing Cash Flow 3,353 -2,295 -1,462 -1,452 -1,405<br />

Net Cash Flow 3,194 -483 -1,000 1,117 2,524<br />

Balance Sheet Summary (GBP m) Mar 09 Mar-10 Mar-11E Mar-12E Mar-13E<br />

Cash & Equivalents 4,878 4,423 3,423 4,540 7,065<br />

Tangible Fixed Assets 19,250 20,642 21,605 20,814 19,261<br />

Goodwill & Intangibles 74,938 74,258 74,258 74,258 74,258<br />

Associates & Financial <strong>Investment</strong>s 34,715 36,377 40,731 43,922 46,118<br />

Other Assets 18,918 21,285 22,385 23,210 23,760<br />

Total Assets 152,699 156,985 162,402 166,744 170,461<br />

Interest Bearing Debt 41,373 39,795 39,795 39,795 39,795<br />

Other Liabilities 26,549 26,380 28,230 29,380 30,297<br />

Total Liabilities 67,922 66,175 68,025 69,175 70,092<br />

Shareholders' Equity 86,162 90,381 93,923 96,992 99,666<br />

Minority Interests -1,385 429 454 578 703<br />

Total Equity 84,777 90,810 94,377 97,569 100,369<br />

Net Debt 34,223 33,316 34,316 33,199 30,674<br />

http://www.execution-noble.com<br />

Page 28 of 44


THIRD QUARTER 2010<br />

BBVA<br />

Uncompelling risk/reward<br />

We include BBVA in this quarter's Silver Bullets as a SELL, paired<br />

with a long recommendation in LLOY. The pair is selected based on<br />

the view that BBVA is over-valued (1.8x P/TNAV 2010) and faces<br />

deteriorating fundamentals in its domestic market (which accounts<br />

for >45pct of net earnings). Further the bank's balance sheet has not<br />

undergone such a purposefully draconian stress test as the UK's FSA<br />

conducted on LLOY last year (and which resulted in a £13.5bn rights<br />

issue and £9.0bn debt exchange for that bank). Catalysts for the<br />

SELL on BBVA will be the likely publication of Europe-wide stress<br />

tests this summer, as well as Q2 results on 4th August.<br />

Stress test to reveal balance sheet weakness<br />

We have stress tested BBVA's balance sheet using moderately severe cumulative<br />

loss assumptions across the group's domestic book and also a 10% haircut on<br />

Spanish sovereign bonds. Our stress test reveals that BBVA would need EUR11bn<br />

in order to maintain an 8% core T1 ratio following the burndown analysis.<br />

The Spanish stress tests will need to be sufficiently conservative to draw a line<br />

under market concerns that the capital position is not strong enough to withstand<br />

the macro pressures in Spain and dislocation in the international wholesale funding<br />

markets. In addition publishing assumed haircuts on sovereign bonds may be self<br />

fulfilling and be negative for the cost of equity.<br />

Loss absorbing capacity at risk<br />

Historically the attraction of the Spanish banks was high pre provision earnings so<br />

that their loss absorbing capacity was not in question. Now net interest income is<br />

under pressure from the lagged impact of EURIBOR. At the same time wholesale<br />

funding costs are elevated (as a proxy, BBVA's CDS has increased 170bp in the last<br />

three months) and likely to further pressure pre-provision profitability. BBVA has a<br />

significant reliance on wholesale funding in Europe with a 217% loan/deposit ratio<br />

(group is 127%). This is not reflected in consensus (downgrades of 4% ytd) and we<br />

are more than 20% below consensus in 2010-2011.<br />

No escape from Spanish macro<br />

Iberia is >45% of group earnings and the macro outlook for this market is<br />

fundamentally deteriorating. We expect negative credit growth of 5% per annum<br />

over 2010-2012, and NPLs are expected to peak in 2011.<br />

Valuations<br />

We value BBVA at EUR 8.6, or a multiple of 1.3x our 2012 book value however such<br />

a multiple may indeed be hard to fetch in the context of a prospective capital raise<br />

and ongoing uncertainty in the wholesale funding system.<br />

http://www.execution-noble.com<br />

SELL<br />

0% upside<br />

Fair Value €8.60<br />

RIC, Bloomberg Code BBVA.MC, BBVA SM<br />

Share Price €8.6<br />

Market Capitalisation €32,270<br />

Free Float 100%<br />

€m (unless stated) 2009 2010E 2011E 2012E<br />

Pre-provision profit 12,307 12,046 11,604 11,916<br />

Pre-tax profit 6,988 5,414 5,872 7,530<br />

Adjusted net profit 5,459 3,626 3,968 5,156<br />

EPS adj 1.45 0.96 1.06 1.37<br />

DPS 0.42 0.15 0.16 0.21<br />

BV (adj) ps 4.02 4.69 5.53 6.66<br />

ROE (adj) (%) 34% 22% 21% 23%<br />

LLP as % loans -1.62% -1.72% -1.45% -1.03%<br />

Core Tier 1 ratio (%) 7.6% 7.7% 8.6% 9.8%<br />

€ (unless stated) 2009 2010E 2011E 2012E<br />

Adjusted P/E 5.9 8.9 8.2 6.3<br />

Pre-provision multiple 2.6 2.7 2.8 2.7<br />

Price / book 1.1 1.0 0.9 0.8<br />

Price / adj book 2.1 1.8 1.6 1.3<br />

Yield (%) 4.9% 1.7% 1.8% 2.4%<br />

ROE (%) 20% 12% 12% 14%<br />

Cost income ratio (%) 40% 39% 40% 40%<br />

BVps 7.82 8.54 9.44 10.63<br />

Analysts<br />

Joseph Dickerson<br />

+44 20 7426 4228<br />

joseph.dickerson@execution-noble.com<br />

Page 29 of 44


THIRD QUARTER 2010<br />

BBVA<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: SELL PER (adjusted) (x) 5.8 5.9 8.9 8.2 6.3<br />

Fair Value: EUR 8.60 Price/Pre Provis Profit per share (x) 2.7 2.6 2.7 2.8 2.7<br />

P/NAV (adjusted) (x) 1.88 2.14 1.84 1.56 1.29<br />

Share Price: EUR 8.61 RoE (%) (adjusted) 30.7 33.8 22.2 20.7 22.6<br />

Upside / Downside -0.1% RoRWA (%) 1.88 1.90 1.21 1.27 1.59<br />

Implied cost of equity (curve) (%) 18.3 13.2 13.2 14.2<br />

Bloomberg: BBVA Yield (net) (%) 5.8 4.9 1.7 1.8 2.4<br />

Key ratios 2008 2009 2010E 2011E 2012E<br />

Core tier 1 ratio 6.0 7.6 7.7 8.6 9.8<br />

Shares In Issue 3,748 Leverage ratio 31.3 35.2 30.2 25.7 21.8<br />

Market Cap 32,270 Cost income ratio 36.8 40.5 39.1 40.2 39.8<br />

Free Float 100% Loan loss charges / loans -0.89 -1.62 -1.72 -1.45 -1.03<br />

RoE (%) (adjusted) 30.7 33.8 22.2 20.7 22.6<br />

NAV 2010E 17,567 RoA (stated) 1.06 1.01 0.68 0.74 0.95<br />

NAV per share 2010 4.7 RoRWA 1.88 1.90 1.21 1.27 1.59<br />

Forthcoming Catalysts<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Q2 Results 28 July 2010 Net interest income 11,686 13,885 12,973 12,341 12,581<br />

Total non interest income 7,292 6,784 6,798 7,072 7,215<br />

Total gross operating income 18,978 20,670 19,771 19,413 19,797<br />

Costs -6,981 -8,362 -7,725 -7,809 -7,881<br />

Pre Provision Net Operating Income 11,997 12,307 12,046 11,604 11,916<br />

Execution Noble Analysts Loan loss charges -2,940 -5,472 -5,729 -4,824 -3,479<br />

Post provision profit 7,625 6,376 6,117 6,579 8,237<br />

Joseph Dickerson Pre Tax Profit 7,434 6,988 5,414 5,872 7,530<br />

(44) 20 7456 4228 Net profit 5,528 5,459 3,626 3,968 5,156<br />

joseph.dickerson@execution-noble.com<br />

EPS adj. 1.49 1.45 0.96 1.06 1.37<br />

Growth rates % 2008 2009 2010E 2011E 2012E<br />

Operating income 4 9 -4 -2 2<br />

Pre provision profit 7 3 -2 -4 3<br />

EPS adj. -12 -3 -34 9 30<br />

NAV (adjusted)/share -9 -12 16 18 20<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Total adj assets 538,817 531,194 530,502 532,963 543,449<br />

Goodwill & Intangibles 8,440 14,219 14,436 14,660 14,891<br />

Shareholders' Equity (adjusted) 17,192 15,082 17,567 20,735 24,952<br />

NAV (adjusted)/share 4.6 4.0 4.7 5.5 6.7<br />

NAV per share 6.8 7.8 8.5 9.4 10.6<br />

RWA 283,320 291,026 306,648 319,175 329,167<br />

Tier 1 equity 22,365 27,523 29,150 32,882 37,636<br />

Core tier 1 equity 16,970 22,125 23,752 27,484 32,238<br />

http://www.execution-noble.com<br />

Page 30 of 44


THIRD QUARTER 2010<br />

Deutsche Telekom<br />

T-Mobile USA remains a drag<br />

Deutsche Telekom is our least favourite large cap Telco. T-Mobile<br />

USA continues to struggle and we do not believe that the business is<br />

out of the woods in Germany, in our view there is a significant risk of<br />

a further dividend cut and recent outperformance provides an<br />

opportunity to sell the shares. We reiterate our SELL rating on the<br />

shares with a recently lowered €7.60 per share fair value.<br />

T-Mobile is getting it all wrong in the USA<br />

T-Mobile is getting it all wrong in the USA; the business has lost subscribers,<br />

suffered a sharp decline in ARPU and seen service revenues decline by around 3%<br />

y-o-y over recent quarters. Over the last four quarters its service revenue market<br />

share has fallen from 12.7% to 11.9% and its market share of EBITDA and Op FCF<br />

has fallen even faster. In the context of a growing market this is an abysmal result<br />

for a challenger operator but we see little prospect of the trends improving.<br />

Our in depth report “US Mobile Survey: VZW dominates” published on the 2 nd of<br />

July highlights T-Mobile’s weak customer perception and that churn is likely to stay<br />

at high levels. The lack of a credible data strategy is another key concern and we<br />

believe that there is a significant risk that T-Mobile will have to acquire additional<br />

spectrum in order to compete for data revenue; this is not yet in our numbers.<br />

German mobile is not out of the woods<br />

German mobile service revenues returned to growth in the first quarter but we do<br />

not believe this will be a permanent feature. The next wave of MTR cuts are likely<br />

to be announced in October and given the precedent from recent announcements<br />

in UK, Netherlands and Belgium could well be more severe than the cut to €0.05<br />

assumed in our forecasts. The loss of iPhone exclusivity in the fourth quarter of<br />

2010 would remove a key support.<br />

Cable operators are rolling out 100Mbps offers<br />

Over recent months the German cable operators (Kabel Deutschland and<br />

Unitymedia) have started to roll out 100Mbps broadband packages over Docsis 3.0<br />

technology. We believe this will add to the pressure on fixed access line trends<br />

even with Deutsche Telekom fighting back with its own triple play offering. The<br />

target for 5 million Entertain customers by 2012 is aggressive and could well<br />

require further investment in margin. Line loss could also trigger an accelerated<br />

FTTH rollout, the costs of which are not in our forecasts.<br />

Dividend may face further pressure<br />

Given the weak cash cover and negative earnings growth we see significant risk to<br />

the medium-term dividend, on our numbers it will fall below €0.70 in 2012. The<br />

recent cut to OTE’s dividend will add further pressure but the requirement to fund<br />

US Spectrum or FTTH could result in a material cut.<br />

Shares have outperformed, opportunity to SELL<br />

Deutsche Telekom has outperformed its European peers over recent months, in<br />

our view this has not been justified by the financial and operating performance.<br />

Our DCF-based fair value of €7.60 is more than 20% below the current share price<br />

and we reiterate our SELL recommendation<br />

http://www.execution-noble.com<br />

SELL<br />

21.7% downside<br />

Fair Value €7.60<br />

RIC, Bloomberg Code DTEGn.DE, DTE GY<br />

Share Price €9.70<br />

Market Capitalisation €42.3bn<br />

Free Float 68.3%<br />

EUR bn 2009 2010E 2011E 2012E<br />

Net revenue 64.64 61.99 60.04 58.83<br />

EBITDA 20.67 19.70 18.91 18.05<br />

Capex 9.20 9.11 9.03 8.49<br />

FCFE 5.71 3.99 4.51 4.41<br />

Net Debt 40.91 41.90 40.79 39.79<br />

EPS (EUR) 0.78 0.87 0.77 0.67<br />

DPS (EUR) 0.78 0.70 0.70 0.68<br />

All financial estimates are "as reported"<br />

DPS includes special dividends<br />

2009 2010E 2011E 2012E<br />

EV / Sales 1.4 1.5 1.4 1.5<br />

EV / EBITDA 4.6 4.6 4.7 4.9<br />

P/E 12.5 11.2 12.7 14.8<br />

FCF Yield (%) 9.8% 8.0% 8.5% 8.3%<br />

FCFE Yield (%) 13.5% 9.4% 10.6% 10.4%<br />

Dividend Yield (%) 8.0% 7.2% 7.2% 7.0%<br />

Net Debt / EBITDA 2.0 2.1 2.2 2.2<br />

All multiples based on underlying financials<br />

Proportionate adjustments made where appropriate<br />

Analysts<br />

Andrew Hogley<br />

+44 20 7456 1652<br />

andrew.hogley@execution-noble.com<br />

Will Draper<br />

+44 20 7456 1694<br />

will.draper@execution-noble.com<br />

Nick Brown<br />

+44 20 7456 1669<br />

nick.brown@execution-noble.com<br />

Page 31 of 44


THIRD QUARTER 2010<br />

DEUTSCHE TELEKOM<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: SELL Execution P/E 12.4 12.5 11.2 12.6 14.5<br />

Fair Value: EUR 7.60 Reported P/E 12.4 12.5 11.8 13.8 16.2<br />

EV / Sales 1.4 1.4 1.5 1.4 1.5<br />

Share Price: EUR 9.70 EV / EBITDA 4.5 4.6 4.6 4.7 4.9<br />

Upside / Downside -21.7% EV / EBIT 10.0 10.3 9.7 10.5 11.5<br />

FCF Yield 10.0% 9.8% 8.0% 8.5% 8.3%<br />

Previous Fair Value EUR 7.60 Dividend yield 8.0% 8.0% 7.2% 7.2% 7.0%<br />

% change to fair value 0.0%<br />

Bloomberg: DTE GY Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: DTE-XE<br />

Model Published On: 01 July 2010 EBITDA margin 31.6% 32.0% 31.8% 31.5% 30.7%<br />

EBIT margin 14.3% 14.2% 15.0% 14.2% 13.1%<br />

Capex / Revenue 14.1% 14.2% 16.9% 16.7% 16.0%<br />

Shares In Issue (Less Treasury) 4,361 Capex / Depreciation 0.82 0.80 1.01 0.96 0.91<br />

Market Cap 42,318 Net Debt / EBITDA 2.0 2.0 2.1 2.2 2.2<br />

Net Debt 40,911 EBITDA / Net Interest 6.6 6.6 6.4 6.2 6.1<br />

Adjustments For Associates & Minorities 0 ROE 9% 9% 9% 8% 7%<br />

Enterprise Value 83,229<br />

Net Pension Deficit -5,871<br />

P&L Summary (EUR m) 2008 2009 2010E 2011E 2012E<br />

Forthcoming Catalysts Revenue 61,666 64,639 61,990 60,045 58,829<br />

% change -1.4% 4.8% -4.1% -3.1% -2.0%<br />

1Q 2010 results 12 May 2010 EBITDA 19,459 20,668 19,698 18,906 18,049<br />

2Q 2010 results 05 August 2010 % change 0.7% 6.2% -4.7% -4.0% -4.5%<br />

3Q 2010 results 04 November 2010 % margin 31.6% 32.0% 31.8% 31.5% 30.7%<br />

Depreciation & Amortisation -10,639 -11,510 -10,416 -10,396 -10,332<br />

EBIT 8,820 9,158 9,282 8,510 7,717<br />

% change 9.1% 3.8% 1.4% -8.3% -9.3%<br />

% margin 14.3% 14.2% 15.0% 14.2% 13.1%<br />

Associates 0 0 0 0 0<br />

Execution Analyst Operating Profit 8,820 9,158 9,282 8,510 7,717<br />

Will Draper Net Financials -2,936 -3,125 -3,093 -3,053 -2,936<br />

(44) 20 7456 1694 Other Pre-tax Income 0 0 0 0 0<br />

will.draper@executionlimited.com Pre Tax Profit 5,884 6,033 6,190 5,457 4,781<br />

Income Tax Expense -1,889 -2,102 -2,052 -1,801 -1,578<br />

Disconitinued Operations 0 0 0 0 0<br />

Revenue Breakdown (2010E) Minority Interests -569 -541 -557 -618 -643<br />

Net Income 3,426 3,390 3,581 3,038 2,560<br />

Execution Net Income 3,426 3,390 3,781 3,337 2,864<br />

Reported EPS 0.79 0.78 0.82 0.70 0.60<br />

Execution EPS 0.79 0.78 0.87 0.77 0.67<br />

DPS 0.78 0.78 0.70 0.70 0.68<br />

Payout Ratio 99.3% 100.3% 85.3% 99.6% 113.8%<br />

Shares In Issue (Less Treasury) 4,361 4,361 4,361 4,325 4,286<br />

Cash Flow Summary (EUR m) 2008 2009 2010E 2011E 2012E<br />

USA<br />

26%<br />

EBITDA 19,459 20,668 19,698 18,906 18,049<br />

Taxes Paid -520 -928 -1,005 -1,065 -1,095<br />

Operating Profit Breakdown (2010E) Interest Paid / Received -2,257 -2,476 -2,648 -2,563 -2,498<br />

Margin Trends<br />

Margin<br />

35%<br />

30%<br />

25%<br />

20%<br />

15%<br />

10%<br />

5%<br />

0%<br />

Southern &<br />

Eastern<br />

Europe<br />

15%<br />

Europe<br />

11%<br />

Southern &<br />

Eastern<br />

Europe<br />

14%<br />

Europe<br />

12%<br />

Systems<br />

Solutions<br />

10%<br />

USA<br />

23%<br />

Systems<br />

Solutions<br />

3%<br />

Germany<br />

38%<br />

Germany<br />

48%<br />

2007 2008 2009 2010E 2011E 2012E<br />

EBITDA margin EBIT margin<br />

Change in Working Capital 156 118 -344 100 50<br />

Associate & Minority Dividends -548 -856 -319 -454 -514<br />

Other Operating Cash Flow -922 -731 -363 367 625<br />

Operating cash flow 15,368 15,795 15,019 15,290 14,617<br />

Capital Expenditure -8,707 -9,202 -10,506 -10,032 -9,391<br />

Free Cash Flow 6,100 5,708 3,992 4,506 4,408<br />

Acquisitions & Disposals 1,252 591 121 0 0<br />

Dividends Paid To Shareholders -3,402 -3,402 -3,402 -3,053 -3,027<br />

Equity Raised / Bought Back 3 2 0 -347 -373<br />

Other Financing Cash Flow -3,127 -903 -1,662 0 0<br />

Net Cash Flow 826 1,996 -950 1,106 1,008<br />

Balance Sheet Summary (EUR m) 2008 2009 2010E 2011E 2012E<br />

Cash & Equivalents 3,026 5,022 4,072 5,177 6,185<br />

Tangible Fixed Assets 41,559 45,468 39,777 38,413 36,572<br />

Goodwill & Intangibles 53,927 51,705 54,813 55,813 56,713<br />

Associates & Financial <strong>Investment</strong>s 3,555 3,740 3,379 3,379 3,379<br />

Other Assets 21,073 21,839 26,564 25,140 24,119<br />

Total Assets 123,140 127,774 128,605 127,922 126,968<br />

Interest Bearing Debt 46,594 51,191 50,940 50,940 50,940<br />

Other Liabilities 33,434 34,646 33,984 33,499 33,256<br />

Total Liabilities 80,028 85,837 84,924 84,439 84,196<br />

Shareholders' Equity 39,997 36,354 38,028 37,964 37,428<br />

Minority Interests 3,115 5,583 5,654 5,519 5,344<br />

Total Equity 43,112 41,937 43,681 43,483 42,772<br />

Net Debt 38,158 40,911 41,899 40,794 39,786<br />

http://www.execution-noble.com<br />

Page 32 of 44


THIRD QUARTER 2010<br />

Electrolux<br />

Squeezed from all sides<br />

We believe Electrolux is unlikely to replicate its strong performance<br />

in 2009 for 2010. In 2009 it benefitted from both its US-rebranding<br />

and a dramatic fall in its raw materials bill. Fundamentally Electrolux<br />

is in a challenged position, with little power over either its suppliers<br />

or customers, white-hot competition from Asian manufacturers and a<br />

raw materials bill that has increased in 2010, despite recent easing of<br />

some material prices. We reiterate our Sell rating and SEK164 price<br />

target.<br />

Raw materials headwind continues into 2011<br />

Raw materials constitute 17% of sales, and fluctuations in price are a major driver of<br />

earnings. Since 2004 Electrolux has absorbed an increase in its raw material bill of<br />

Skr7.0bn. In 2009, the company positioned itself for falling raw materials prices by<br />

moving to shorter-term contracts. This paid off in 2009, but the company failed to<br />

lock in these lower rates for 2010 believing they would continue to fall. We believe<br />

2Q10 will be the first quarter in which Electrolux experiences a headwind and that<br />

this will continue through the remainder of 2010 (albeit with little additional risk<br />

given 70% of steel required for 2010 has been locked-in with suppliers). Our<br />

analysis indicates a Skr1bn raw material headwind in 2010 and a further Skr1.7bn<br />

headwind in 2011. Without further restructuring savings, this headwind will directly<br />

impact EBIT margins in the same way it can be shown has happened historically.<br />

Margin gap to Capital Goods sector has widened<br />

Electrolux has narrowed the margin gap to its appliance peers from 270bp in 2000<br />

to 80bp in 2009 through restructuring and brand structure rationalisation, but it<br />

has actually increased relative to the Capital Goods sector from 400bp in 2000 to<br />

760bp in 2009. Electrolux’s valuation over the same period has recovered to such<br />

an extent that it now trades inline with Cap Goods peers. Fundamentally<br />

Electrolux is coming from a weaker position than the broader European Capital<br />

Goods due to the characteristics of the appliance industry in which it operates.<br />

Absent a change in the structure of the white goods industry we would continue to<br />

argue a significant discount for Electrolux relative to the Capital Goods sector.<br />

6.0% EBIT margin will be a challenge to achieve<br />

Electrolux introduced a 6.0% EBIT margin goal in 2007 but even with the boost<br />

from lower raw materials and ‘crisis management’ initiatives in 2009, it only<br />

achieved 4.9% last year. In 2010, operational gearing, restructuring savings and the<br />

North American rebranding will help the margin reach 6.1%, we believe, but<br />

thereafter we see the margin falling in the absence of another significant<br />

restructuring programme and charge. This is not inconsistent with Electrolux’s<br />

guidance which is on a pre-restructuring basis, but we believe the market may be<br />

overestimating profitability by assuming a 6.0% post restructuring margin.<br />

Valuation: Deserves a discount to Capital Goods Sector<br />

Electrolux is currently trading on 9.1x2011E EV/EBITA, inline with the European<br />

Capital Goods sector average of 9.2x 2011E EV/EBITA. Our target price applies an<br />

8.5x 2011E EV/EBITA multiple on which we find Skr164 per share value. We believe<br />

Electrolux deserves this discount because 1. its growth has significantly<br />

underperformed the sector over the last 10 years, 2. its margins are structurally<br />

lower and under more pressure, 3. its value proposition to customers is weak<br />

compared to companies with industrial customers, 4. it has limited emerging<br />

market exposure and 5. its financial performance is too heavily dependent on raw<br />

materials and factors beyond management’s control. Our DCF valuation yields<br />

Skr154 per share value.<br />

http://www.execution-noble.com<br />

SELL<br />

13% downside<br />

Fair Value SEK 164<br />

RIC, Bloomberg Code ELUXb.ST, ELUXB SS<br />

Share Price SEK 190<br />

Market Capitalisation $7,516m<br />

Free Float 100%<br />

$m 2009 2010E 2011E 2012E<br />

Sales 109,132 109,123 112,790 116,696<br />

Adjusted EBITA 4,940 6,229 6,205 6,054<br />

Adjusted EPS 11.10 14.22 14.18 13.98<br />

Dividend 4.00 4.60 4.95 4.62<br />

FCF* 5,757 3,647 3,427 4,367<br />

EV Adjustments** 2,168 2,233 2,300 2,369<br />

Net Debt 4,068 1,657 -350 -3,187<br />

* FCF = EBITDA - capex - NWC - int ex. - tax<br />

** Pension, Tax, Equity and non-consolidated assets<br />

X (unless stated) 2009 2010E 2011E 2012E<br />

EV/Sales 0.4 0.6 0.5 0.5<br />

EV/EBITA Adjusted 8.6 10.0 9.8 9.6<br />

P/E Adjusted 10.6 13.4 13.4 13.6<br />

Dividend Yield (%) 2.1% 2.4% 2.6% 2.4%<br />

FCF Yield (%) 15.8% 6.2% 5.8% 7.4%<br />

Net Debt/EBITDA 0.5 0.2 0.0 -0.3<br />

Analysts<br />

Nick Paton, CFA<br />

+44 20 7456 1190<br />

nick.paton@execution-noble.com<br />

Rob Virdee<br />

+44 20 7456 9222<br />

rob.virdee@execution-noble.com<br />

Page 33 of 44


THIRD QUARTER 2010<br />

Electrolux<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: Sell Execution P/E 96.6 10.6 12.4 12.5 12.6<br />

Fair Value: SEK 164 Reported P/E 90.1 14.0 13.5 12.5 13.4<br />

EV / Sales 0.46 0.39 0.54 0.50 0.46<br />

Share Price: SEK 177 EV / EBITDA 11.8 5.1 6.2 6.1 5.9<br />

Upside / Downside -6.9% EV / EBITA 43.2 8.6 9.4 9.1 8.9<br />

FCF Yield 4.1% 15.8% 6.7% 6.3% 8.0%<br />

Previous Fair Value SEK 156 Dividend yield 0.0% 2.3% 2.6% 2.8% 2.6%<br />

% change to fair value 5.4%<br />

Bloomberg: ELUXB SS Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: ELUX'B-SK<br />

Model Published On: 02 July 2010 EBITDA margin 3.9% 7.7% 8.6% 8.2% 7.8%<br />

Adj. EBITA margin 1.1% 4.5% 5.7% 5.5% 5.2%<br />

Capex / Revenue 3.5% 2.4% 2.8% 2.8% 2.8%<br />

Shares in Issue, mn 309 Capex / Depreciation -1.23 -0.75 -0.98 -1.02 -1.05<br />

Market Cap 54,524 Net Debt / EBITDA 1.4 0.5 0.2 0.0 -0.3<br />

Net Debt -350 EBITDA / Net Interest 7.7 30.3 55.1 77.7 186.8<br />

Net Pension Deficit 2,300 ROE 2.2% 13.8% 18.7% 17.8% 15.0%<br />

Enterprise Value (Dec 2011E) 56,474<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Revenue 104,792 109,132 109,123 112,790 116,696<br />

% change 0.1% 4.1% 0.0% 3.4% 3.5%<br />

Forthcoming Catalysts Adj. EBITDA 4,136 8,382 9,373 9,305 9,133<br />

% change -41.8% 102.6% 11.8% -0.7% -1.8%<br />

% margin 3.9% 7.7% 8.6% 8.2% 7.8%<br />

2Q 2010 Results 19 July 2010 Depreciation 3,010 3,442 3,144 3,101 3,079<br />

3Q 2010 Results 27 October 2010 Adj. EBITA 1,126 4,940 6,229 6,205 6,054<br />

% change -74.2% 338.6% 26.1% -0.4% -2.4%<br />

% margin 1.1% 4.5% 5.7% 5.5% 5.2%<br />

Operating Profit 1,188 3,761 5,749 6,190 5,718<br />

Execution Analyst Net Financials -535 -277 -170 -120 -49<br />

Nick Paton, CFA Pre Tax Profit 653 3,484 5,579 6,070 5,669<br />

(44) 20 7456 1190 Income Tax Expense -287 -877 -1,523 -1,700 -1,587<br />

nick.paton@executionlimited.com Minority Interests -<br />

-<br />

-<br />

-<br />

-<br />

Net Income 366 2,607 4,056 4,371 4,082<br />

Revenue Breakdown<br />

Execution Net Income 341 3,430 4,392 4,381 4,317<br />

Reported EPS 1.29 8.44 13.13 14.15 13.21<br />

Professional<br />

Indoor<br />

7%<br />

Execution EPS 1.21 11.10 14.22 14.18 13.98<br />

DPS 0.00 4.00 4.60 4.95 4.62<br />

Payout Ratio 0.0% 47.4% 35.0% 35.0% 35.0%<br />

Shares in Issue mn 309 309 309 309 309<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

Pre Tax Profit 653 3,484 5,579 6,070 5,669<br />

Depreciation 3,010 3,442 3,144 3,101 3,079<br />

Taxes Paid -918 -929 -1,523 -1,700 -1,587<br />

Net Financials 535 277 170 120 49<br />

Operating profit before items Breakdown Change in Working Capital 1,503 1,919 -485 -895 442<br />

Other Operating Cash Flow 401 157 -170 -120 -49<br />

Operating cash flow 5,184 8,350 6,715 6,576 7,602<br />

Capital Expenditure -3,702 -2,593 -3,069 -3,149 -3,235<br />

Free Cash Flow 1,482 5,757 3,647 3,427 4,366<br />

Acquisitions & Disposals -19 -<br />

-<br />

-<br />

-<br />

Dividends Paid To Shareholders -1,204 -<br />

-1,236 -1,420 -1,530<br />

Equity Raised / Bought Back 17 69 -<br />

-<br />

-<br />

Other Financing Cash Flow -1,060 -4,068 -<br />

-<br />

-<br />

Net Cash Flow -784 1,758 2,411 2,007 2,837<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Cash & Equivalents 7,305 9,537 11,948 13,955 16,792<br />

Margin Trends Tangible Fixed Assets 17,035 15,315 15,064 14,936 14,917<br />

Goodwill & Intangibles 4,918 5,273 5,449 5,625 5,801<br />

10%<br />

Associates & Financial <strong>Investment</strong>s 3,487 3,146 3,146 3,146 3,146<br />

8%<br />

Other Assets<br />

Total Assets<br />

40,282<br />

73,027<br />

36,395<br />

69,666<br />

36,540<br />

72,146<br />

38,332<br />

75,994<br />

39,075<br />

79,732<br />

6%<br />

Interest Bearing Debt 13,131 13,605 13,605 13,605 13,605<br />

4%<br />

2%<br />

Other Liabilities<br />

Total Liabilities<br />

Shareholders' Equity<br />

43,807<br />

56,938<br />

16,385<br />

40,250<br />

53,855<br />

18,841<br />

39,910<br />

53,515<br />

21,661<br />

40,807<br />

54,412<br />

24,613<br />

41,992<br />

55,597<br />

27,165<br />

0%<br />

Minority Interests -<br />

-<br />

-<br />

-<br />

-<br />

2007 2008 2009 2010E 2011E<br />

Total Equity 16,089 15,811 18,631 21,583 24,135<br />

Adj. EBITDA margin Adj. EBITA margin<br />

Net Debt 5,826 4,068 1,657 -350 -3,187<br />

Margin<br />

Asia Pacific<br />

7%<br />

Latin America<br />

13%<br />

North America<br />

33%<br />

Asia Pacific<br />

9%<br />

Professional<br />

Indoor<br />

11%<br />

Latin America<br />

15%<br />

North America<br />

25%<br />

Europe<br />

40%<br />

Europe<br />

40%<br />

http://www.execution-noble.com<br />

Page 34 of 44


THIRD QUARTER 2010<br />

Home Retail Group<br />

Far from Home<br />

Home Retail Group management has affirmed that it expects to be<br />

able to drive a “similar level of profitability” to last year despite the<br />

disappointing performance from Argos in the first quarter. Consensus<br />

estimates reflect this confidence and whilst forecasts have fallen 7%<br />

since the 1Q IMS in early June, we would argue that consensus<br />

estimates are still too bullish, particularly for 2011/12. Structural<br />

pressures remain and as a 100% UK consumer-exposed stock, we<br />

reiterate our Sell recommendation and downgrade our fair value to<br />

175p, at which the shares would trade at 9x our cal 2011 EPS.<br />

Share price underperformance to continue in our view<br />

Home Retail Group shares are down 21% (18% relative to the SXRP) in the past<br />

quarter, vindicating our decision to include them as our Silver Bullet Sell in 2Q10,<br />

but perhaps raising the question as to whether including them for a second<br />

consecutive quarter is advisable. Trading relative to peers suggests that the<br />

company is suffering from both structural and cyclical pressures and with our EPS<br />

estimate 27% below FY12 consensus, we still think the shares represent both an<br />

excellent absolute and relative short with the 2Q IMS on 9 th September a potential<br />

catalyst. What’s more, Home Retail Group is currently one of the smallest stocks in<br />

the FTSE100 and risks dropping out of the index (and the associated index funds)<br />

in the September review.<br />

Likely further pressure on consensus forecasts…<br />

We had assumed that the World Cup would provide a small boost for TV sales, but<br />

Argos seemingly saw no such benefit (in stark contrast to its specialist<br />

competitors). We feel this could be an early sign of structural pressures facing the<br />

business as the market polarises between low-priced commodity products and<br />

high-priced service-led products, leaving Argos squarely in the middle with little<br />

point of differentiation.<br />

Given the weakness in both vision and gaming, we admit to being slightly<br />

perplexed by the company’s affirmation that it expects to see a “similar level of<br />

profitability” to last year (although it is unclear if this guidance refers to absolute<br />

profit or a profit margin). In an attempt to stress-test our assumptions, reverseengineering<br />

consensus PBT of £276m implies a LfL sales deterioration of c..2.5-3%<br />

at Argos (assuming gross margins in line with guidance – down 50bps). This is<br />

where we take issue, particularly given the comps become more difficult for the<br />

next TWO quarters and hence the implied 2-year LfL is demanding. We expect this<br />

to become increasingly evident as we head into the 2Q IMS statement on 9 th<br />

September and note that we are looking for a LfL sales decline of 5% in FY11.<br />

Given the ‘delay’ to the proposed increase in VAT (the 20% rate will come into<br />

effect 4 Jan 2011) it was plausible that we would raise our FY11 LfL sales estimate,<br />

but we are sufficiently concerned that trading will remain difficult that we have left<br />

this assumption unchanged. We have instead lowered our 2012 LfL sales estimate<br />

with a corresponding fall in our PBT forecast; we now look for £218m of PBT, 27%<br />

below current consensus.<br />

Valuation not compelling even with attractive dividend<br />

Thus whilst the consensus valuation of 8.6x cal 2011 EPS might look appealing<br />

given the historic valuation of the stock (12.3x average since demerger in<br />

November 2006 but as low as sub 7x consensus EPS in 2008), we remain far from<br />

convinced on the value proposition. On our new lowered forecasts the shares trade<br />

on 11x our cal 2011 EPS whereas we believe the fair value should be closer to 9x<br />

given the declining earnings momentum. As such we lower our fair value to 175p,<br />

implying 17% downside, and retain our Sell recommendation.<br />

http://www.execution-noble.com<br />

SELL<br />

17% downside<br />

Fair Value 175p<br />

RIC, Bloomberg Code HOME.L, HOME LN<br />

Share Price 210p<br />

Market Capitalisation £1,832m<br />

Free Float 99%<br />

Year to 3 Mar, £m 2010 2011e 2012e 2013e<br />

Sales 6,023 5,876 5,776 6,012<br />

PBT 293 245 218 274<br />

EPS (p) 23.1 20.2 18.8 24.4<br />

Dividend (p) 14.7 14.7 14.7 16.2<br />

FCF*1 262 124 82 259<br />

Invested Capital 3,080 3,124 3,196 3,139<br />

Net Debt/(net cash)<br />

1. Post capex<br />

-414 -268 -231 -358<br />

Year to 3 Mar, x 2010 2011e 2012e 2013e<br />

EV / Sales 0.24 0.27 0.27 0.26<br />

EV / EBITDA 3.4 4.3 4.7 4.0<br />

PE 9.1 10.4 11.2 8.6<br />

Dividend Yield (%) 7.0 7.0 7.0 7.7<br />

FCF Yield (%) 14.3 6.8 4.5 14.1<br />

ROIC (%) 6.2 5.4 4.7 6.0<br />

Net Debt / EBITDA -1.0 -0.7 -0.7 -0.9<br />

Analysts<br />

Caroline Gulliver<br />

+44 20 7456 9173<br />

caroline.gulliver@execution-noble.com<br />

Robert Evans<br />

+44 20 7426 4210<br />

robert.evans@execution-noble.com<br />

Richard Cathcart<br />

+44 20 7456 9155<br />

richard.cathcart@execution-noble.com<br />

Page 35 of 44


THIRD QUARTER 2010<br />

Home Retail Group<br />

Valuation Metrics, y/e Feb 2009 2010 2011e 2012e 2013e<br />

Recommendation: SELL Execution P/E 8.2 -9.6 -9.2 11.2 8.6<br />

Fair Value: 175p Reported P/E -4.5 8.7 10.6 11.2 8.6<br />

EV / Sales 0.3 0.3 0.3 0.3 0.3<br />

Share Price: 210p EV / EBITDA 3.3 3.6 4.2 4.6 3.9<br />

Upside / Downside -16.7% EV / EBIT 5.1 5.7 6.3 7.2 5.8<br />

FCF Yield 18.6% 18.0% 7.8% 4.9% 16.3%<br />

Previous Fair Value Dividend yield 7.0% 7.0% 7.0% 7.0% 7.7%<br />

% change to fair value<br />

Bloomberg: HOME LN Key ratios, y/e Feb 2009 2010 2011e 2012e 2013e<br />

T-One: HOME-LN<br />

Model Published On: 03 July 2010 EBITDA margin 7.8% 7.0% 6.2% 5.7% 6.5%<br />

EBIT margin 5.1% 4.5% 4.1% 3.7% 4.4%<br />

Capex / Revenue 1.9% 1.2% 2.1% 2.6% 2.7%<br />

Shares In Issue (Less Treasury) 849 Capex / Depreciation 0.7 0.5 1.0 1.3 1.3<br />

Market Cap 1,783 Net Debt / EBITDA n/a n/a n/a n/a n/a<br />

Net Debt / (Cash) -268 EBITDA / Net Interest n/a n/a n/a n/a n/a<br />

Adjustments For Associates & Minorities 0 ROE 8.1% -6.6% -7.1% 5.5% 7.0%<br />

Enterprise Value 1,515<br />

Net Pension Deficit 25<br />

P&L Summary, y/e Feb 2009 2010 2011e 2012e 2013e<br />

Forthcoming Catalysts Revenue 5,897 6,023 5,876 5,776 6,012<br />

% change -1.5% 2.1% -2.4% -1.7% 4.1%<br />

2Q Trading statement 09 September 2010 EBITDA 460 420 363 332 388<br />

1H2011 results 20 October 2010 % change -17.9% -8.7% -13.5% -8.7% 17.1%<br />

3Q Sales (tbc) 13 January 2011 % margin 7.8% 7.0% 6.2% 5.7% 6.5%<br />

0 00 January 1900 Depreciation & Amortisation -159 -150 -121 -119 -124<br />

Operating profit 300 270 242 213 264<br />

% change 13.4% -10.2% -10.2% -12.2% 24.4%<br />

% margin 5.1% 4.5% 4.1% 3.7% 4.4%<br />

Associates (2) (2) (2) (2) (2)<br />

Execution Analysts EBIT 298 268 240 211 262<br />

Caroline Gulliver +44 20 7456 9173 Net Financials 30 5 5 7 12<br />

Robert Evans +44 20 7426 4210 Other Pre-tax Income (18) 0 0 0 0<br />

Richard Cathcart +44 20 7456 9155 Pre Tax Profit (core) 328 272 245 218 274<br />

Income Tax Expense (104) (91) (74) (63) (74)<br />

Minority Interests 0 (371) (367) 0 0<br />

Revenue breakdown (2011e) Net Income (core) 224 (190) (195) 155 200<br />

Net income (published) (413) 210 168 155 200<br />

Execution EPS 25.6 -21.8 -22.9 18.8 24.4<br />

Reported EPS -47.1 24.1 19.8 18.8 24.4<br />

DPS 14.7 14.7 14.7 14.7 16.2<br />

Payout Ratio 57.5% -67.5% -64.2% 78.1% 66.4%<br />

Shares In Issue (Less Treasury) 877 872 849 822 822<br />

Argos<br />

71%<br />

Cash Flow Summary, y/e Feb 2009 2010 2011e 2012e 2013e<br />

EBITDA 460 420 363 332 388<br />

Taxes Paid (75) (107) (72) (63) (74)<br />

Profit breakdown (2011e) Interest Paid / Received 17 7 5 7 12<br />

Sales growth trends<br />

4%<br />

2%<br />

0%<br />

-2%<br />

-4%<br />

-6%<br />

-8%<br />

-10%<br />

-12%<br />

Homebase<br />

27%<br />

Homebase<br />

17%<br />

Financial<br />

Services<br />

2%<br />

Financial<br />

Services<br />

2%<br />

Argos<br />

81%<br />

2009 2010 2011e 2012e 2013e<br />

Argos LFL Homebase LFL<br />

Change in Working Capital 164 30 (46) (43) 93<br />

Associate & Minority Dividends 0 0 0 0 0<br />

Other Operating Cash Flow (157) 4 (5) 0 0<br />

Operating cash flow 409 354 245 233 419<br />

Capital Expenditure (111) (74) (121) (151) (160)<br />

Free Cash Flow 298 280 124 82 259<br />

Acquisitions & Disposals (44) (18) 0 0 0<br />

Dividends Paid To Shareholders (127) (126) (120) (120) (131)<br />

Equity Raised / Bought Back (22) (9) (150) 0 0<br />

Other Financing Cash Flow 6 3 0 0 0<br />

Net Cash Flow 111 129 (146) (37) 127<br />

Balance Sheet Summary, y/e Feb 2009 2010 2011e 2012e 2013e<br />

Cash & Equivalents 284 414 268 231 358<br />

Tangible Fixed Assets 559 525 525 557 594<br />

Goodwill & Intangibles 1,645 1,634 1,634 1,634 1,634<br />

Associates & Financial <strong>Investment</strong>s 8 8 6 4 2<br />

Other Assets 1,693 1,696 1,708 1,719 1,694<br />

Total Assets 4,190 4,277 4,142 4,145 4,282<br />

Interest Bearing Debt 0 0 0 0 0<br />

Other Liabilities (1,431) (1,411) (1,376) (1,344) (1,413)<br />

Total Liabilities (1,431) (1,411) (1,376) (1,344) (1,413)<br />

Shareholders' Equity 2,758 2,867 2,765 2,800 2,869<br />

Minority Interests 0 0 0 0 0<br />

Total Equity 2,758 2,867 2,765 2,800 2,869<br />

Net Debt / (Cash) (284) (414) (268) (231) (358)<br />

http://www.execution-noble.com<br />

Page 36 of 44


THIRD QUARTER 2010<br />

Reckitt Benckiser<br />

Respect the Cincinatti Kid<br />

Reckitt Benckiser is currently under attack on a number of fronts.<br />

P&G is trying to make inroads in to stain removers and auto dish and<br />

we believe air care will be next. Perrigo should get FDA approval for<br />

store brand Mucinex imminently and surface care is now lapping<br />

some very difficult swine flu related comparisons. At the same time<br />

RB’s rate of media investment appears to be lagging behind peers.<br />

P&G ups the ante…..<br />

P&G is focusing its firepower at a number of RB’s key categories right now. P&G’s<br />

new stain removal brand Tide/Ariel Acitilift has already been launched in 20+<br />

markets and is due to launch in the key UK market on July 5 th . At the same time the<br />

latest Fairy auto dishwash variant is being rolled out through Europe and we feel<br />

sure that the AmbiPur aircare acquisition will be marked by a strong H2 roll-out<br />

programme – if anyone is any doubt we refer you to the latest presentations on the<br />

P&G website. This competitive activity should ensure that the promotional pressure<br />

evident in the last few quarters is at least maintained at similar levels.<br />

…..and comps get more difficult elsewhere<br />

As we look into Q3, the comps in surface care - another of RB’s key categories -<br />

also get more difficult as we begin to lap last year’s swine flu pandemic panic. Sure<br />

the headline numbers are supported by a few more quarters of Suboxone but<br />

these incremental revenues have very limited impact on Enterprise value. We have<br />

already inverted our Suboxone timings and now assume that we will have a<br />

competitor launch to Suboxonne at some stage in H2 which will reduce revenues<br />

by 30% this year and another 70% next year. The exact timing of this is still<br />

unclear, however the FDA action in fast tracking Vivitrol indicates that these 2011<br />

forecasts may yet prove too conservative – we will hear more on Vivitrol on<br />

September 16 th .<br />

Wake me up before you Perrigo<br />

Perrigo currently have an ANDA pending with the FDA for a 600mg Guaifenesin<br />

extended release tablet which is basically a generic version of RB’s Mucinex tablet.<br />

We anticipate that FDA approval is fairly imminent now that Perrigo has been<br />

granted a favourable judgement in the patent litigation case with Adams (now RB).<br />

We reckon Adams revenues are around £320m or rougly 5% of group sales. In May,<br />

Perrigo acquired the generic rights for Delysm, another RB cough/cold medication<br />

which is a further indication of their ambitions in this category. As a case study it is<br />

worth noting that when Perrigo launched Omeprazole as a generic store brand<br />

version of Procter and Gamble’s market leading heartburn medicine Prilosec in<br />

2008, it captured 35% of the market within 4 months. A similar result in the cough<br />

cold category would depress RB’s group revenue by 1.5%<br />

Valuation no great support<br />

We have no desire to join the graveyard of other analysts who have prematurely<br />

predicted the demise of Reckitt Benckiser. We are certainly NOT predicting<br />

anything so drastic, however, we feel there are enough headwinds right now to put<br />

the model under greater pressure than it has hitherto endured. Against this, the<br />

valuation is rich as ever with RB currently trading at a PE multiple of some 16.5<br />

times 2011. This stands at a marked premium to Unilever (14.4x), Nestle (14.7x), ABI<br />

(12.5x), and more importantly P&G (14.0x), Colgate (14.8x) and Clorox (12.9x). Nor<br />

can the group rely on its cash flow any more as a 6.6% free cash flow yield is also<br />

in line with sector averages. By the time of the Q2 results (July 26) RB will have net<br />

cash on the balance sheet. Clearly any acquisition priced below say 30 times would<br />

be usefully earnings enhancing – albeit with a questionable IRR - and this is clearly<br />

the risk to our thesis of earnings losing momentum. We continue to believe any<br />

move on a share buy-back would not be taken positively.<br />

http://www.execution-noble.com<br />

SELL<br />

2% downside<br />

Fair Value £30.69<br />

RIC, Bloomberg Code RB.L, RB/ LN<br />

Share Price £31.32<br />

Market Capitalisation £22,807m<br />

Free Float 85%<br />

£m (unless stated) 2009 2010E 2011E 2012E<br />

Sales 7,753 8,188 8,239 8,590<br />

Ebitda 2,070 2,048 1,938 2,003<br />

EPS (£) 1.95 1.99 1.90 1.97<br />

Dividend (£) 1.00 1.13 1.27 1.39<br />

FCF 1,841 1,571 1,508 1,571<br />

Invested Capital 5,189 5,059 4,919 4,774<br />

Net Debt -220 -1,016 -1,653 -2,256<br />

X (unless stated) 2009 2010E 2011E 2012E<br />

EV/Sales 2.8 2.7 2.6 2.5<br />

EV/Ebitda 10.5 10.6 11.2 10.9<br />

PE 16.1 15.7 16.5 15.9<br />

Dividend Yield (%) 3.2 3.6 4.0 4.4<br />

FCF Yield (%) 8.1 6.9 6.6 6.9<br />

ROIC (%) 26.5 28.1 26.8 28.1<br />

Net Debt/Ebitda -0.11 -0.50 -0.85 -1.13<br />

Analysts<br />

Martin Dolan<br />

+44 20 7456 1674<br />

martin.dolan@execution-noble.com<br />

James Edwardes Jones<br />

+44 20 7456 1697<br />

james.ej@execution-noble.com<br />

Ved Vyas<br />

+44 20 7426 4262<br />

ved.vyas@execution-noble.com<br />

Page 37 of 44


THIRD QUARTER 2010<br />

Reckitt Benckiser<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: SELL Execution P/E 20.4 16.1 15.7 16.5 15.9<br />

Fair Value: GBP 30.69 Reported P/E 20.4 15.6 15.7 16.6 16.0<br />

EV / Sales 3.3 2.8 2.7 2.6 2.5<br />

Share Price: GBP 31.32 EV / EBITDA 13.5 10.5 10.6 11.2 10.9<br />

Upside / Downside -2.0% EV / EBIT 14.5 11.3 11.5 12.2 11.8<br />

FCF Yield 5.0% 8.1% 6.9% 6.6% 6.9%<br />

Previous Fair Value GBP 35.5 Dividend yield 2.6% 3.2% 3.6% 4.0% 4.4%<br />

% change to fair value -13.5%<br />

Bloomberg: RB/ LN Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: RB.L<br />

Model Published On: 01 July 2010 EBITDA margin 24.6% 26.7% 25.0% 23.5% 23.3%<br />

EBIT margin 22.9% 24.9% 23.2% 21.7% 21.5%<br />

Capex / Revenue 3.2% 1.9% 2.0% 2.2% 2.2%<br />

Shares In Issue (Less Treasury) 728 Capex / Depreciation 1.93 1.06 1.12 1.22 1.23<br />

Market Cap 22,807 Net Debt / EBITDA 0.7 -0.1 -0.5 -0.9 -1.1<br />

Net Debt -1,016 EBITDA / Net Interest 52.0 -66.1 -29.4 -19.8<br />

Adjustments For Associates & Minorities 0 ROE 34% 36% 31% 27% 25%<br />

Enterprise Value 21,791<br />

Net Pension Deficit 0<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Forthcoming Catalysts Revenue 6,563 7,753 8,188 8,239 8,590<br />

% change 24.6% 18.1% 5.6% 0.6% 4.3%<br />

Half year results 26 July 2010 EBITDA 1,612 2,070 2,048 1,938 2,003<br />

% change 25.6% 28.4% -1.1% -5.4% 3.3%<br />

% margin 24.6% 26.7% 25.0% 23.5% 23.3%<br />

Depreciation & Amortisation -107 -139 -147 -148 -154<br />

EBIT 1,505 1,931 1,902 1,790 1,849<br />

% change 26.5% 28.3% -1.5% -5.9% 3.3%<br />

Execution Analyst % margin 22.9% 24.9% 23.2% 21.7% 21.5%<br />

James Edwardes Jones Associates 0 0 0 0 0<br />

(44) 20 7456 1697 Operating Profit 1,505 1,931 1,902 1,790 1,849<br />

james.edwardesjones@execution-noble.com Net Financials -31 1 31 66 101<br />

Other Pre-tax Income 0 0 0 0 0<br />

Pre Tax Profit 1,474 1,932 1,933 1,856 1,950<br />

Income Tax Expense -361 -474 -483 -483 -526<br />

Minority Interests 0 0 0 0 0<br />

Revenue Breakdown Net Income 1,113 1,458 1,449 1,374 1,423<br />

Execution net income 1,113 1,418 1,449 1,384 1,433<br />

Reported EPS 153.7 200.3 199.0 188.6 195.4<br />

Execution EPS 153.7 194.8 199.0 190.0 196.8<br />

DPS 80.00 100.00 113.00 126.56 139.22<br />

Payout Ratio 52.0% 49.9% 56.8% 67.1% 71.2%<br />

Shares In Issue (Less Treasury) 724 728 728 728 728<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

EBITDA 1,612 2,070 2,048 1,938 2,003<br />

Taxes Paid -280 -371 -378 -378 -412<br />

Operating Profit Breakdown Interest Paid / Received -27 -4 31 66 101<br />

Margin Trends<br />

Margin<br />

28%<br />

26%<br />

24%<br />

22%<br />

20%<br />

Developing<br />

Markets<br />

23%<br />

North America<br />

and Australia<br />

29%<br />

Pharma<br />

11%<br />

Developing<br />

Markets<br />

15%<br />

North America<br />

and Australia<br />

29%<br />

Pharma<br />

5%<br />

Europe<br />

43%<br />

Europe<br />

45%<br />

2008 2009 2010E 2011E 2012E<br />

EBITDA margin EBIT margin<br />

Change in Working Capital -36 247 -30 -10 -10<br />

Associate & Minority Dividends 0 0 0 0 0<br />

Other Operating Cash Flow 89 46 65 71 79<br />

Operating cash flow 1,358 1,988 1,736 1,688 1,760<br />

Capital Expenditure -207 -147 -165 -180 -189<br />

Free Cash Flow 1,151 1,841 1,571 1,508 1,571<br />

Acquisitions & Disposals -1,081 0 0 0 0<br />

Dividends Paid To Shareholders -441 -648 -775 -872 -969<br />

Equity Raised / Bought Back -237 163 0 0 0<br />

Other Financing Cash Flow -333 -40 0 0 0<br />

Net Cash Flow -941 1,316 796 636 602<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Cash & Equivalents 417 351 351 351 351<br />

Tangible Fixed Assets 637 639 657 689 724<br />

Goodwill & Intangibles 6,454 6,090 6,090 6,090 6,090<br />

Associates & Financial <strong>Investment</strong>s 0 0 0 0 0<br />

Other Assets 1,674 1,581 1,660 1,670 1,734<br />

Total Assets 9,182 8,661 8,759 8,800 8,899<br />

Interest Bearing Debt 1,575 136 -665 -1,302 -1,905<br />

Other Liabilities 1,719 3,878 4,744 4,925 5,169<br />

Total Liabilities 3,294 4,014 4,078 3,623 3,264<br />

Shareholders' Equity 3,292 4,012 4,678 5,175 5,633<br />

Minority Interests 2 2 2 2 2<br />

Total Equity 3,294 4,014 4,680 5,177 5,635<br />

Net Debt 1,096 -220 -1,016 -1,653 -2,256<br />

http://www.execution-noble.com<br />

Page 38 of 44


THIRD QUARTER 2010<br />

Rolls Royce<br />

Challenges converging<br />

Rolls shares have rallied strongly in the past 12 months with the<br />

improving civil aerospace market outlook. We argue that a number<br />

of factors in Q3 could lead to profit taking, with Rolls Royce trading<br />

near the top end of its historic range on 2010e P/E of 14.3x. We are<br />

downgrading to Sell, lowering our fair value to 530p from 550p.<br />

Marine exposure to offshore<br />

The Marine division, which accounts for 26% of group EBIT in our 2010e forecast<br />

has 43% exposure to the offshore oil and gas industry, and we believe that demand<br />

may be negatively affected by the Gulf of Mexico incident.<br />

The EBIT growth rate for the Marine business has been strong with a 133% increase<br />

in divisional EBIT from 2007 to 2009. The company has guided for broadly flat<br />

EBIT for Marine in 2010e, and we would argue that the market would react<br />

negatively to any evidence of a meaningful downturn.<br />

R&D requirements in civil<br />

The company has guided for an increase in expensed R&D in 2010 driven by the<br />

Trent-XWB engine programme for the Airbus A350. The engine had its first run in<br />

June 2010 in ground testing and now enters an important phase of development as<br />

the programme progresses towards flight testing. This is a massive programme for<br />

Rolls Royce Civil, and any potential escalation in R&D could pose a headwind to<br />

EBIT in the coming years.<br />

Furthermore, there are plans currently being discussed by Airbus and Boeing to<br />

produce new or re-engined families of narrowbody aircraft. This could present<br />

another upward pressure on R&D spend if Rolls Royce were to decide to<br />

participate in one of these programmes.<br />

UK defence<br />

We estimate that 40% of defence division revenues are from the UK airforce, of<br />

which approximately half original equipment and half aftermarket. The aftermarket<br />

portion is vulnerable to cuts in the UK active aircraft fleet, particularly Harrier and<br />

Tornado aircraft, which could be announced in the UK Strategic Defence Review in<br />

October or November. Leaks are likely to become public during Q3.<br />

FX sensitivity<br />

We estimate that every 10 cent move in the GBP/USD rate creates EBIT impact for<br />

Rolls Royce of around £110m or 10%, on an unhedged basis. There is substantial<br />

hedging for the next five years, starting at 1.69 in 2010e (our estimate) meaning<br />

that recent strengthening of Sterling vs USD does not impact near term earnings.<br />

However, any further strengthening would be negative for long term value.<br />

Catalysts<br />

The Farnborough airshow, July 19-23 rd , is the main industry event of the year, and<br />

often serves as a catalyst for share price moves in the sector. Rolls Royce will make<br />

an investor presentation on the morning of Tuesday 20 th .<br />

The following week Rolls will report H1 results, July 29 th . We believe that in absence<br />

of an earnings upgrade the stock could succumb to profit taking.<br />

Valuation<br />

Our new fair value of 530p would value the shares on a P/E of 13.5x for 2010e, in<br />

line with the (reduced) average for our coverage universe. Although the downside<br />

to fair value is modest, we believe that there is strong chance that one or more of<br />

the negatives we’ve highlighted will crystalise in Q3, and we would sell the stock.<br />

http://www.execution-noble.com<br />

SELL<br />

5.5% downside<br />

Fair Value 530p<br />

RIC, Bloomberg Code RR.L, RR/ LN<br />

Share Price 561p<br />

Market Capitalisation £10,350m<br />

Free Float 100%<br />

£m (unless stated) 2009 2010E 2011E 2012E<br />

Sales 10108 10250 10410 10850<br />

Ebitda 921 921 921 921<br />

Adj. EPS (p) 37.3 39.2 41.3 44.7<br />

Dividend (pps) 15.00 16.00 16.00 16.00<br />

FCF -45 454 475 654<br />

EV adjustments 0.0 0.0 0.0 0.0<br />

Net Cash -117 -294 -474 -833<br />

X (unless stated) 2009 2010E 2011E 2012E<br />

EV/Sales 0.99 0.98 0.97 0.93<br />

EV/Ebitda 10.92 10.92 10.92 10.92<br />

PE 15.05 14.33 13.58 12.56<br />

Dividend Yield (%) 2.51 2.67 2.85 2.85<br />

FCF Yield (%) -0.45 4.51 4.72 6.50<br />

Net Debt/Ebitda -0.13 -0.32 -0.51 -0.90<br />

Analysts<br />

Edward Stacey<br />

+44 20 7456 9135<br />

edward.stacey@execution-noble.com<br />

Rob Virdee<br />

+44 20 7456 9222<br />

rob.virdee@execution-noble.com<br />

Page 39 of 44


THIRD QUARTER 2010<br />

Rolls Royce<br />

Valuation Metrics 2008 2009 2010E 2011E 2012E<br />

Recommendation: Sell Execution P/E 15.3 15.0 14.3 13.6 12.6<br />

Fair Value: 530 Reported P/E 15.3 14.2 14.2 13.6 12.6<br />

EV / Sales 1.1 1.0 1.0 1.0 0.9<br />

Share Price: 561p EV / EBITDA 8.8 8.5 8.2 7.8 7.5<br />

Upside / Downside -5.5% EV / EBIT 12.11 11.50 11.00 10.34 9.70<br />

FCF Yield 14.9% 2.4% 5.1% 5.1% 6.6%<br />

Previous Fair Value 550p Dividend yield 2.5% 2.7% 2.9% 2.9% 2.9%<br />

% change to fair value -3.6%<br />

Bloomberg: RR/ LN Key ratios 2008 2009 2010E 2011E 2012E<br />

T-One: RR.-LN<br />

Model Published On: 02 July 2010 EBITDA margin 12.7% 11.9% 12.1% 12.5% 12.6%<br />

Adj. EBITA margin 9.2% 8.8% 9.1% 9.5% 9.7%<br />

Capex / Revenue -6.8% 6.7% 4.9% 4.8% 3.5%<br />

Shares In Issue (Less Treasury) 1,845 Capex / Depreciation -1.97 2.17 1.59 1.59 1.19<br />

Market Cap 10,350 Net Debt / EBITDA -0.1 -0.1 -0.2 -0.4 -0.6<br />

Net Debt (incl Pension liability) -117 EBITDA / Net Interest 29.7 17.7 19.5 29.7 57.1<br />

ROE 33% 19% 17% 16% 15%<br />

Enterprise Value 10,233<br />

P&L Summary 2008 2009 2010E 2011E 2012E<br />

Forthcoming Catalysts Revenue 9,147 10,108 10,250 10,410 10,850<br />

% change 17.0% 10.5% 1.4% 1.6% 4.2%<br />

Full year Results 2009 11 February 2010 EBITDA 1,160 1,205 1,245 1,305 1,370<br />

AGM 28 April 2010 % change 16.1% 3.9% 3.3% 4.8% 5.0%<br />

Farnborough Air Show 19 July 2010 % margin 12.7% 11.9% 12.1% 12.5% 12.6%<br />

1H 2010 Interim Results 29 July 2010 Depreciation & Amortisation -315 -315 -315 -315 -315<br />

EBIT 845 890 930 990 1,055<br />

% change 10.3% 5.3% 4.5% 6.5% 6.6%<br />

Execution Analyst % margin 9.2% 8.8% 9.1% 9.5% 9.7%<br />

Edward Stacey Associates 74 93 95 95 95<br />

(44) 20 7456 9135 Operating Profit 919 983 1,025 1,085 1,150<br />

edward.stacey@executionlimited.com Net Financials -39 -68 -64 -44 -24<br />

Minority Interests 5 0 0 0 0<br />

Pre Tax Profit 885 915 961 1,041 1,126<br />

Revenue Breakdown Income Tax Expense -217 -187 -231 -281 -304<br />

Net Income 668 728 730 760 822<br />

Execution Net Income 730 760 822 0 0<br />

Reported EPS 36.70 39.46 39.59 41.19 44.55<br />

Execution EPS 36.70 37.29 39.16 41.31 44.68<br />

DPS 14.30 15.00 16.00 16.00 16.00<br />

Payout Ratio 39.0% 38.0% 40.4% 38.8% 35.9%<br />

Shares In Issue (Weighted, Less Treasury) 1,820 1,845 1,845 1,845 1,845<br />

Defence<br />

Aerospace<br />

18%<br />

Cash Flow Summary 2008 2009 2010E 2011E 2012E<br />

Pre Tax Profit 885 915 961 1,041 1,126<br />

EBITA Breakdown Depreciation & Amortisation 315 315 315 315 315<br />

Margin Trends<br />

Margin<br />

14%<br />

12%<br />

10%<br />

8%<br />

6%<br />

4%<br />

2%<br />

0%<br />

Marine<br />

24%<br />

Defence Aerospace<br />

23%<br />

Marine<br />

19%<br />

Energy<br />

8%<br />

Energy<br />

0%<br />

Civil Aerospace<br />

50%<br />

Civil Aerospace<br />

58%<br />

2007 2008 2009 2010E 2011E<br />

Adj. EBITDA margin Adj. EBIT EBIT margin margin<br />

Taxes Paid -217 -119 -231 -281 -304<br />

Change in Working Capital -38 -381 4 -5 -13<br />

Other Operating Cash Flow -79 129 -95 -95 -95<br />

Operating cash flow 866 859 954 975 1,029<br />

Capital Expenditure 620 -682 -500 -500 -375<br />

Free Cash Flow 1,486 177 454 475 654<br />

Dividends Paid To Shareholders -237 -250 -277 -295 -295<br />

Equity Raised / Bought Back -231 0 0 0 0<br />

Other Financing Cash Flow<br />

Net Cash Flow 1,018 -73 177 180 359<br />

Balance Sheet Summary 2008 2009 2010E 2011E 2012E<br />

Cash & Equivalents 2,469 2,960 3,037 2,717 3,076<br />

Tangible Fixed Assets 3,597 2,881 3,066 3,251 3,311<br />

Goodwill & Intangibles 2,286 2,472 2,472 2,472 2,472<br />

Associates & Financial <strong>Investment</strong>s 419 695 790 885 980<br />

Other Assets 6,575 6,483 6,464 6,565 6,842<br />

Total Assets 15,346 15,491 15,829 15,890 16,681<br />

Interest Bearing Debt 2,368 2,843 2,743 2,243 2,243<br />

Other Liabilities 10,920 8,784 8,768 8,864 9,129<br />

Total Liabilities 13,288 11,627 11,511 11,107 11,372<br />

Shareholders' Equity 2,049 3,864 4,318 4,782 5,309<br />

Minority Interests 9 0 0 0 0<br />

Total Equity 2,058 3,864 4,318 4,782 5,309<br />

Net Debt (including pension liability) -101 -117 -294 -474 -833<br />

http://www.execution-noble.com<br />

Page 40 of 44


THIRD QUARTER 2010<br />

RWE<br />

Time To Bite The Bullet<br />

This is not a long note (most of the work is in our modeling). It is our<br />

third report on the fallout from the proposed German windfall tax<br />

(‘Your country needs YOU!’, 23rd June, ‘German nuclear levy’, 8th<br />

June). This time, we see no option but to slash 2011-2012 estimates<br />

(by 15% and 20%) and fair value (by 15%) for RWE. A dividend cut<br />

after the tax seems unavoidable in 2011 (-17%) and uncertainty still<br />

prevails over 2013. Whilst there are still uncertainties as to the final<br />

outcome, we believe that it is only a matter of degree. RWE<br />

continues to be a Sell.<br />

Utility sector in turmoil<br />

Many Continental European utility stocks are reeling from political backlash.<br />

Germany shocked the sector with a proposed windfall tax (even the companies did<br />

not see that one coming). Belgium has decided that might also be a good idea.<br />

Finland may follow suit with a tax discussed in 2009. Spain undid a decade of<br />

liberalization by freezing tariffs and there is also talk of a windfall tax. French<br />

Finance Minister likes the idea of freezing gas tariffs, another step backward.<br />

We have rebuilt and updated our model, marked to market<br />

What is more, we have completely rebuilt our RWE model to comply with the new<br />

reporting format. Our estimates fully reflect the prevailing forward curves (plus our<br />

own views further out).<br />

We have assumed windfall tax & life extensions<br />

• Windfall tax: €15MWh (c€700m) pa till 2020, i.e. beyond 2014<br />

• Nuclear life extensions: 15 years with 25% clawback<br />

We are slashing our estimates<br />

EPS: -15% for 2011, -19% for 2012 and -9% for 2013<br />

DPS: -17% for 2011, -17% for 2012 and -9% for 2013<br />

Capex: our spend is now c€4bn lower than company guidance 2009-2013<br />

We are cutting our fair value<br />

Whilst DCF value is largely unchanged (life extension off-setting windfall tax, plus<br />

higher commodity prices), we believe consensus EPS estimates will have to come<br />

down by 14% in 2011 and 19% in 2012. With this background, we do not believe that<br />

DCF valuations (€56ps) will be achieved. Instead, the share price will be driven by<br />

earnings and dividend downgrades and potential growing concerns over the<br />

impact of the tax on balance sheet gearing. Hence we have cut our fair value by<br />

15% to €47ps. RWE remains a Sell.<br />

http://www.execution-noble.com<br />

SELL<br />

12.5% downside<br />

Fair Value €47.00<br />

RIC, Bloomberg Code RWEG.DE, RWE GY<br />

Share Price €53.70<br />

Market Capitalisation €28,629<br />

Free Float 78.0%<br />

EUR 2009A 2010E 2011E 2012E<br />

Revenues m 47,741 49,557 50,628 51,653<br />

EBITDA m 9,165 10,041 9,682 10,051<br />

EPS 5.59 7.08 5.86 5.86<br />

DPS 3.50 3.55 3.10 3.22<br />

FCF ps 6.05 3.94 3.91 4.22<br />

EV 62,177 62,177 62,177 62,177<br />

Net Debt 13,782 15,328 18,123 20,068<br />

Net Debt/Ebitda 1.5 1.5 1.9 2.0<br />

At Current Price: 2009A 2010E 2011E 2012E<br />

PE 9.6 7.6 9.2 9.2<br />

EV/Ebitda 6.8 6.2 6.4 6.2<br />

Dividend Yield (%) 6.5% 6.6% 5.8% 6.0%<br />

FCF Yield (%) 11.3% 7.3% 7.3% 7.9%<br />

At Target Price: 2009A 2010E 2011E 2012E<br />

PE 8.4 6.6 8.0 8.0<br />

EV/Ebitda 5.8 5.3 5.5 5.3<br />

Dividend Yield (%) 7.4% 7.6% 6.6% 6.9%<br />

Analysts<br />

Lawson Steele<br />

+44 20 3364 6771<br />

lawson.steele@execution-noble.com<br />

Andrew Fisher<br />

+44 20 3364 6773<br />

andrew.fisher@execution-noble.com<br />

Page 41 of 44


THIRD QUARTER 2010<br />

RWE<br />

Key Metrics 2007A 2008A 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

Recommendation Sell Execution adj P/E 9.8 8.0 9.6 7.6 9.2 9.2 12.0 10.6 9.7<br />

Share Price 53.70 EPS growth 22% -17% 27% -17% 0% -24% 13% 10%<br />

Target Price 47.00 EV / EBITDA #DIV/0! 7.1 6.8 6.2 6.4 6.2 6.7 6.3 6.0<br />

Upside / Downside -12.5% FCF Yield 13.8% 23.9% 11.3% 7.3% 7.3% 7.9% 8.5% 11.1% 12.3%<br />

Previous target price na Dividend yield 5.9% 8.4% 6.5% 6.6% 5.8% 6.0% 5.0% 5.2% 5.7%<br />

% change to previous target price na DPS growth 43% -22% 1% -13% 4% -17% 3% 10%<br />

SOP DCF/EVA 55.99 Net Debt / EBITDA #DIV/0! 1.9 2.9 2.8 3.2 3.2 3.7 3.5 3.6<br />

ROIC -5.3% 16.6% 15.2% 12.8% 10.8% 10.2% 8.5% 8.8% 9.0%<br />

Bloomberg RWE GY Equity<br />

T-One 0 Key Drivers 2007A 2008A 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

Model Published On 05 Jul 2010<br />

Achieved Power Price (core EUR/MWh) 47.00 58.00 70.00 61.00 56.07 54.47 55.13 57.15 58.42<br />

Market Cap 28,629 Output sold forward (core market) 100.0% 100.0% 100.0% 100.0% 70.0% 30.0% 0.0% 0.0% 0.0%<br />

Economic Net Debt (ie inc nuclear provisions) 30,669 Achieved Coal Price (core EUR/MWh) 76.45 106.39 114.95 96.71 96.99 100.90 106.11 113.78 117.34<br />

Adjustments For Associates & Minorities 925 Achieved Gas Price (core EUR/MWh) 20.64 21.33 19.82 18.63 21.73 24.02 25.30 25.66 25.66<br />

Enterprise Value 62,177 Achieved CO2 Price (EUR/t) 10.50 14.20 18.87 14.38 15.03 15.92 16.72 17.26 17.26<br />

o/w nuclear provisions 9,051<br />

Forthcoming Catalysts<br />

P&L Summary (EURm) 2007A 2008A 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

1H 2010 Results 12 Aug 2010 Revenue 42,507 48,950 47,741 49,557 50,628 51,653 53,343 55,094 55,996<br />

3Q 2010 Results 11 Nov 2010 EBITDA by division<br />

Germany 0 5,545 5,811 6,419 5,373 5,313 4,065 4,100 3,999<br />

Netherlands/Belgium 0 0 277 635 666 706 788 862 886<br />

United Kingdon (npower) 0 714 445 537 687 615 442 520 615<br />

Execution Analysts Central & Eastern Europe 0 1,142 1,285 1,083 1,072 1,073 1,086 1,110 1,126<br />

Lawson Steele / Andrew Fisher Renewables 0 103 126 251 516 760 979 1,188 1,394<br />

(44) 20 3364 6771 / 6773 Gas, Oil and Trading 0 1,235 1,423 1,052 1,304 1,520 1,838 2,074 2,341<br />

lawson.steele@execution-noble.com / andrew.fisher@execution-noble.com EBITDA 0 8,773 9,165 10,041 9,682 10,051 9,261 9,917 10,425<br />

% change #DIV/0! #DIV/0! 4.5% 9.6% -3.6% 3.8% -7.9% 7.1% 5.1%<br />

Company contacts % margin 0.0% 17.9% 19.2% 20.3% 19.1% 19.5% 17.4% 18.0% 18.6%<br />

Dr Jurgen Grossman CEO o/w associates 0 0 0 0 0 0 0 0 0<br />

Dr Rolf Pohlig CFO Depreciation & Amortisation 0 (1,947) (2,075) (2,414) (2,582) (2,781) (2,971) (3,069) (3,153)<br />

Ingo Alpheus IR head EBIT 0 6,826 7,090 7,627 7,100 7,270 6,290 6,848 7,272<br />

% change #DIV/0! #DIV/0! 3.9% 7.6% -6.9% 2.4% -13.5% 8.9% 6.2%<br />

EBITDA Breakdown (2010) % margin 0.0% 13.9% 14.9% 15.4% 14.0% 14.1% 11.8% 12.4% 13.0%<br />

Gas, Oil and<br />

Renewables Trading<br />

3% 11%<br />

Central &<br />

Eastern<br />

Europe<br />

11%<br />

Net Financials<br />

Exceptional items<br />

Pre Tax Profit<br />

Income Tax Expense<br />

Disconitinued Operations<br />

(1,138)<br />

(149)<br />

5,246<br />

(2,081)<br />

(274)<br />

(1,475)<br />

(485)<br />

4,866<br />

(1,423)<br />

(567)<br />

(1,990)<br />

498<br />

5,598<br />

(1,858)<br />

91<br />

(1,804)<br />

0<br />

5,824<br />

(1,790)<br />

0<br />

(1,913)<br />

0<br />

5,187<br />

(1,803)<br />

0<br />

(2,083)<br />

0<br />

5,187<br />

(1,802)<br />

0<br />

(2,201)<br />

0<br />

4,089<br />

(1,444)<br />

0<br />

(2,310)<br />

0<br />

4,539<br />

(1,586)<br />

0<br />

(2,338)<br />

0<br />

4,933<br />

(1,710)<br />

0<br />

United<br />

Kingdon<br />

(npower)<br />

5%<br />

Netherlands/<br />

Germany<br />

64%<br />

Minority Interests<br />

Net Income<br />

Execution Net Income<br />

224<br />

2,891<br />

3,314<br />

318<br />

2,876<br />

3,928<br />

260<br />

3,831<br />

3,242<br />

260<br />

4,033<br />

4,033<br />

5.3%<br />

260<br />

3,384<br />

3,384<br />

260<br />

3,385<br />

3,385<br />

260<br />

2,645<br />

2,645<br />

260<br />

2,953<br />

2,953<br />

260<br />

3,223<br />

3,223<br />

Belgium<br />

6%<br />

Reported EPS<br />

Execution EPS<br />

4.74<br />

5.49<br />

4.75<br />

6.71<br />

6.70<br />

5.59<br />

7.08<br />

7.08<br />

5.86<br />

5.86<br />

5.86<br />

5.86<br />

4.47<br />

4.47<br />

5.05<br />

5.05<br />

5.56<br />

5.56<br />

DPS 3.15 4.50 3.50 3.55 3.10 3.22 2.68 2.78 3.06<br />

Payout Ratio 57.3% 67.1% 62.6% 50.2% 52.9% 55.0% 60.0% 55.0% 55.0%<br />

Group ROIC vs WACC Weighted average shares in issue (m) 562 538 533 533 533 533 533 533 533<br />

18.0%<br />

Cash Flow Summary (EURm) 2007A 2008A 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

16.0%<br />

14.0%<br />

12.0%<br />

10.0%<br />

8.0%<br />

6.0%<br />

Operating cash flow<br />

Maitenance capex<br />

Free Cash Flow<br />

Growth capex<br />

Acquisitions & Disposals + Other<br />

Cash used for investing<br />

6,085<br />

(1,923)<br />

4,162<br />

(2,142)<br />

(418)<br />

(4,483)<br />

8,853<br />

0<br />

6,906<br />

0<br />

(3,584)<br />

(3,584)<br />

5,299<br />

0<br />

3,224<br />

0<br />

(8,326)<br />

(8,326)<br />

6,335<br />

0<br />

2,100<br />

0<br />

(6,015)<br />

(6,015)<br />

5,900<br />

0<br />

2,083<br />

0<br />

(6,802)<br />

(6,802)<br />

6,103<br />

0<br />

2,252<br />

0<br />

(6,395)<br />

(6,395)<br />

5,512<br />

0<br />

2,421<br />

0<br />

(5,580)<br />

(5,580)<br />

5,914<br />

0<br />

3,184<br />

0<br />

(4,959)<br />

(4,959)<br />

6,320<br />

0<br />

3,511<br />

0<br />

(7,037)<br />

(7,037)<br />

4.0%<br />

Cash used for financing (2,458) (5,617) 4,904 (1,394) 902 292 68 (954) 716<br />

2.0%<br />

ROIC Group WACC<br />

o/w Dividends Paid To Shareholders (2,199) (2,005) (2,592) (1,866) (1,893) (1,653) (1,719) (1,431) (1,481)<br />

0.0%<br />

Net Cash Flow (872) (673) 1,825 (1,074) 0 0 0 0 0<br />

2008A 2009A 2010E 2011E 2012E 2013E<br />

Balance Sheet Summary (EURm) 2007A 2008A 2009A 2010E 2011E 2012E 2013E 2014E 2015E<br />

EPS Forecasts vs Consensus (EUR ps) Cash & Equivalents 12,780 8,984 6,364 5,290 5,290 5,290 5,290 5,290 5,290<br />

Tangible Fixed Assets 29,478 30,561 39,243 42,844 47,064 50,679 53,288 55,178 59,062<br />

10.00<br />

Intangible Non-Current Assets 11,882 11,202 17,320 17,320 17,320 17,320 17,320 17,320 17,320<br />

8.00<br />

6.00<br />

Other Assets<br />

Total Assets<br />

Interest Bearing Debt<br />

29,280<br />

83,420<br />

13,285<br />

42,683<br />

93,430<br />

13,483<br />

30,511<br />

93,438<br />

20,146<br />

30,992<br />

96,446<br />

20,618<br />

31,276<br />

100,950<br />

23,413<br />

31,547<br />

104,836<br />

25,358<br />

31,995<br />

107,893<br />

27,145<br />

32,459<br />

110,247<br />

27,622<br />

32,697<br />

114,369<br />

29,819<br />

4.00<br />

Other Liabilities 55,476 66,807 59,575 59,944 60,161 60,370 60,713 61,069 61,252<br />

2.00<br />

Total Liabilities (exc equity) 68,761 80,290 79,721 80,562 83,575 85,728 87,858 88,691 91,071<br />

0.00<br />

2007A 2008A 2009A 2010E 2011E 2012E<br />

Shareholders' Equity<br />

Minority Interests<br />

Total Equity<br />

13,925<br />

734<br />

14,659<br />

11,587<br />

1,553<br />

13,140<br />

12,792<br />

925<br />

13,717<br />

14,959<br />

925<br />

15,884<br />

16,450<br />

925<br />

17,375<br />

18,183<br />

925<br />

19,108<br />

19,109<br />

925<br />

20,034<br />

20,631<br />

925<br />

21,556<br />

22,373<br />

925<br />

23,298<br />

Actual EPS<br />

Net Debt 505 4,499 13,782 15,328 18,123 20,068 21,855 22,332 24,529<br />

Economic Net Debt (ie inc nuclear provns) 13,054 17,045 26,328 27,874 30,669 32,614 34,401 34,878 37,075<br />

http://www.execution-noble.com<br />

Page 42 of 44


THIRD QUARTER 2010<br />

Wolters Kluwer<br />

Strategy differences<br />

As key competitors stepped up investments in the legal segment, the<br />

risk of compression in Wolters Kluwer’s operating margins increases,<br />

in our view. Wolters Kluwer is widely considered a defensive stock,<br />

but we believe it is set to underperform peers in the near term. We<br />

reaffirm our sell rating and raise our target price to target price of<br />

€11.2 from €10.6 to reflect recent currency fluctuations.<br />

Different strategy<br />

Both Reed Elsevier and Thomson Reuters have guided for margin decline in their<br />

legal divisions, over and above the below-the-line restructuring charges due to<br />

recent M&A deals. In stark contrast, Wolters Kluwer expects "improved operating<br />

margin” in 2010 though below-the-line charges increased (guidance of eu70m).<br />

Such a difference in strategy (investment for growth VS savings/rationalization)<br />

may arise from a different assessment on the potential economic recovery: the more<br />

conservative the outlook, the lower the level of growth investments one would<br />

expect. However, Wolters Kluwer’s track record seems to suggest that the company<br />

is simply underinvesting which may lead to further pressure on organic revenue<br />

growth and eventually on operating margins. Fig. 1 shows Wolters Kluwer’s legal<br />

division margins compared to Reed Elsevier and Thomson Reuters. Our long term<br />

margins are set below industry average because of higher fragmentation, by<br />

geography (especially in Europe) and by product (compliance, tax, accounting,<br />

regulatory, etc.). For Wolters Kluwer’s operating margins in 2010 we have used<br />

company guidance rather than our forecasts.<br />

Figure 1: Global legal segment - Operating margins by company<br />

35%<br />

33%<br />

31%<br />

29%<br />

27%<br />

25%<br />

23%<br />

21%<br />

19%<br />

17%<br />

15%<br />

1999<br />

2000<br />

2001<br />

Source: ExecutionNoble, Company data<br />

2002<br />

2003<br />

2004<br />

2005<br />

2006<br />

2007<br />

2008<br />

REL - Legal TRI - Legal WKL - Legal<br />

Our estimates are ~17%% below consensus<br />

Our forecasts for organic revenue growth remain unchanged at 1.3% decline for<br />

2010 qnd 0.5% decline for 2011, which we believe are broadly in line with<br />

consensus. In the medium term we forecast group margin compression to 18%-19%,<br />

below consensus and management guidance of 20%+, to reflect the need for the<br />

company to start investing again in content, distribution platforms and sales force.<br />

Valuation<br />

On our forecasts (~17% below consensus for Ordinary EPS 2010-12E, on average)<br />

Wolters Kluwer trades on ~5% premium to industry peers, based on P/E and FCF<br />

yield. Due to its lower growth potential and further earnings downgrade risk, we<br />

believe that Wolters Kluwer should trade on 20% discount to the sector average.<br />

We reiterate our sell rating and raise our DCF-based fair value to €11.2 from €10.6<br />

to reflect favourable currency fluctuations over the past three months.<br />

2009<br />

2010E<br />

http://www.execution-noble.com<br />

SELL<br />

29% downside<br />

Fair Value € 11.2<br />

RIC, Bloomberg Code WLSNc.AS, WKL NA<br />

Share Price € 15.8<br />

Market Capitalisation €4,636m<br />

Free Float 100%<br />

(eu m) 2008A 2009A 2010E 2011E<br />

Turnover 3,374 3,425 3,557 3,644<br />

EBITDA 756 783 755 783<br />

EBITA 678 682 650 676<br />

Adj. EPS (EUR)* 1.47 1.45 1.29 1.35<br />

Dividend (EUR) 0.65 0.66 0.66 0.67<br />

FCF** 381 387 364 409<br />

Net Debt 2,252 2,008 1,969 1,697<br />

* fully diluted, ex. GW amortisation<br />

** FCF = EBITDA - capex - NWC - int ex. - tax<br />

2008A 2009A 2010E 2011E<br />

EV/Sales*** 2.1x 2.0x 2.0x 1.9x<br />

EV/Ebitda*** 9.5x 8.9x 9.3x 8.7x<br />

EV/EBITA*** 10.6x 10.3x 10.8x 10.1x<br />

P/E*** 11.6x 11.7x 13.1x 12.6x<br />

Dividend Yield*** 3.8% 3.9% 3.9% 4.0%<br />

FCF Yield*** 7.8% 7.8% 7.2% 8.0%<br />

Net Debt/Ebitda 3.0x 2.6x 2.6x 2.2x<br />

*** adjusted for pension, tax and other assets/liabilities<br />

Analysts<br />

Giasone Salati<br />

+44 20 7456 1163<br />

giasone.salati@execution-noble.com<br />

Mark Evans<br />

+44 20 3364 6753<br />

mark.evans@execution-noble.com<br />

Page 43 of 44


THIRD QUARTER 2010<br />

Wolters Kluwer<br />

Valuation Metrics 2008A 2009A 2010E 2011E 2012E<br />

Recommendation: SELL Execution P/E 11.6 11.7 13.1 12.6 12.1<br />

Fair Value: EUR 11.2 Reported P/E 14.5 39.3 21.8 18.2 14.7<br />

EV / Sales 2.1 2.0 2.0 1.9 1.8<br />

Share Price: EUR 15.78 EV / EBITDA 9.5 8.9 9.3 8.7 8.2<br />

Upside / Downside -29.0% EV / EBITA 10.6 10.3 10.8 10.1 9.5<br />

FCF Yield 7.8% 7.8% 7.2% 8.0% 8.1%<br />

Previous Fair Value EUR 9.9 Dividend yield 3.8% 3.9% 3.9% 4.0% 4.1%<br />

% change to fair value 13.1%<br />

Bloomberg: WKL NA Key ratios 2008A 2009A 2010E 2011E 2012E<br />

T-One: WKL-AE<br />

Model Published On: 02 July 2010 EBITDA margin 22.4% 22.9% 21.2% 21.5% 21.5%<br />

EBIT margin 16.4% 9.2% 13.8% 14.2% 14.3%<br />

Capex / Revenue 4.1% 3.6% 3.6% 3.6% 3.6%<br />

Shares In Issue (Less Treasury) 294 Capex / Depreciation 0.69 0.26 0.48 0.49 0.50<br />

Market Cap 4,636 Net Debt / EBITDA 3.0 2.6 2.6 2.2 1.8<br />

Net Debt 2,008 EBITDA / Net Interest 6.5 6.4 5.3 5.9 7.1<br />

Adjustments For Associates & Minorities 350 ROE 22% 9% 15% 17% 19%<br />

Enterprise Value 6,994<br />

Net Pension Deficit 117<br />

P&L Summary 2008A 2009A 2010E 2011E 2012E<br />

Forthcoming Catalysts Revenue 3,374 3,425 3,557 3,644 3,741<br />

% change -1.1% 1.5% 3.8% 2.4% 2.7%<br />

AGM 21 April 2010 EBITDA 756 783 755 783 804<br />

Trading update 12 May 2010 % change 1.2% 3.6% -3.6% 3.7% 2.7%<br />

Second quarter results 28 July 2010 % margin 22.4% 22.9% 21.2% 21.5% 21.5%<br />

Trading update 03 November 2010 Depreciation & Amortisation -202 -469 -265 -267 -270<br />

Full year results expected 23 February 2011 EBIT 554 314 490 516 534<br />

% change 1.5% -43.3% 56.1% 5.2% 3.6%<br />

% margin 16.4% 9.2% 13.8% 14.2% 14.3%<br />

Associates -1 2 2 2 2<br />

Execution Analyst Operating Profit 553 316 492 518 536<br />

Giasone Salati Net Financials -116 -123 -143 -132 -113<br />

+44 20 7456 1163 Other Pre-tax Income -51 -80 -70 -45 0<br />

giasone.salati@execution-noble.com Pre Tax Profit 386 113 279 341 423<br />

Income Tax Expense -71 -3 -64 -78 -94<br />

Minority Interests -2 8 0 0 0<br />

Revenue Breakdown Net Income 313 118 215 262 329<br />

Execution Net Income 423 427 385 407 429<br />

Reported EPS 1.08 0.40 0.72 0.87 1.07<br />

Execution EPS 1.47 1.45 1.29 1.35 1.40<br />

DPS 0.65 0.66 0.66 0.67 0.70<br />

Payout Ratio 17.8% 44.5% 44.3% 50.8% 49.8%<br />

Shares In Issue (Less Treasury) 288 294 298 302 307<br />

Cash Flow Summary 2008A 2009A 2010E 2011E 2012E<br />

EBITDA 756 783 755 783 804<br />

Taxes Paid -91 -89 -88 -105 -115<br />

Operating Profit Breakdown Interest Paid / Received -94 -120 -112 -103 -88<br />

Change in Working Capital -19 -7 -18 -12 -13<br />

Margin Trends<br />

Margin<br />

Health<br />

22%<br />

Corporate &<br />

Financial<br />

Services, (NA)<br />

18%<br />

25%<br />

20%<br />

15%<br />

10%<br />

5%<br />

0%<br />

Corporate &<br />

Financial<br />

Services, (NA)<br />

15%<br />

Tax,<br />

Accounting &<br />

Legal (NA)<br />

27%<br />

Health<br />

17%<br />

Tax,<br />

Accounting &<br />

Legal (NA)<br />

33%<br />

Legal, Tax &<br />

Regulation<br />

(EU)<br />

36%<br />

Legal, Tax &<br />

Regulation<br />

(EU)<br />

32%<br />

2008A 2009A 2010E 2011E 2012E<br />

EBITDA margin EBIT margin<br />

Other Operating Cash Flow -31 -57 -45 -22 -34<br />

Operating cash flow 521 510 492 541 555<br />

Capital Expenditure -140 -123 -128 -132 -136<br />

Free Cash Flow 381 387 364 409 419<br />

Acquisitions & Disposals -665 -54 0 0 0<br />

Dividends Paid To Shareholders -125 -125 -134 -136 -141<br />

Equity Raised / Bought Back 0 0 0 0 0<br />

Other Financing Cash Flow 602 -144 -191 0 0<br />

Net Cash Flow 193 64 39 273 278<br />

Balance Sheet Summary 2008A 2009A 2010E 2011E 2012E<br />

Cash & Equivalents 345 409 409 409 409<br />

Tangible Fixed Assets 146 135 158 183 208<br />

Goodwill & Intangibles 4,600 4,226 4,066 3,906 3,746<br />

Associates & Financial <strong>Investment</strong>s 71 41 43 45 47<br />

Other Assets 1,226 1,242 1,169 1,114 1,054<br />

Total Assets 6,388 6,053 5,846 5,657 5,464<br />

Interest Bearing Debt 2,597 2,417 2,378 2,106 1,827<br />

Other Liabilities 2,344 2,281 2,031 1,989 1,886<br />

Total Liabilities 4,941 4,698 4,409 4,094 3,713<br />

Shareholders' Equity 1,414 1,334 1,415 1,541 1,730<br />

Minority Interests 33 21 21 21 21<br />

Total Equity 1,447 1,355 1,436 1,562 1,751<br />

Net Debt 2,252 2,008 1,969 1,697 1,418<br />

http://www.execution-noble.com<br />

Page 44 of 44


IMPORTANT INFORMATION<br />

Analyst Certifications<br />

Each of the research analysts referenced in connection with the section of this research report for which he or she is responsible hereby certifies that all of the views expressed<br />

in this report accurately reflect my personal views about any and all of the subject securities or issuers discussed herein.<br />

In addition, each of the research analysts referenced in connection with the section of this research report for which he or she is responsible hereby certifies that no part of his or<br />

her compensation was, is, or will be, directly or indirectly related to the specific recommendations or views that he or she has expressed in this research report, nor is it tied to<br />

any specific investment banking transactions performed by Execution Noble Limited its Group or affiliates thereof.<br />

Explanation of rating system<br />

A rating of Buy indicates that the analyst has a high conviction that the stock will outperform their relevant sector index over the next twelve months.<br />

A rating of Sell indicates that the analyst has a high conviction that the stock will underperform their relevant sector index over the next twelve months.<br />

A rating of Hold indicates that the analyst believes that the stock should perform in line (+ or – 5%) with their relevant sector index over the next twelve months.<br />

The relevant sector index is the DJ Stoxx sector subgroup which includes the subject company.<br />

Distribution of Execution Noble Recommendations for <strong>Investment</strong> Research (End May 2010 - Rolling twelve month basis)<br />

All stocks Corporate Clients<br />

Buy 81 43% 9 100%<br />

Hold 49 26% 0 0%<br />

Sell 59 31% 0 0%<br />

*This distribution of recommendations is data from Execution Noble Limited for the past 12 months; this excludes data from Clear Capital Limited prior to 22nd February<br />

2010.<br />

The Corporate relationships disclosed are for the past 12 months.<br />

The historic Clear Capital Limited ratings regime classified stocks as Positive, Negative, Neutral and Corporate. The table below explains how they are now classified.<br />

Historic Rating Convention Current Rating Convention<br />

Positive Buy<br />

Negative Sell<br />

Neutral Hold<br />

Corporate Either dropped coverage or initiated with a buy, Sell or Hold rating<br />

<strong>Investment</strong> Research Disclaimer<br />

This <strong>Investment</strong> Research is independent and does not constitute a personal recommendation as defined in the Glossary of the FSA Handbook.<br />

This material constitutes "investment research" for the purposes of the Markets in Financial Instruments Directive and as such contains an objective or independent<br />

explanation of the matters contained in the material. Any recommendations contained in this document must not be relied upon as investment advice based on the<br />

recipient's personal circumstances.<br />

In the event that further clarification is required on the words or phrases used in this material, the recipient is strongly recommended to seek independent legal or financial<br />

advice.<br />

This research report has been prepared by Execution Noble Limited and is for information purposes only. This research report does not constitute an offer, invitation or<br />

inducement to invest in securities or other investments. Neither the information contained in this research report nor any further information made available with the subject<br />

matter contained herein will form the basis of any contract.<br />

This research report does not purport to be comprehensive or to contain all the information on which a prospective investor may need in order to make an investment<br />

decision. The information contained herein is based on publicly available information and sources, which we believe to be reliable, but we do not represent it as accurate or<br />

complete. The recipient of this research report must make its own investigation and assessment of the information presented herein. No representation, warranty or<br />

undertaking, express or implied, is or will be made or given and no responsibility or liability is or will be accepted by Execution Noble Limited or by any of its directors,<br />

officers, employees, agents or advisers, in relation to the accuracy or completeness of this presentation or any other written or oral information made available in<br />

connection with the information presented herein. Any responsibility or liability for any such information is expressly disclaimed.<br />

In furnishing this research report, Execution Limited undertakes no obligation to provide the recipient with access to any additional information, or to update, or to correct<br />

any inaccuracies, which may become apparent in this presentation or any other information made available in connection with the information presented herein.<br />

All prices provided within this research report are taken from the close of business on the day prior to the issue date unless explicitly otherwise stated.<br />

Please note that Execution Noble Limited is part of the Execution Holdings Limited group of companies. Lloyds <strong>Bank</strong>ing Group has a shareholding of 8% in Execution<br />

Holdings Limited.<br />

Any opinion reflects the analyst’s judgment at the date of publication and neither Execution Noble Limited, nor any of its affiliated or associated companies, nor any of their<br />

directors, officers or employees accepts any responsibility in respect of the information or recommendations contained herein which, moreover, are subject to change<br />

without prior notice.<br />

This research report is private and confidential and is being made available to the recipient on the understanding that it will be kept confidential and that the recipient shall<br />

not copy, reproduce, distribute or pass to third parties this research report in whole or in part at any time. It is intended for the information of clients only and is not for<br />

publication in the press nor is it being issued or distributed to persons who are retail clients.<br />

The material in this research report is general information intended for recipients who understand the risks associated with investment. It does not take account of whether<br />

an investment, course of action, or associated risks are suitable for the recipient.<br />

Execution Noble may provide services (including Corporate Finance, Corporate Broking or Equity Capital Markets advice) where the flow of information is restricted by a<br />

Chinese Wall. Accordingly, information may be available to Execution Noble that is not reflected in this document.<br />

This document is intended to be used by market professionals (eligible counterparties and professional clients but not retail clients). Retail clients must not rely on this<br />

document and should note that the services of Execution Noble Limited are not available to them.<br />

This research report has been prepared by Execution Noble Limited, who are a correspondent of Execution Noble LLC, 102 Greenwich Avenue, Greenwich, CT06830.<br />

Execution Noble LLC are distributing this research report in the US and accept responsibility for its contents subject to the terms set out herein. Any US persons receiving<br />

this research report and wishing to effect a transaction in any security discussed herein, should do so only with Execution Noble, LCC or an individual registered therewith.<br />

Execution Noble Limited is registered in England and Wales no. 4058971, is a Lloyds Broker, a member of The London Stock Exchange, Xetra, Virt-x, EuroNext,<br />

NYSE Liffe and Nasdaq OMX and is authorised and regulated by the Financial Services Authority.<br />

Please see UK Equity Research Conflicts Management Policy on http://www.execution-noble.com/ResearchConflictsPolicy<br />

Please see UK Disclosures for <strong>Investment</strong> Research Recommendations on http://www.execution-noble.com/<strong>Investment</strong>ResearchDisclosures


UK<br />

LONDON<br />

Execution Noble Ltd<br />

The Old Truman Brewery<br />

91 Brick Lane<br />

London E1 6QL<br />

UK<br />

T +44 20 7456 9191<br />

F +44 20 7456 9188<br />

EDINBURGH<br />

Execution Noble Ltd<br />

76 George Street<br />

Edinburgh<br />

EH2 3BU<br />

UK<br />

T +44 131 225 9677<br />

F +44 131 225 5831<br />

<strong>SILVER</strong> <strong>BULLETS</strong><br />

EUROPE<br />

PARIS<br />

Execution Noble Ltd<br />

59 Rue des Petits Champs<br />

75001<br />

Paris<br />

France<br />

T +33 1 73 77 55 78<br />

F +33 1 73 77 55 75<br />

USA<br />

GREENWICH<br />

Execution Noble LLC<br />

102 Greenwich Avenue<br />

Greenwich<br />

CT 06830<br />

United States<br />

T +1 203 983 EXEC (3932)<br />

F +1 203 869 3937<br />

BOSTON<br />

Execution Noble LLC<br />

22 Batterymarch Street<br />

Boston<br />

MA 029109<br />

United States<br />

T +1 617 531 7080<br />

F +1 617 451 1089<br />

MANHATTAN<br />

Execution Noble LLC<br />

450 Park Avenue, Suite 2700<br />

New York<br />

NY 10022<br />

United States<br />

T +1 212 843 8805<br />

F +1 212 486 2843<br />

ASIA<br />

HONG KONG<br />

Execution Noble (Hong Kong) Ltd<br />

15th Floor, St John’s Building<br />

33 Garden Road, Central<br />

Hong Kong SAR<br />

China<br />

T +852 3181 4050<br />

F +852 3575 9001<br />

MUMBAI<br />

Execution Noble Ltd<br />

701 Powai Plaza Hirandani Gardens<br />

Powai<br />

Mumbai - 400 076<br />

India<br />

T +91 22 2570 1152/3<br />

F +91 22 2570 1154

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!